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This thesis sought to expand upon the synthetic application of the underexploited 
ipso, ortho diene cis-diol microbial arene oxidation product from benzoic acid.  
 
The microbial oxidation of benzoic acid by mutant strains of bacteria to give the 
ipso, otho diene cis-diol may be considered to be a green and clean method. This 
biocatalytic route yields large quantities of an enantiopure chiral building block, 
which is not assessable via traditional synthetic methods.  
 
The fermentation product has seen application towards the synthesis of 
aminocylitols, which have been tested for their biological activity. Attempts to 
synthesise the fully oxygenated counterparts, cyclitols, were investigated. 
Expansion of previous work using a bromine substituted derivative led to a range of 
cross-coupled and iron co-ordinated products. Finally, a range of novel chiral acids 
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1 Introduction: Microbial Arene Oxidation 
1.1 Sustainable biocatalysis 1,2 
Chemical transformations that are cleaner, more efficient, environmentally benign 
and cost effective are becoming ever more prevalent within the chemical industry 
and in research. This can be surmised by the growth in the field of green chemistry, 
which addresses all of these issues to ensure that chemical manufacture remains a 
key and prominent industry which grows and develops in a sustainable manner so 
that future generations can expect products for a quality of life to which we are 
accustomed. 
 
Traditional synthetic methods have in most (but not all) cases their known hazards, 
risks and costs, associated with the process. For example most transformations 
require the use of volatile organic solvents, toxic and hazardous reagents, 
occasionally forcing reactions conditions (with the associated energy requirements) 
and the use of precious metals, although hopefully in catalytic amounts.  
 
Biocatalysis is the use of an enzyme, either isolated or whole cell, which catalyses a 
chemical transformation. As an alternative to traditional synthesis, biocatalysis 
presents many benefits. Biological systems require mild reaction conditions and 
often produce non-toxic waste. Additionally they often proceed with very high 
degrees of regio–, stereo– and enantioselectivity.  This selectivity is attributed to 
the specific size and shape of the folded proteins that make up the enzyme active 
site environment. As a result biocatalysis often functionalises a compound in ways 
which traditional chemical synthesis cannot. 
 
Despite this biocatalysis does have its downfalls and barriers to implementation; 
including difficulty of enzyme isolation, necessity of co-factors, optimisation being 
required due to the differences between cellular and industrial setting and the need 
for expensive and specialised equipment which require specialised training and 
knowledge.  
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Overall, if applied correctly, biocatalysis can be viewed as a sustainable alternative 
to traditional synthesis. 
1.2 Traditional synthetic methods which disrupt aromaticity 
Selective oxidation of aromatic compounds is traditionally difficult to achieve due to 
the high stability of the aromatic system. Only a few synthetic methods are known 
to permanently disrupt this stable aromaticity, without cleaving the ring. These 
reactions often require harsh reaction conditions and use or produce toxic or 
hazardous substances, which is obviously undesirable. 
 
 
Scheme 1: Reduction and oxidation of aromatic compounds. 
 
One of the few examples that demonstrates the de-aromatisation of arenes is the 
Birch reduction 1 → 2.3 This achieves the 1,4 reduction of aromatic rings to the 
corresponding cyclohexadienes using alkali metals (e.g. Li, Na, K) dissolved in liquid 
ammonia in the presence of an alcohol.  However, this procedure entails 
undesirable hazards associated with the use of highly reactive metal reagents and 
toxic liquid ammonia. Scheme 1. 
 
Recently the complete reduction of benzene has been reported with the use of a 
water soluble rhodium catalyst in a biphasic system 1 → 3.4 The work demonstrated 
high catalytic activity, excellent thermal stability and good catalytic recovery 
facilitated by the biphasic system. Scheme 1. 
 
Many iron and other metal based catalysis are noted to be able to oxidise aromatic 
species,5 however this only temporarily disrupts the aromaticity within the 
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transition state of the reactions. The driving force for the completion of the reaction 
is often the re-aromatisation step. 1 → 4. Scheme 1. 
 
Perhaps the most relevant transformation relating to this project was pioneered by 
Motherwell in 1995. He sought a simple chemical method to produce diene diols as 
building blocks for biologically important molecules such as conduritols and 
inositols. The method involved a photochemically induced charge transfer between 
osmium tetroxide and benzene 1. The presence of a suitable oxygen transfer 
reagent, either barium chlorate or bromate, led to formation of an osmate esters of 
benzene dihydrodiol 5, which with further processing led to the synthesis of cyclitol 
derivatives 6 and 76 and later (±)-pinitol 107. Scheme 2. 
 
Scheme 2: Motherwell et al., 6,7 Catalytic Photoinduced Charge-Transfer Osmylation. 
Reagents and conditions: a) i) OsO4 (cat.), hν, Ba(ClO3)2; ii) Ac2O, Et3N, DMAP, 6 5%, 7 31%; b) i) OsO4 
(cat.), hν, NaBrO3; ii) pTSA, acetone, H2O, 8%; c) K2CO3, MeOH, Δ, 83%; d) i)Al2O3, MeOH , Δ; ii) H2O, 
THF, HCl, 60%. 
 
Related to the work of Motherwell, Que et al. sought a bio-inspired catalyst to 
mimic the oxidation of aromatic compounds by bacteria 11 → 12. Insertion of the 
diol moiety breaks the aromaticity of the naphthalene starting material. This is the 
only known chemical example which mimics a bacterial transformation of the type 
with which this thesis is concerned and has helped to further the understanding of 
the role of the iron centre present in the enzymes that carry out these oxidative 
transformations. 8,9 Scheme 3. 
 




 TPA = tris(2-pyridylmethyl)-amine) 
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1.3 Microbial arene oxidation (MAO) 
As highlighted above, disrupting the aromaticity is difficult to achieve via traditional 
synthetic means. A recent review in 2011 highlighted the importance of 
dearomatisation strategies in the synthesis of complex natural products. This review 
noted the importance of microbial arene oxidation (MAO) as a viable alternative to 
traditional synthetic methods, and detailed its use in synthesis. 10 
Microbial arene oxidations are performed by bacteria which contain dioxygenase 
enzymes. Dioxygenase enzymes are known to occur within certain soil bacteria 
which have the ability to metabolise and mineralise aromatic compounds. The full 
degradation pathway of aromatic compounds by this class of bacteria is shown 
below. 11 Scheme 4. 
 
Scheme 4: Benzene degradation pathway 
 
Mutant strains of the bacterium containing the dioxygenase enzyme which are 
blocked in the DHB (1,2-dihydro-1,2-dihydroxybenzoate) pathway accumulate and 
excrete the cis-diol 13, which can be isolated and used in synthesis.12 Scheme 4. 
 
Scheme 5: Transformation of toluene with Pseudomonas putida F1 
 
This transformation was first reported by Gibson in 1968, who successfully isolated 
and identified the cis-dihydrodiol product 21 from the oxidation of toluene 20 with 
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P. putida F1. Scheme 5.13 Since the time of Gibson the area of microbial arene 
oxidation has seen rapid expansion, today over 400 arene cis-diol products have 
been reported and their use and application to synthesis is vast. 2,12,14 
1.4 Classes of microbial arene oxidation 
1.4.1 Common classes of microbial arene oxidation 
Many different microorganisms, including naturally occurring, mutant and 
genetically modified recombinant strains have been reported to contain 
dioxygenase enzymes which can carry out MAO. These dioxygenase enzymes are 
classified due to their substrate specificity. The vast majority of organisms express 
toluene dioxygenase (TDO) 20 – 21, other significant classes include naphthalene 
dioxygenase (NDO) 11 – 22 and biphenyldioxygenase (BPDO) 23 – 24. Scheme 6. 
These classes of enzyme are not as tightly defined as the term suggests as in many 
cases there is no such specificity and several enzymes act on a number of different 
substrates.  
 
Scheme 6: Microbial arene oxidation classes 
 
Nevertheless these transformations are well understood and reliable predictive 
models have been developed for these enzyme classes. The transformations are 
known to occur with high levels of regio– and stereospecificity. Boyd et al.,15 
investigated the dihydroxylation of a variety of 1,4-disubstituted benzenes, 25, and 
measured and compared their associated enantioselectivities of the corresponding 
diols, 26. Their conclusions led to a predictive model for the observed 
enantioselectivities based on the size of either substituent. If L>S high 
enantioselectivities are observed and a single cis-diol enantiomer is obtained. In 
contrast if L≈S (e.g. L = F, S = H) enantioselectivities dramatically decrease. He 
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concluded that size of the substituents was a dominant factor in the selection of 
which bond is preferentially oxidized. Scheme 7. 
 
Scheme 7: Boyd’s model for size and selectivity of dihydroxylation products. 15 
 
Possible problems with the use of mutant strains of the dioxygenase enzyme is that 
the blocked DHB dioxygenase pathway, which allows for the accumulation of  the 
desired cis-diol product, may become reactivated if the bacteria is stressed and may 
need to metabolise the cis-diol for energy. The use of recombinant dioxygenase 
expression in Escherichia coli prevents the reactivation of DHB dioxygenase, as it is 
no longer present. TDO, the most commonly used dioxygenase enzyme has been 
readily expressed in E. coli over a number of different generations and mutations. 
The use of E. coli enables faster turnover and greater stability in the production of 
the microbial oxidation product.16 
1.4.2 Less common MAO class: Benzoate Dioxygenase (BZDO) 
An example of a less common class of microbial arene oxidation enzyme is that of 
benzoate dioxygenase 29 → 30.  In comparison to the more common classes of 
dioxygenase as described above, the BZDO dioxygenase enzyme displays not only 
different regioselectivity but the opposite sense of enantio-induction. e.g. the 
substrate is oxidised ipso, ortho as shown in B as opposed to ortho, meta as shown 
by A. Scheme 8. 
 
Scheme 8: Benzoate dioxygenase transformation. 
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There are few BZDO containing bacteria prevalent in the literature, the most 
commonly reported strains include Ralstonia eutropha B917, P. putida U10318 and P. 
putida KTSY0119. 
Oxidation of benzoic acid by bacteria was first reported in 1948.20 Not until 1971 did 
Reiner and Hegeman first report the breakdown of benzoic acid by a mutant strain 
of bacteria, R. eutropha B9 (formerly Alcaligenes eutrophus), blocked in the DHB 
dioxygenase pathway, and isolate diene cis-dihydrodiol 30. Scheme 8B.21 
This chemical oxidation of benzoic acid is considered to be a unique transformation 
as there is no equivalent in synthesis for the insertion of a cis-diol of ipso-ortho 
substitution pattern to benzoic acid.16 
1.4.3 Halogenated substituents in MAO  
A common substrate utilised in TDO dihydroxylation is bromo benzene 31, giving 
32. Beneficially, the bromine acts as a synthetic handle to further functionalise the 
compound. The presence of the bromine does not reduce the activity of the 
enzyme. Other substituted benzenes have also been used in TDO containing 
bacteria to widen the substrate and synthetic scope 33 – 36.22-25 When there is 
more than one substituent present enantioselectivities decrease as is the case with 
34 which presents a 20% ee. This is expected as per Boyds predictive models, which 
states with similar size substituents results in a reduction in observed 
enantioselectivities.15,22,23  Scheme 9. 
 
Scheme 9: Substrate scope within TDO 
 
As shown above, TDO can tolerate a variety of substituents on the aromatic ring and 
hence shows great versatility in organic synthesis. In contrast BZDO shows little 
tolerance to aromatic substituents and therefore has less broad synthetic scope. 
There is very little work on the use of substituted benzoates in MAO. In all cases 
work is focused on halogenated benzoates. In consideration of the possible 
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oxidation products of meta-substituted benzoate, it has been suggested that two 
possible products could exist, 38 and 39. These arise due to the different 
orientation of the substrate within the enzyme active site. Scheme 10. 
 
Scheme 10: Two possible products 3- and 5- substituted cis-diols. 
There is little consistency within the literature with regards to the preference for 
formation of either the 3- 38 or the 5- 39 substituted cis-diols, though it has been 
suggested that electron withdrawing and bulky substituents both reduced the rate 
of the biotransformation. This suggests that both steric and electronic effects are 
involved in the rate determining step. 13,21,26-28 
(More detailed literature on halogenated substrates in BZDO can be found at the 
start of Chapter 3, where it finds relevance to the results of the bromobenzoic acid 
MAO product being exploited in synthesis.)  
1.5 Other diols available from bacteria 
We have seen above, that microbial arene oxidation produces cis-diols. Access to 
the biologically derived trans-diol is not so straightforward 29 and has been the 
significant work of Müller et al. This work utilises the biologically derived 
chorismate 40. It was found that chorismate could be subjected to further biological 
transformation using a mutant strain of Klebsiella,30 and later recombinant E. coli.31 
This enabled production of trans-diols 41 – 42 on a large scale (up to 15 gL-1).  
 
Scheme 11: Use of trans-diol in synthesis 
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The synthetic potential for these substrates was realised as the building blocks for 
carbohydrate and cyclitol synthesis, as demonstrated in the synthesis of plant growth 
inhibitor streptol 43,
31
 biologically active epoxides crotepoxide 44 and senepoide 
45
32




1.6 Examples in synthesis 
Dihydrodiol metabolites produced from bacteria, offer a range of functionalities 
which have the possibility to be manipulated further into synthetically and 
biologically interesting complex molecules.  
 
Figure 1: Synthetic utility of dihydrodiols. 
 
Some of these synthetic handles have been highlighted. Figure 1. This next section 
describes some key examples where cis-diol compounds have been utilised in 
synthesis. 
There is a large abundance of organic synthesis research publications which 
showcase the use of microbial arene oxidation in synthesis. The majority of works 
utilise TDO enzymes which have been expressed in E. coli for ease of use and 
stability.  
This section includes a brief overview of the historical examples of MAO in synthesis 
and further discusses the targeted synthesis of cyclitols, inositiols, 
aminocarbasugars, carbasugars and other natural products. 
1.6.1 Historical perspective 
It was not until 20 years after Gibson13 first identified and assigned the 
stereochemistry of the enzymatic dihydroxylation products that synthetic 
applications were found: The earliest known example of microbial arene oxidation 
in synthesis dates back to 1983, where ICI (Imperial Chemical Companies) 
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developed the use of cis-dihydrodiol 13 in the synthesis of polyphenylene 47. 34,35 
Scheme 12.  
 
Scheme 12: Synthesis of polyphenylene from benzene via microbial arene oxidation. 
Reagents and conditions: a) P. putida; b) Ac2O, Py; c) Radical initiator then Δ.   
 
The continued work of Gibson et al. in 1983 exploited NDO in the synthesis of indigo 
50, 36 which was later optimised and scaled up as an industrial process. 37 Scheme 
13. 
 
Scheme 13: Synthesis of indigo 
1.6.2 Cyclitols 
Cyclitols are polyhydroxy-substituted cycloalkanes with at least three hydroxy 
groups, each attached to a different ring carbon atom. Many naturally occurring 
cyclitols are biologically active and hence are interesting targets for organic 
synthesis. 
Ley and co-workers in 1987 was first to realise the potential of the possible 
products from microbial arene oxidation in the synthesis of cyclitols. They 
synthesised a series of highly oxygenated structures: (+) and (–)-pinitol 51, 38 (+)-
conduritol-F 52, myo-inositol and myo-inositol-1,4,5-triphosphate 53.39 Figure 2.  
 
 
Figure 2: Cyclitols, Ley’s work 
 
Further elaborating on Ley’s original work, Hudlicky designed an enantio-divergent 
synthesis of both enantiomers of pinitol 51.40 Scheme 14. This utilises the plane of 
symmetry present in either enantiomer. Using identical reagents but changing their 
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order of addition allowed the two enantiomers to be synthesised from the same 
starting material. Enantio-divergent synthesis has been employed in the synthesis of 
many other cyclitols, carbohydrates and other natural products with latent planes 
of symmetry.41 
 
Scheme 14: Hudlicky 1990 40 enantio-divergent synthesis of pinitol. Reagents and 
conditions: a) DMP, pTSA, acetone, quantitative; b) OsO4, NMO, H2O, acetone, 85%; c) LiAlH4, THF, 
85%; d) mCPBA, CH2Cl2, 86%; e) MeOH, Al2O3, 90%; f) HCl, H2O, acetone. 
 
Later Hudlicky in 2006 also synthesised (–)-conduritol E 63, from di-bromo benzene 
59. Scheme 15.42 Conduritols are a class of cyclitols which contain a derivative 
double bond, and four hydroxyl groups. There are six possible isomeric forms, all of 
which have been synthesised via microbial arene oxidation.43  
 
 
Scheme 15: Hudlicky 1996 42 synthesis of (–)-conduritol E. Reagents and conditions: a) DMP, 
pTSA, acetone, 95%; b) OsO4, NMO, H2O, acetone, 71%; c) nBu3SnH, AIBN, THF, 64%; d) HCl, MeOH, 
81%. 
 
There are many noted advantages of the use of cis-diols in cyclitol synthesis.43 
Firstly MAO offers substrates in high yields and high enantiomeric purities while 
providing the six carbon skeleton of the targeted compounds. The double bonds are 
easily oxygenated via epoxidation or dihydroxylation methods to the desired 
cyclitols. Additionally synthesis is often enantio-divergent, as demonstrated by 
Hudlicky in 1990, allowing access to both enantiomers.44 
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1.6.3 Inositols 
Inositols are structures which consist of a cyclohexane core substituted with six 
hydroxy groups. This gives rise to six contiguous stereocentres, the arrangement of 
which gives rise to nine possible stereoisomers.45  
 
Chemists have extensively studied inositols, due to their important biological 
application including as glycosidase inhibitors, for intercellular communication, 
protein anchoring and phosphate storage.46 Traditional synthetic techniques require 
transformation of simple carbohydrates or oxidation of alkenic compounds, but this 
can be difficult. Microbial arene oxidation offers a technique to give high levels of 
selectivity in the synthesis.43 
 
Carless in 1993 reported synthesis of muco-, chiro-, allo- and epi- inositol 65 – 68 
from meso-diol 31. The work utilised photo-oxidation with singlet oxygen to obtain 
an endo peroxide bridge 64. Scheme 16. 47  
 
 
Scheme 16: Careless 1993, use of singlet oxygen in inositol synthesis. 
 
Subsequent work from Hudlicky 1993 – 2000 48,49 synthesised neo, (+)-chiro, muco, 
allo and myo- inositol from products of microbial oxidation, using similar methods 
and reagents. A more recent publication details the synthesis of neo-inositol 74 in a 
17% overall yield over six steps without need for chromographic purification of any 
of the intermediate compounds.50 Scheme 17. 
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Scheme 17: Inositols from microbial arene oxidation.50 Reagents and conditions: a) DMP, 
pTSA, acetone; then 1,3-dibromo-5,5-dimethylhydantoin, H2O, acetone; b) 10% aq KOH, DME; c) r.t., 
to Δ; d) Bu3SnH, AIBN, benzene, Δ; e) OsO4, NMO, 
t
BuOH, acetone-H2O, f) conc. HCl, MeOH. 
 
Further application of MAO to inositol targets has seen bromo-diene 31 used in the 
targeted synthesis of oligomers of conduritol-F and muco-inositol, which were 
synthesised and evaluated for their glycosidase inhibition.51 Here alcohol 75 was 
used as a nucleophile to couple with epoxide 57 to form an oligomer. Final 




Scheme 18: Conduritol-F from MAO as a glycosidase inhibitor51 Reagents and conditions: a) 
DMP, pTSA, acetone; b) mCPBA, CH2Cl2, 75% 2 steps; c) 57, BF3·OEt2, CH2Cl2, 0 °C, 55%; d) -3.0 V, 
Et4NBr, MeCN; then TFA:THF:H2O (4:1:1), 40%.   
 
Chapter 1    Introduction: Microbial Arene Oxidation 
Page | 14  
1.6.4 Aminocyclitols 
Aminocyclitols pose structural similarities to that of a variety of antibiotics, 
glycosidase inhibitors and other biologically active molecules, and as such they 
prove important synthetic targets for chemists. Aminocyclitols are cycloalkanes 
containing at least one free or substituted amino group and three additional 
hydroxyl groups on the ring atoms. Because of their structural similarity, 
aminocyclitols are often referred to as aminocarbasugars.53 
We have seen that microbial arene oxidation has been applied to cyclitols, 
conduritols and inositols, expansion is therefore straightforward to similar amine 
analogues. 
(This area is reviewed in detail at the beginning of Chapter 2: Aminocyclitols) 
1.6.5 Carbasugar derivatives 
Pseudo sugars or carbasugars also have potential biological activity and can act as 
glycosisdase inhibitors.54 These are usually synthesised from naturally occurring 
sugars or metabolites from plants or bacteria on small scales.  
 
Scheme 19: Boyd sugar derivative work55 Reagents and conditions: a) DMP, pTSA, 98%; b) 
OsO4, NMO, acetone, H2O, 87%; c) Pd(OAc)2, CO, NaOAc, MeOH, 81%; d) Rh/Al2O3, H2; e) BzCl, Py, 
28% 2 steps; f) LiAlH4, 74%; g) TFA, 90%. 
 
Scheme 19 highlights an example of how cis-diols have been used to synthesise 
several sugar analogues 85 – 88. It is worth nothing that in these examples the 
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seventh sugar carbon had to be added onto the six carbon framework of the 
microbial oxidation product, 80 – 81, it would be more step and atom efficient if the 
microbial oxidation product already contained the seven carbon framework. 
1.6.6  Natural product synthesis 
The aminocyclitol motif is found in many natural products for example the 
amaryllidaceae group of alkaloids e.g. pancratistatin 89, narciclasine 90 and 
lycoricidine 91. These have antimicrobial activity against mycobacteria as well as 
possessing anti-tumour and glycosidase inhibition. Again these have been 
synthesised via routes employing microbial arene oxidation. Figure 3.56-58 
 
 
Figure 3: Natural Product Synthesis 
 
Other natural products synthesised from microbial arene oxidation include codeine 
92,41,59 balanol 93 a protein kinase C inhibitor60 and Zeylena 9461 a structurally 
interesting natural product. Figure 3. 
1.7 Benzoate dioxygenase in synthesis 
BZDO has seen few uses in synthesis, there are notably fewer examples of BZDO in 
current literature (i.e. only ≈15 examples as of 2013) than the more common TDO, 
NDO and BPDO.  
 
Widdowson in 1995, reported the first example of BZDO used in synthesis. Scheme 
20. 
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The work utilised P. putida U103 as a source of BZDO, in an attempt to determine 
the absolute stereochemistry of the MAO product. As well as describing 1S, 2R 
stereochemistry of the diol by synthesis of a crystalline derivative, the work also 
sets precedent for [4 + 2] cycloadditions with peroxide 95, nitroso 96 and urazole 97 
dienophiles. The work observed syn addition of the dienophile in the presence of 
the free diol dienes (attributed to a favourable interaction between the diol and 
approaching dienophile). In contrast, when the diol was protected as an acetonide, 
the opposite selectivity was observed and the dienophile added in an anti fashion. 
This was attributed to an unfavourable steric clash between approaching dienophile 
and bulky acetonide group.18 
 
Scheme 20: Widdowson 1995.18 
 
Not until 2001 did Myers et al. realise the synthetic potential of substrates derived 
from the cis-dihydrodiol 30. The work created a library of 16 novel compounds that 
could be used as chiral building blocks in organic synthesis, e.g. 98 – 100. Scheme 
21. The work demonstrated the synthetic utility and robustness of the substrate 30 
under different reaction conditions. Additionally the work also described large scale 
preparation of the cis-diol acid 30, allowing for the process to become more 
accessible to the everyday chemist, who may be unfamiliar with biological 
techniques and processes.17 
 
Scheme 21: Myers work17 
 
Later work by Myers, 2005, developed total syntheses of unnatural deoxycycline 
11262 antibiotic from the product of microbial arene oxidation in which all of the 
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stereocentres were installed under substrate control from the initial benzoate cis-
diol 30. Scheme 22. 
 
Scheme 22: Myers’ antibiotics.62 Reagents and conditions: a) mCPBA, EtOAc, 83%; b) i) TMSCHN2; 
ii) TBSOTf, Et3N, 70%; c) THF, -78 °C, organolithium reagent 103, 73%; d) i) LiOTf, PhCH3, 60 °C; ii) 
TFA, CH2Cl2, 62%; e) i) CBr4, PPh3; ii) PhSH, Et3N, 87%; f) i) chiral oxidant 107; ii) P(OMe)3, MeOH, 70 
°C, 76%; g) i)BnO2CCl, DMAP; ii) TBAF, HOAc; iii) IBX, DMSO; iv) TBSOTf, Et3N 85%; h) LDA, TMEDA, 
THF, -78 °C, 109, -78 °C - 0 °C, 79%; j) i) HF, MeCN; ii) H2, Pd, THF, MeOH, 90%. 
 
In 2004 Parker et al. reported the synthesis of a series of Topiramate analogues 
such as 118, a novel anticonvulsant, in only seven steps from microbial oxidation 
product 30. This highlighted the synthetic utility of the compounds described by 
Myers in 2001. The paper also describes the use of 30 to synthesise carba-β-L-
fructopyranose, a carbohydrate target.63 Scheme 23. 
 
Scheme 23: Parker et al. 63 Reagents and conditions: a) TMSCHN2, MeOH, C6H6, 96%; b) DMP, HCl, 
acetone, 98%; c) OsO4, NMO, t-BuOH, H2O, acetone, 73%; d) H2 Pd/C, EtOAc, 95%; e) DMP, HCl, 
acetone, 80%; f) DIBAL-H, THF, 85%; g) ClSO2NH2, NaH, DMF, 93%. 
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Mihovilovic64,65 with access to R. eutropha B9 concentrated on intramolecular Diels–
Alder reactions using tethered dieneophiles under microwave conditions to produce 
product 120. Scheme 24. 
 
 
Scheme 24: Mihovilovic 2004, 2010. Reagents and conditions: a) i) DMP, pTSA, acetone, 94%; ii) 
EDC, HOBt, Et3N, allylamine, DCM, 83%; b) Microwave 210 °C, 500 min, 28%. 
 
Recent work from Hudlicky in 2011, synthesised the dimeric natural product 
Idesolide 125 in only 4 steps from the microbial oxidation product 30.66 The 
synthetic procedure involved diimide reduction of diene 121 to form a 
regioselective mixture of alkenes 122 and 123 in a 2:1 ratio, of which 122 was 
isolated and oxidised to ketone 124. Dimerisation of 124 was eventually achieved 
with Na2HCO3 to give (–)-idesolide 125 in a 19 % overall yield. This work again 
reiterates the possible ease of fast and efficient synthesis from MAO products. 
Scheme 25. 
 
Scheme 25: Hudlicky 2011.66 Reagents and conditions: a) CH2N2, THF, 0 °C, 79%; b) Potassium 
azodicarboxylate, AcOH, MeOH, 0 °C, 61%; c) IBX, DMSO, 60%; d) NaHCO3, 66%. 
 
The most recent work this year from Hudlicky67 exploited the ipso, ortho diene 30 
for the targeted synthesis of hydroxylated pyrrolidines 135. Polyhydroxylated 
pyrrolidines are interested targets as this structural motif arises in many biologically 
active molecules and natural products. Hudlicky’s synthesis utilised hetero Diels–
Alder methodology through to regioisomers 126 and 127. Ozonolysis and 
subsequent reduction of the ozonide and acylation gave separable isoxazolidine 
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acetates 128 and 129. Hydrolysis and immediate N-O bond reduction with Mo(CO)6 
gave tetrol 130. Oxidative cleavage and acylation gave bis acetate 131. Removal of 
the Boc protecting group with TFA to furnished the stable salt, which under basic 
hydrolysis conditions gave pyrroline 133. Finally hydrogenation and salt formation 
gave final pyrrolidine 1375 Scheme 26.  
 
Scheme 26: Hudlicky67 Pyrrolidines. Reagents and conditions: a) BocNHOH, NaIO4, MeOH, H2O, 
96%; b) i) O3, CH2Cl2, -78 °C, NaBH4; ii) Ac2O, 22%; c) i) K2CO3, MeOH; ii) Mo(CO)6, MeCN, H2O, 87%; d) 
i) SiO2, NaIO4, CH2Cl2, 0 °C; ii) Ac2O, Et3N, DMAP, CH2Cl2, 56%; e) TFA, CH2Cl2, 62%; f) K2CO3, MeOH, 
81%; g) Pd/C, H2, AcOH, H2O, quant; h) MeOH, HCl, 40 °C, 75%. 
1.8 Work originating from the Lewis group 
Much of the work within the Lewis group 2010 – 2013 has centred on the use of the 
benzoate cis-dihydrodiol 30. Work by Ali-Khan et al. 68,69 has concentrated on the 
use of tricarbonyliron(0) co-ordination in order to stabilise or protect the diene 
moiety to obtain structures which would not be accessible with the uncomplexed 
diene, such as synthesis of compound 137 from 136. Scheme 27. Later work 
investigated the facial selectivity of the iron co-ordination and found that when the 
diol was protected as an acetonide 113, co-ordination of the metal to the upper 
face led to unexpected rearrangement of the acetonide 138. Following the removal 
of the iron an arene cis diol with a different substitution could be obtained, 139, 
being ortho, meta substituted, similar to that obtained with TDO but the opposite 
enantiomer. 
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Scheme 27: Ali-Khan et al. 
 
Most recently Ali-Khan utilised iron complexation towards a known intermediate in 
the synthesis of Oseltamivir (Tamiflu®) 145. This work exploits many *η5] cationic 
complexes and susceptibility to nucleophilic addition to obtain a wide library of 
synthetic intermediates. Scheme 28. 
 
Scheme 28: Ali-Khan63,70  Reagents and conditions: a) EtI, CsF, DMF, 23 h, 69%; b) [Fe2(CO)9], THF, 
5 d, 61%; c) i) HBF4, Ac2O. ii) NaBH4, 18 h, MeCN, 0 °C, 39%; d) HBF4, CH2Cl2, 100%; e) iPr2NEt, 




Within the Lewis group use of these iron complexes has seen application to the 
synthesis of the natural product (+)-grandifloracin 150. Scheme 29. 72 
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Scheme 29: Grandifloracin synthesis.72 Reagents and conditions: a) DIBAL-H, THF/CH2Cl2, -78 °C; 
b) BzCl, 2,4,6-collidine, THF, 33% (2 steps); c) MnO2, CH2Cl2, 78%; d) CAN, acetone, 34%.  
 
At the time of this publication, (–)-grandifloracin had been isolated from nature, but 
its absolute configuration was not known. The final material synthesised in this 
study was (+)-grandifloracin 150, and therefore assumed that at the time this 
material was not the natural product. However, further publications have also 
identified and isolated (+)-grandifloracin 150 from a natural source, suggesting both 
enantiomers are natural products. Furthermore, the (+)-grandifloracin 150 has since 
been found to be a potent antiausterity agent against human pancreatic cancer 
cells.73  
 
Expanding on the topic of metal complexation to ipso, ortho diene 30, diverging 
away from the use of iron; Cobalt complexes were investigated 152.74 This brief 
report highlights the viability of cobalt co-ordination to MAO products with 
synthetic applications yet to be scoped. Scheme 30. 
 
Scheme 30: Cobalt complex of MAO product.74 Reagents and conditions: a) PhMe, r.t., 30 mins, 
26% after recrystallisation.  
 
Natural products have been targeted in the total synthesis of zeylenols and 
zeylenones structures from the ipso, ortho diene 153. 75 This work utilises singlet 
oxygen methodology to reach a series of natural products, highlighting novel 
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Kornblum–DeLaMare rearrangement via neighbouring group participation through 
to targeted structures 154 – 156. Scheme 31.  (This work has significant relevance to 
Chapter 3: Cyclitols). 
 
Scheme 31: Synthesis of zeylenols via photooxygenation.75 Reagents and conditions: a) O2, 
TPP, CCl4, 12 h, 10°C, 81-90%; b) iPr2NEt, CH2Cl2, 94-100%; c) thiourea, CH2Cl2/MeOH, r.t., 12 h, 63-
99%.   
 
Additional work has targeted compounds with potential biological activity. 
Structurally similar compounds are known glycosidase inhibitors used for treatment 
of diabetes. In particular three aminocarbasugars 157 – 159, were synthesised and 
tested. However these compounds showed no biological activity. Figure 4.76 
 
Figure 4: Aminocarbasugar synthesis 
1.9 Glycosidase inhibitors 
As shown above by the numerous synthetic examples a common application of 
MAO products is the synthesis of natural products which possess biological activity, 
notably glycosidase inhibition. This section describes in detail that application. 
 
Glycosidases are enzymes that catalyse the cleavage of glycosidic bonds in 
oligosaccharides and glycoconjugates 160 – 161. Scheme 32.54 Glycosidases are 
fundamental to several biological processes including digestion, metabolism as well 
as immune response, intercellular recognition, cellular differentiation and solubility 
of proteins etc.77 
Chapter 1    Introduction: Microbial Arene Oxidation 
Page | 23  
 
Scheme 32: Glycosidase enzyme function 
The two types of glycosidase, α and β, each hydrolyse the corresponding forms of 
the sugar, depending on the stereochemistry of the hydroxyl group at the anomeric 
position. Figure 5. 
 
Figure 5: α and β glycosidases and their transition states 
The mechanism of the breakdown of sugars by glycosidase involves a key transition 
state. Figure 5.54 The intermediates of both α and β glycosidase react via slightly 
different transition states depending on the position of the anomeric hydroxyl 
group. In both transition states there is a syn relationship between the attacking 
nucleophilic oxygen from the carboxyl group and the anomeric carbon. In the α 
case, the other carboxyl oxygen interacts directly with the endocyclic oxygen 
developing a oxocarbenium like transition state. In comparison with the β case the 
remaining carboxy oxygen interacts with the hydroxyl group at C2, favouring 
carbocation formation. 
 
Furthermore both α and β glycosidase can act via two distinctive mechanisms; 
either resulting in inversion or retention of the cleaved glycosidic bond. Below is an 
example of both β glycosidase mechanisms. Scheme 33. Both involve 
oxacarbenium-ion-like transition states and a pair of carboxylic acids at the active 
site.  
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Scheme 33: β-glycosidase mechanisms. Inversion and retention. 
 
In the case of the inversion mechanism, the reaction is completed in a single step 
and via a single transition state structure. The acidic enzyme residues have to be 
approximately 10 Å apart in order to fit both the substrate and the water molecule 
into the enzymatic cavity.   
In contrast, the retaining glycosidase proceeds via a two-step process; first via the 
enzyme being glycosylated which forms an intermediate, which is then broken 
down by nucleophilic water in the deglycosidation step. In this case the enzyme 
residues are approximately 5.5 Å apart.78,79 
 
Common glycosidase inhibitors both natural and synthetic include disaccharides, 
iminosugars, carbasugars and thiosugars. Glycosidase inhibitors interact with their 
targets by mimicing this transition state, hence rendering it either inactive or less 
efficient at metabolising carbohydrates. Glycosidase inhibitors have many potential 
medical applications, and have been studied as HIV agents and treatments for 
diabetes, obesity, glycosphingolipid lysosomal storage disease and cancers.  
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Commercial glycosidase inhibitors include acarbose (Precose®) 162, voglibose 
(Basen®) 163, miglitol (Glyset®) 164 and N-butyl-1-deoxynojirimycin (Zavesca®) 165. 
Figure 6. 162 – 164 are used in the treatment for non-insulin dependent, type II, 
diabetes. These drugs act to reduce postprandial hyperglycemia by interfering with 
the digestion of carbohydrates. While 165 is employed for the control of Gaucher’s 
disease, which relates to disturbed lysosomal storage.  
 
Figure 6: commercially available glycosidase inhibitors. 
 
Concentrating on carba and pseudoamino sugars, these are of great structural 
interest as the cyclic oxygen is replaced with a carbon, which is similar enough in 
structure to fit into the enzymatic site, but does not induce the same level of 
electronic effects as seen in the transition states described above. Additionally the 
presence of a basic nitrogen attached to the ring has been shown to increase the 
hydrophobic interaction within the enzyme pocket. 54  
 
Carbasugars and aminocarbasugars therefore have great potential as glycosidase 
inhibitors, and if synthesised via MAO this could potentially provide sustainable 
routes to biologically active compounds.  
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2 Chapter 2: Aminocyclitols  
2.1 Introduction 
 
Aminocyclitols are poly-hydroxylated cycloalkanes containing at least one free or 
substituted amino group. Aminocyclitols are an interesting class of compounds 
which can serve as effective mimics of natural carbohydrates; this similarity is 
acknowledged in their alternative name of aminocarbasugars.1 The amino 
functionality is fundamental in affecting the biological activity, and lack of the 
endocyclic oxygen leads to enhanced hydrolytic stability.1 2 Several aminocylitols 
possess structural similarities to a variety of antibodies,80 glycosidase inhibitors81 
and other biologically active molecules, and as such they prove important synthetic 
targets for chemists. Natural aminocylitols include antibiotics such as validamycins 
166. Table 1.82,83 Simpler aminocylitols of the inosamine 167 class are found in 
several natural products which display antibiotic characteristics.83 Notably a few 
aminocyclitols are currently in clinical use; e.g. acarbose 162,84 Voglibose 163,85 
miglitol 164 81 (technically an aminosugar, not azacarbasugar) which are α- 
glycosidase inhibitors that are used in the treatment of type II diabetes.86 Figure 7. 
 
 
Validamycin R1 R2 R3 R4 R5 R6 
A H H β-D-Glc H H H 
B H H β-D-Glc H OH H 
C H α-D-Glc β-D-Glc H H H 
D H H H H H α-D-Glc 
E H H 
α-D-Glc(1-4)- 
β-D-Glc 
H H H 
F α-D-Glc H β-D-Glc H H H 
G H H β-D-Glc OH H H 
H H H 
α-D-Glc(1-4) 
-β-D-Glc 
H H H 
 
Table 1: Validamycin R groups 
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Figure 7: Natural and commercially available aminocyclitols 
 
2.1.1 Aminocyclitols from MAO 
The application of MAO towards the formation of a variety of cyclic, poly-
hydroxylated and complex structures including cyclitols, conduritols and inositols 
has been discussed previously in the introduction. Expansion is therefore 
straightforward to similar amine analogues; aminocyclitols.  
The significant difference lies in the chemical procedures utilised to insert the 
nitrogen functionality into this class of compound. This is most often achieved via a 
hetero-Diels-Alder (HDA)  approach, as in Hudlicky 1991, synthesis of Conduramine 
A-1 171.87 Addition of benzyl-N-hydroxycarbamate to BuNIO4 generates the reactive 
acylnitroso in situ which adds to the diene with complete regioselectivity. Reductive 
cleavage of the N-O bond and further transformation gave conduramine 171 in a 
24% overall yield. Scheme 34.  
 
Scheme 34: Hudlicky Conduramine A-1 Synthesis. Reagents and Conditions: a) DMP, acetone, 
pTsOH, 95%; b) nBu4NIO4, benzyl-N-hydroxycarbamate, 52%; c) Al/Hg, THF/H2O, 91%; d) AcOH, 
THF/H2O, 99%; e) H2, Pd/C, MeOH, 54%. 
An alternative method of nitrogen insertion involves alkene epoxidation followed by 
ring opening with a nitrogen nucleophile e.g.  azide,88 phthalimide,89 ammonia90 or 
other amines.91 An example from Carless92 utilises the dihydrodiol MAO product of 
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toluene from P.putida 21. Photooxidation and epoxidation inserts the oxygen 
functionality stereospecifically due to substrate control. The azide attacks 
regioselectively to form 175 followed by reduction and deprotection to give 
aminocyclitol 176 in 18% yield over 6 steps form the MAO product. Scheme 35.  
 
Scheme 35: Carless aminocyclitol sysnthesis azide nitrogen insertion.92 Reagents and 
Conditions:  a) O2, methylene blue, hv; then thiourea, MeOH, 18 h, 53%; b) DMP, acetone, TsOH, 
92%; c) mCPBA, CH2Cl2, 2 days, 61%; d) DMF, H2O (20:1), NaN3, reflux, 20 h, 71%; e) AcOH, H2O (1:9), 
80°C, 1 h, 96%; f) H2, Pt, 50 psi, EtOH, 4 h, 92%. 
 
2.1.2 Tamiflu 
An interesting example of an amine-containing bioactive product is that of 
oseltamivir, or Tamiflu®. The current industrial synthesis relies on the availability of 
naturally occurring pure shikimic acid which can be problematic, additionally the 
process utilises an azide reagent, which on a large industrial scale can present a risk 
of explosion.93  Several different methods have been used to synthesise Tamiflu 
without using shikimic acid, 94 herein we describe approaches which utilize MAO 
derived 1,2 cis–dihydrodiols. 
 
The first from 2008, Fang et al.93 started with commercially available bromo cis–
dihydrodiol 31 transformed regio– and stereoselectively via bromo-acetamidation 
to 177. This was converted to the aziridine 178 which was ring opened with 3-
pentanol to give 179. Bromination gave 181 which was reduced using super hydride 
LiBHEt3 to alcohol 182.  This was converted to the carbamate via the isocyanate to 
give 183, avoiding the previous azide route. Subsequent coupling reactions to 
convert the side chains gave the desired Tamiflu product 186. Scheme 36. 
Chapter 2                                                                                                           Aminocyclitols 
 
Page | 29  
 
 
Scheme 36: Fang Synthesis of Tamiflu.93 Reagents and Conditions: a) i) DMP, acetone, cat. H
+
, 0 
°C to r.t., 0.5 h; ii) cat. SnBr4, NBA, H2O, CH3CN, 0 °C, 0.5 h, 75% 2 steps; b) LHMDS, THF -10 °C to 0 °C, 
0.5 h; c) 3-pentanol, BF3·OEt2, -10 °C to 0 °C, 6 h, 73% 2 steps; d) conc. HCl, MeOH, 50 °C, 6 h, 94%; e) 
AcOCMe2COBr, THF, 0 °C to r.t., 3.5 h; f) LiBHEt3, THF, 0 °C to r.t., 2 h, 82% 2 steps; g) DDQ, PPh3, 
nBu4NOCN, CH3CN, r.t., 18 h, then tBuOH, Δ, 24 h, 78%; h) CuI, DMEDA, nBuOH, 120 °C, 24 h; i) cat. 
[Pd(OAc)2], CO, NaOAc, EtOH, r.t., 24 h, 82% 2 steps; j) H3PO4, EtOH, 50 °C, 6 h, 81%.     
In summary Fang provides an azide free route presenting good yields, 26% over 11 
steps, from the commercially available MAO bromo cis-dihydrodiol. Described as 
hazardous and toxic free, utilising simple procedures Fang intends to work towards 
a large scale synthesis.93  
 
Banwell et al.95,96 in 2008 developed upon Fang’s synthesis providing a route to key 
intermediate 180,  again utilising the MAO derived bromo cis-dihydrodiol 31. 
Banwell sought to use the copper catalysed intramolecular aziridiation97 to afford a 
cyclic carbamate intermediate 192, formed through 3-pentanol ring opening of 
acylaziridine 191. Subsequent basic hydrolysis ring opening of the carbamate, 
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acylation, and acid deprotection of the PMB group gave intermediate 180 from 
Fang’s synthesis.  
 
Scheme 37: Banwell’s Synthesis of key Tamiflu intermediate.95,96 Reagents and Conditions: a) 
pMBDMA, (+)-camphor sulfonic acid, toluene, 0 °C, 1.5 h; b) DIBAL-H, Et3N, toluene, -78 °C to -30 °C, 
5 h, 85%; c) i) CDI, MeCN, 0 °C, 1 h; ii) NH2OH·HCl, imidazole, 0 °C to 18 °C, 16 h, 56%; d) pTsCl, Et3N, 
Et2O, 0 °C to 18 °C, 16 h, 79%; e) Cu(MeCN)4PF6, K2CO3, MeCN, 3-pentanol, 0 °C to 18 °C, 16 h, 43%; f) 
LiOH, 1,4-dioxane, H2O, 100 °C, 48 h, 85%; g) AcCl, Et3N, 0 °C to 18 °C, 1 h, 99%; h) HCl, MeOH, 35 °C, 
16 h, 90%; i) Fang’s synthesis. 
93
      
      
Banwell presents 16 step enantioselective synthesis of Tamiflu, again azide free and 
an alternative to Fang’s.  
 
The most recent synthesis by Hudlicky et al.98  has seen Tamiflu produced in 10 
chemical steps in a 55% overall yield from the MAO derived cis-dihydrodiol 195. It is 
advantageous that the starting material 195 already possesses the ethyl ester side 
chain which instantly reduces the number of transformations needed. Nitrogen is 
inserted via an acylnitroso Diels-Alder cycloaddition to form key intermediate 197, 
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which is reductively opened to form 198. The new protocol avoided the use of azide 
and employed [3,3] oxidative rearrangement to enone 199. This work displays the 
Dauben-Michno oxidative transposition applied to electron withdrawing 
substituents. Formation of the oxime 200 proceeded without need for purification. 
Basic elimination using NaOEt formed alkene product 202. Aziridine formation 
followed by Copper triflate-catalysed ring opening using 3-pentanol gave Boc 
protected Tamiflu product 186.   
 
Scheme 38: Hudlicky TamiFluSynthesis Tamiflu synthesis.98  Reagents and Conditions: a) 
DMP, TsOH, r.t.; b) CH3CONHOH, NaIO4, MeOH, r.t., 88% 2 steps; c) Mo(CO)6, MeCN, H2O, (15:1), 
reflux, 87%; d) CrO3, Ac2O, CH2Cl2, 4 °C, 5 min; e) NH2OH·H2O, EtOH, Py, r.t., 75-82% 2 steps; f) 5% 
Rh/Al2O3, H2 (60 psi), 96% EtOH(aq), (Boc)2O (2-3 equiv), 93%, g) 0.05 M EtONa, EtOH, 94%; h) 
PhMe2P, DIAD, CH2Cl2, 4 °C, 78%; i) 3-pentanol, Cu(OTf)2, 60%; j) H3PO4, EtOH, 50 °C, 6 h, 81%.    
 
In summary, Hudlicky presents a shorted and concise synthesis of Tamiflu. Key 
intermediate 200 can be synthesised on a multi-gram scale in just five steps in 52% 
yield from the MAO cis-dihydrodiol, this suggests that this route could be 
industrially viable.  
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2.2 Project Aims 
The frequent use of the ortho, meta arene cis-dihydrodiols in aminocyclitols 
synthesis has been shown. In contrast the ipso, ortho arene cis-diol has been 
remarkably underexploited. In a single report, originating from the Lewis group in 
2011,76 starting with the MAO product, zwitterionic aminocyclitols, 204, were 
synthesised and tested for their inhibitory activity against a range of glycosidase 
enzymes. In this present work we aim to synthesise aminocyclitols with the side 
chain in the lower oxidation state, 205, in hope that they will have markedly 
different solubilities and biological activity. Figure 8. 
 
Figure 8: Current research aims. 
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2.3 Results and Discussion 
Starting with the ipso, otho arene cis diol 30, formation of acetonide-protected 
methyl ester 113, could be achieved via two routes: Either following the previously 
utilised TMS-diazomethane procedure 12164 or avoiding this expense via the use of 
coupling agents 206.18 Reduction to form the corresponding alcohol 207, was best 
achieved using mild LiBH4. Silyl ether protection of the primary alcohol to form 208, 
was needed so it is not oxidised in subsequent steps. Scheme 39.   
 
 
Scheme 39: Protection of microbial arene oxidation product. 
 
These first protections steps are necessary due to the sensitive nature of these 
MAO derived diene diols as they readily undergo rearomatisation under acidic 209 
or basic conditions 210.99 Notably the ipso, otho arene cis–diols have the ability to 
decompose via a decarboxylation mechanism, which isn’t possible for the more 
common ortho, meta cis–diols. Figure 9. 
 
Figure 9: Rearomatisation of diene diols.  
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In order to form a final product in which there is controlled and predicatble stereo 
chemistry of all ring bound atoms, we considered the acylnitroso hetero Diels–Alder 
methodology. It is well known that oxidation of N-hydroxycarbamate esters 212 
with tetraethylammonium or sodium periodate allows formation of an acyl 
intermediate in situ which is trapped by a diene 211, to give N-alkoxycarbonyl-3,6-
dihydro-2H-l, 2-oxazines 213.  Scheme 40. 100 
 
Scheme 40: Nitroso–Diels–Alder reaction 
 
This method has been commonly applied in synthesis using the more common 
analogue from microbial arene oxidation 28, both in the synthesis of 
aminocyclitols87,101  and of (+)-lycoricidine 102 and has shown both high levels of 
stereo– and regio– specificity in good yields. 
 
For this work, experiments were carried out in accordance with literature 
precedent. Scheme 41.76  
 
Scheme 41: HDA reaction 
The reaction proceeded in good yields, with high levels of specificity with sole attack 
of the dienophile to the upper face with a preference of regio– selectivity with the 
carbamate and silyl ether groups on the same side, which is perhaps surprising on 
steric grounds.  
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Facial selectivity studied previously103-105 and facial selectivity observed here is 
consistent with that previously reported.18,87 For both of the products isolated a 
clear NOESY correlation was observed between the protons of the acetonide 
concave methyl groups and those of the alkene. This confirmed the approach of the 
dieneophile to the upper face of 208 in both cases. Figure 10 & Figure 11. 
 
Figure 10: NOESY 2D-NMR of 214. Indicating acetonide alkene through space interaction  
 
 
Figure 11 NOESY 2D-NMR of 215. Indicating acetonide alkene through space interaction 
 
Identifying whether the Cbz group was distal 214 or proximal 215 to the 
CH2OTBDMS side chain could not be achieved unambiguously by means of NOESY 
spectra alone. The assignments were instead inferred from the structure of a 
derivative synthesised subsequently (Figure 12) whose identity was established 
beyond doubt by X-ray crystallography.  
ppm
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2.3.1 Dihydroxylations 
At this stage dihydroxylation was chosen for controlled facial selectivity for the 
introduction of the final oxygen functionality. Experiments were carried out in 
accordance with literature procedure.76 In the case of the minor distal regio isomer 
214, a single product 216 was observed in a high yield. In contrast the major 
proximal regio isomer 215, gave the desired product 217 in a moderate yield as well 
as a side product 220.  
 
The proposed structure of the byproduct would have arisen due to reaction 
between the nucleophilic hydroxyl oxygen and the nearby carbamate group, thus 
eliminating benzyl alcohol. Scheme 42.  The structure was assigned to key analytical 
data, through analysis of molecular mass, a characteristic ν(C=O) absorbance at 1808 
cm–1 and a 13C NMR resonance at δ = 154.4 ppm.  
 
Scheme 42: Dihydroxylation results. Reagents and conditions: a) OsO4 (2 mol%), 1equiv NMO, 
acetone/H2O, 4:1, r.t., 48 h, 81% 216, 44% 217, 17% 220. 
Additionally in support of the assigned structure 220, in an attempt to desilylate 216 
to complete the synthesis, treatment of cis diol 216 with TBAF did not give the 
expected alcohol 221, but instead gave cyclic carbonate 222 in a 24% yield with no 
recovery of starting material. Scheme 43. Comparison of analytical data to 220 
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indicated a Cyclic carbonate has ν(C=O) = 1800 cm
–1 and a 13C NMR resonance at δ = 
154.6 ppm. Furthermore the structure of 222 was secured by X-ray crystallographic 
analysis. Figure 12. 
  
Scheme 43: Desilylation. Reagents and conditions: b) TBAF, THF, 0 °C, 12 h, 24%. 
 
 
Figure 12:  ORTEP diagram of X showing ellipsoids at 50% probability. H atoms are 
shown as spheres of arbitrary radius. 
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2.3.2 Hydrogenations 
As silicon deprotection was not viable at this stage due to risk of forming cyclic 
byproducts, an alternative strategy was implemented to perform the reductive 
hydrogenation to open the bridging N-O bond. Hydrogenation has been shown to 
be a common method of opening the N-O bridge of analogous compounds.76  
Additionally under standard hydrogenation conditions we hope to perform multiple 
reductive transformations; deprotection of the Cbz group and reduction of the 
alkene. 
 
Hydrogenations on both the alkenic and dihydroxylated Diels-Alder products, 214 – 
217 were subjected to hydrogenation to yield the resulting ring opened products 
cleanly and in good to excellent yields 223 – 226. Scheme 44. Isolated yields of the 
oxygenated species 225 – 226 were significantly lower; this can be attributed to 
their retention on celite through purification.  
 
 
Scheme 44: Hydrogenation results 
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2.3.3 De-protection of the silicon 
With the ring opened products 223 – 226 in hand, removal of the silyl protection 
group to yield the corresponding alcohol was achieved with some difficulty. Scheme 
45. Under standard TBAF silicon deprotection conditions the water soluble alcohol 
227 was isolated contaminated with tetrabutylammonium salts.  In order to remove 
the contaminant, 227 was subjected to acetonide formation to yield 228 which 
could be purified.  
 
 
Scheme 45: De-protection of the silyl-alcohol. 
 
The structure of poly-acetated 228 was tentatively inferred based on interpretation 
of 13C NMR spectra. Three quaternary acetal carbons were observed δC 110.5, 109.5 
and 90.2 ppm which can be used to indicate ring size and hetero atom binding. 
According to literature studies106 and comparison to previously synthesised 
compounds, values of 110.5 & 109.5 are consistent with 5 membered rings bound 
through oxygen. The lower value of 90.2 ppm is indicative of an acetonide bound 
through nitrogen; this is in agreement of literature values of similar compounds 
where the quaternary carbon appears upfield, ranging from 90-95 ppm.107,108 The 
NMR signals do not suggest a six membered ring, for which one would expect to 
observe at 97-101 ppm. 106,108 
 
The acetonide protecting groups were then cleaved with 1M HCl to give 229 in a 
moderate yield of 58% over 2 steps. Although successfully obtaining the first 
aminocyclitol, these results suggest that TBAF is an unsuitable desilylation reagent, 
due to the potential contamination and extra required steps, for use with these 
compounds.  
 
Additionally final aminocylitol salt 229 isolated via this route did not match the NMR 
spectra of the corresponding final compound 232 isolated further on within this 
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chapter. This suggests that possible epimerisation or rearrangement may have 
occurred via this route and again supports the unsuitability of this synthesis.  A 
shorted and simpler route needs to be considered. 
2.3.4 Acid deprotection – final step 
To our advantage it was found that simple treatment of 223 – 226 with 1M aqueous 
HCl followed by an organic wash to remove the silanol by product, resulted in 
cleavage of both the acetonide and silicon protecting groups cleanly and in high 
yields to give desired final products 230 – 233. This was repeated in high yields for 
all corresponding compounds. Scheme 46. 
 
Scheme 46: Final Products. 
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2.3.5 Biological assays 
This work has led to the successful synthesis of four compounds of aminocyclitol 
structure which were tested for glycosidase inhibitory activity. 109  
 
Scheme 47: Final compounds for testing 
 
Compounds synthesised were tested against α-glucosidase (type I from S. 
cerevisiae), β-glucosidase (almond), β-galactosidases (from A. oryzae and E. coli) 
and β-glucuronidases (from bovine liver, E. coli and P. vulgata); no inhibitory activity 
was observed at 100 μM. The yellow colour indicates all enzymes remained active 
and could still cleave the glycosidic bond to release the yellow para-nitro phenol 
from the sugar substrates.  
 
Figure 13: Biological assay results.  
2.4 Conclusion: Aminocyclitols 
Although the compounds synthesised and tested were inactive as glycosidase 
inhibitors, herein we have showcased novel methodology starting with the 
microbial arene oxidation product through to polyhydroxylated aminated structures 
with up to six contiguous stereo-centres; all inserted under substrate control. Key 
steps include the hetero–Diels–Alder reaction and the advantageous two 
deprotection steps each performing multiple reactions in one pot. 
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3 Chapter 3: Cyclitols 
Singlet oxygen formation of endoperoxides en route to novel cyclitols architectures. 
3.1 Introduction 
Cyclitols are polyhydroxylated alkanes, which are predominantly synthesised and 
studied due to their potential biological activity. Examples of biologically active 
compounds which contain the cyclitol motif include; Inositol hexanicotinate 234, a 
commercial food supplement which releases niacin (vitamin B3). It breaks down to 
form myo-inositol, the most common naturally occurring inositol, which is known to 
play an important role in cell signalling. Bicylitol 235 displayed strong inhibitory 
activity of α-glucosidase in yeast,{Mehta, 2005 #262} and Narciclasine 90 is a potent 
antineoplastic agent.{Kornienko, 2008 #263} Figure 14. 
 
Figure 14: Examples of compounds which display the cyclitol motif. 
 
Synthesis of cyclitols traditionally relies on the availability naturally occurring 
inositols and carbohydrate material as a source of chirality. As a result, synthetic 
procedures often entail many protection, deprotection and auxiliary agents, and 
hence tend to be wasteful and inefficient.{Duchek, 2011 #200} 
 
Cyclitol synthesis derived from the products of MAO offers a viable and efficient 
alternative. With chirality already embedded within the reactive and readily 
adaptable starting material, subsequent synthetic steps often proceed under 
substrate control though to enantiopure targets.  
3.1.1 Cyclitols – Specific MAO singlet oxygen examples 
Synthesis of cyclitols from ortho, meta diene diol products of MAO has been 
extensively investigated and reviewed.{Hudlicky, 1996 #265;Duchek, 2011 #200} 
(references therein & see introduction chapter). Here we highlight cyclitol examples 
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with particular emphasis on the use of singlet oxygen methodology, focusing on the 
formation of bridged bicyclic complexes, and the procedures utilised to open such 
bridged systems are discussed below.   
 
Photochemistry has been used to access cyclitols by Carless et al.{Carless, 1989 
#266;Carless, 1993 #201;Carless, 1992 #215} Procedures utilised singlet oxygen 
cycloaddition to form the endoperoxide bridge in MAO compounds 237, followed 
by opening with thiourea to form alcohol 238. Further transformation, epoxidation 
and ring opening led to pinitol (±)-51 in 18% yield over 4 steps from the silylated 
diene 236. Scheme 48. 
 
Scheme 48: Carless {Carless, 1989 #266} route to pinitol 51. Reagents and conditions: a) P.  
putida; b) TBDMSCl, Et3N, CH2Cl2; c) O2, -80 °C, 32% over 3 steps; d) thiourea/MeOH; e) mCPBA, 95% 
2 steps; f) CF3CO2H(aq), MeOH, 60%.  
 
In addition Carless investigated further irradiation of endoperoxide 237 to form a 
mixture of β-epoxyketones 240 and 241 and bisepoxide 242. Catalytic amounts of 
triethylamine led to formation of hydroxyenones 243 and 244. Scheme 49. 
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Scheme 49: Carless{Carless, 1989 #266} endoperoxide bridge opening. Reagents and 
conditions: a) hν, C6H6, 3:1:1 of 240:241:242; b) cat. Et3N, C6H6, 100%. 
 
In summary, Carless identified a range of methodologies for exploiting the 
endoperoxides derived from MAO through to novel architectures as potential 
building blocks in cyclitol chemistry.  
 
Exploiting application of the less common ipso, otho MAO product from benzoic 
acid, Lewis et al.{Palframan, 2012 #224}  in 2012 synthesised zeylenols and 
zeylenones using singlet oxygen methodology to obtain bicyclic endoperoxide 
species 154. Reductive opening using thiourea gave diols 156, whereas redox 
neutral Kornblum–DeLaMare fragmentation accessed ketone motif 155. Scheme 50. 
 
 
Scheme 50: Synthesis of zeylenols via photooxygenation.{Palframan, 2012 #224} Reagents 
and conditions: a) O2, TPP, CCl4, 12 h, 10°C, 81-90%; b) 
i
Pr2NEt, CH2Cl2, 94-100%; c) thiourea, 
CH2Cl2/MeOH, r.t., 12 h, 63-99%.   
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3.1.2 Cyclitols – specific singlet oxygen examples 
With cyclitol targets in mind, significant contribution to cyclitol synthesis employing 
singlet oxygen should be considered. The work of Balci et al.{Sutbeyaz, 1988 
#251;Balci, 1985 #250;Balci, 1983 #249;Balci, 1983 #248;Balci, 1981 #247;Balci, 
1981 #247;Balci, 1983 #248;Balci, 1983 #249;Balci, 1985 #250;Sutbeyaz, 1988 
#251;Seçen, 1994 #55;Baran, 2008 #264;Cantekin, 2009 #62;Kilbas, 2011 
#184;Baran, 2012 #246} over the last 20 years has developed methodology and 
synthesis based upon endoperoxide opening and cyclitol targets. In 2008 
Balci{Baran, 2008 #264} synthesised various analogues of naturally occurring 
cyclitols, including novel architectures such as 250 which have been evaluated as 
glycosidase inhibitors. Scheme 51. 
 
 
Scheme 51: Bacli {Baran, 2008 #264} 2008, Bishomo-inositols as glycosidase inhibitors. 
Reagents and conditions: a) 
1
O2, TPP, CH2Cl2, hv, 12 h, 85%; b) thiourea, MeOH, 3 h  then Py, Ac2O, 12 
h, 87%; c) OsO4, NMO, Acetone/H2O, then Ac2O, Py 25 h, 73%; d) NH2SO3H, Ac2O/AcOH reflux 24 h, 
84%; e) NH3, MeOH, 5 h, 91%. 
 
 
Endoperoxide 246, derived from diene 245, was opened using mild reduction 
conditions with thiourea. Dihydroxylation conditions followed by acetylation gave 
the tetra acetate 248. Ring opening with sulfamic acid produced the hexa acetate 
249, which was finally subjected to deacetylation with ammonia in methanol to give 
the desired Bishomo-Inositol 250. 250 was tested for its potential glycosidase 
inhibitory, with an inhibition rate of 57 ± 0.96% for 10 μM concentration of 
compound 250 which transposes to a calculated IC50 value of 8 μM.  
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Subsequent work from Balci {Baran, 2012 #246} further exploited singlet oxygen 
derived alkene 246, using alternative endoperoxide opening methodology to form 
other novel bishomo inositol derivatives 255 – 258. Scheme 52. 
 
Scheme 52: Balci{Baran, 2012 #246} 2012, Bishomo-inositols as analogues. Reagents and 
conditions: a) 
1
O2, TPP, CH2Cl2, hv, 12 h, 85%; b) CoTPP, CH2Cl2, 0 °C, 2 h, 84%; c) H2SO4, H2O, 24 h, 
then Py, Ac2O, 24 h, 252 15%, 253 50%, 254 19%; d) i) NH2SO3H, Ac2O/AcOH reflux 24 h, 70%; ii) NH3, 
MeOH, 5 h, 96%. e) i) NH2SO3H, Ac2O/AcOH reflux 24 h, 74%; ii) NH3, MeOH, 5 h, 92%; f) i) NH2SO3H, 
Ac2O/AcOH reflux 24 h; ii) NH3, MeOH, 5 h, 257 97%, 258 90%;     
 
In this work Balci exploited his known methodology {Balci, 1985 #250;Balci, 1983 
#248;Balci, 1983 #249} of opening unsaturated endoperoxides with cobalt(II) 
tetraphenylporphyrin (CoTPP) to form the corresponding diepoxides with syn 
configuration. This work then followed similar procedures to his 2008 work with 
acidic ring opening followed directly by acetylation. Surprisingly tetra-acetate 
compounds 252 – 254 were separable via column chromatography, and fully 
identified and characterised based on their NMR spectroscopic data. Interestingly, 
formation of bishomo–chiro–inositol was explained via neighbouring group 
participation of the acetate group which lead to inversion of one of the 
stereocentres. It is also interesting to consider that this neighbouring group 
participation was not observed for the other structures. Scheme 53. 
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Scheme 53: Neighbouring group participation, explanation of inversion of 
stereochemistry.  
 
From 2013, Balci and co-workers’ most recent publication{Baran, 2013 #371} report 
the first example of three sequential singlet oxygen molecules being incorporated in 
a cascade process. Photooxygenation of diene 260 with a 500 W projection lamp, in 
CH2Cl2 at 0 °C afforded endoperoxide 264. Further irradiation led to 264 undergoing 
a cascade photooxygenation reaction to form the two regioisomeric tricyclic bis-
endoper-oxides 261 and 262. The formation of the major regioisomer 261 was 
attributed to the second attack of singlet oxygen to the more substituted double 
bond in intermediate diene endoperoxide 264, as supported with their previous 
findings.,Yardımcı, 2006 #372- Following the proposed mechanism, diene 264 
undergoes an ene reaction to form diene 266 which then reacts for the third and 
final time with singlet oxygen to form final product 261. Scheme 54. 
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Scheme 54: Balci 2013{Baran, 2013 #371} Trisequential Photooxygenation reaction. 
Reagents and conditions: a) 
1
O2, TPP, CH2Cl2, hv ,r.t., 40 h; b) 
1
O2, TPP, CH2Cl2, hv , 0 °C, 25 min, 86%; 
c)  
1
O2, TPP, CH2Cl2, hv , 0 °C, 56 h. 500 W projection lamp used. 
 
Exploiting the highly functionalized structure of endoperoxide 261 towards cyclitol 
motifs Balci followed his previous experimental precedent of thiourea 
endoperoxide opening, acetate protection, epoxidation, and deprotection. Balci 
displayed elegant synthesis of carbasugar 270 in a 60% yield over 4 steps from the 
endoperoxide 261. Scheme 55. 
 
 
Scheme 55: Balci {Baran, 2013 #371} Carbasugar synthesis from endoperoxides. Reagents 
and conditions: a) i) thiourea/MeOH ii) Ac2O, Py, 82%; b) mCPBA, CH2Cl2, 67%; c) i) H
+
/H2O ii) Ac2O, 
Py, 78%; d) NH3, MeOH, 95%.  
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In summary, Balci’s use of singlet oxygen photochemistry has allowed access to 
highly oxygenated and functionalised architectures which prove ideal substrates for 
the synthesis of carbasugars. In many cases procedures obtain single enantiomers, 
which have been proven to be biologically active. Balci’s simple protocols highlight 
the ease of handling and purification of these types of structures. These approaches 
could be applied to other dienes, for example those derived from MAO, en route to 
enatio-pure carbasugar motifs.    
 
3.2 Aims 
The aim of this project was to synthesise inositol analogues 271 from MAO products 
30. Utilising singlet oxygen methodology already president within the Lewis group, 
and methodology inspired from Balci’s work discussed above. The proposed 
synthetic procedure is shown below. Scheme 56. 
 
Scheme 56: Proposed route to inositol analogues from MAO product 30. 
 
3.3 Results and Discussion 
Following literature procedures through to known compounds, previously discussed 
methyl ester 113 was synthesised via two routes. (Chapter 1 Aminocyclitols) 
Scheme 57. 
 
Scheme 57: Synthesis of methyl ester 113. 
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Formation of the reduced side chain, 207, was achieved using LiAlH4, with a 
reasonable yield of 77% which is enhanced from previous reports using LiBH4 
68%.{Palframan, 2012 #224} Standard acetylation proceeded well to form 274. 
Scheme 58. 
 
Scheme 58: Synthesis of acetylated diene 274. 
 
Following synthetic procedures from Widdowson{Jenkins, 1995 #11}  Balci{Baran, 
2012 #246} and Lewis{Palframan, 2012 #224} reaction of 274 with 1O2 yielded 
endoperoxide 275, in varying yields from 36% to 68% recovering starting material 
and in one instance a byproduct 276. Higher yields were obtained by utilising slow 
addition of TPP (5,10,15,20-Tetraphenyl-21H,23H-porphine) dissolved in CH2Cl2 and 
irradiating for at least 10 h. It was found that after this time reaction progression 
slowed. After approximately 10 h the purple pink colour of the solution would start 
to discolour to green/brown. This indicated that the TPP had degraded and was 
deactivated. Concentrated reaction solutions which contained more TPP did not 
precede any faster and seemed to degrade even quicker. Additionally these yields 
are lower than those previously reported,{Palframan, 2012 #224} however avoid 
the use of extremely toxic carbon tetrachloride. Scheme 59. 
 
Scheme 59: 1O2 yielded endoperoxide 275 and byproduct 276. 
 
The unexpected byproduct 276 was fully characterised by interpretation of 2D-NMR 
spectra and mass spectrometry. Additional support for this structure comes from 
comparison to known literature compound 277, which shows very similar chemical 
resonances and splitting pattern in 1H NMR spectra. This also supports the proposed 
stereochemistry around the epoxide.  Table 2.  {Myers, 2001 #12}  
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Scheme 60: Myers’ {Myers, 2001 #12} synthesised epoxide, for comparison to byproduct 
276. 
 
 Compound 276 Myers 277 {Myers, 2001 #12} 
H2 6.09 (1H, dd, J = 10.0, 4.0 Hz) 6.18 (1H, dd, J = 10.4, 4.4 Hz) 
H3 5.70 (1H, dt, J = 10.0 1.5 Hz) 5.84 (1H, dt, J = 10.0, 1.2 Hz) 
H5 4.65 (1H, t, J = 1.0 Hz) 5.17 (1H, m) 
H4 3.64 (1H, dd, J = 3.5, 2.5 Hz) 3.65 (1H, dd, 1H, J = 3.6, 2.0 Hz) 
H3 3.37 (1H, m) 3.39 (1H, m) 
Table 2: Comparison of byproduct 276 to literature NMR spectroscopy values. 
 
In consideration of how byproduct 276 was formed, a mechanism has been 
proposed below. Scheme 61. Literature suggests that singlet oxygen can react with 
alkenes via an ene-reaction, to form intermediate peroxide 278. This intermediate 
has been previously observed by Balci in 2013,{Baran, 2013 #371} Davis 
1996,{Davis, 1996 #399} and Carless in 1989.{Carless, 1989 #266} Decomposition 
and rearrangement through radical reactions leads to formation of the observed by 
product 276. {Frimer, 1979 #400}  
 
Scheme 61: Proposed mechanism for the formation of byproduct 276.  
 
Following methodology from Balci{Baran, 2012 #246;Balci, 1983 #248;Balci, 1983 
#249;Balci, 1985 #250;Sutbeyaz, 1988 #251} unsaturated bicylic endoperoxides can 
be converted to the diepoxide with syn-configuration on treatment with cobalt (II) 
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tetraphenylporphyrin (CoTPP). On treatment of 275 under these conditions, 
bisepoxide 281 was isolated in near quantitative yields. Scheme 62. 
 
Scheme 62: Formation of endoperoxide 281. 
 
Opening of the bisepoxide 281 was evaluated using various experimental 
procedures. Attempts via acid hydrolysis and ammonia in methanol were 
unsuccessful and both resulted only in cleavage of the acetate to form alcohol 272. 
Scheme 63.  
 
Scheme 63: Diepoxide opening resulted in acetal hydrolysis to form 272. 
 
Attempts at nitrogen incorporation was undertaken following procedures using 
Yb(OTf)3, MsOH,{Kaburagi, 2007 #311} NaN3{Cristina, 1999 #253} all attempts were 
unsuccessful. Scheme 64. 
 
Scheme 64: Endoperoxide opening using nitrogen nucleophiles, unsuccessful. 
 
Attempts to open the bisepoxide 281 under forcing conditions of refluxed aqueous 
acid to form 283 was attempted and unsuccessful. The expected poly-ol product, 
from aqueous acid ring opening, 283 would be extremely polar and difficult to 
column, purify or isolate. Considering methodology from Balci{Baran, 2012 #246}, in 
which acid catalysed ring opening was instantly followed by acetylation, the 
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expected poly acetals products should be able to be purified by column 
chromatography.  
Following this procedure, 281 was subjected to aqueous acid to form 283 in situ, 
then subsequent acetylation to form 284. Variations in reaction time, equivalents of 
all reagents and temperature were investigated. Crude reaction mixtures did 
indicate formation of acetylated compounds; however these proved very difficult to 
isolate and purify. This is potentially due to partially acetylated products all having 
very similar polarity and hence extremely difficult to separate due to co-elution via 
column chromatography. Scheme 65.    
 
 
Scheme 65: Formation of polyacetals 284. 
 
In a rare example, a single poly acetate product (later assigned as 290A) was 
isolated in pure form from one of these reactions, 3mg <1% yield. Enough material 
was isolated only to obtain full NMR data (no further derivatisation was 
undertaken). Below, rationale and discussion follows to suggest which product and 
conformer has been isolated.  
 
Initial inspection of the NMR spectra indicates that the compound is a tetra acetate, 
with four distinct CH3 regions between 1.99 – 2.20 ppm. Additionally the acetonide 
protecting group has been removed as there is an absence of quaternary acetonide 
carbon signal in the 13C spectrum and the methyl acetonide groups from the 1H 
proton spectrum. Figure 15 & Figure 16. 
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Figure 15: 1H NMR spectrum of isolated polyacetate 290A. (500 MHz CDCl3.) 
 
Figure 16: 13C NMR spectra of isolated polyacetate 290A. (100 MHz CDCl3.) 
 
In consideration of the mechanism and possible products that could be formed 
from the reaction of acidic water ring opening the bisepoxide, four possible 
products 288 - 291 may be formed. Scheme 66. 
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Scheme 66: Possible products from acid water hydrolysis of bisepoxide 285 
 
Via interpretation of the proton NMR spectra of the isolated tetra acetate, coupling 
constants of the ring protons suggest a Hax – Hax – Heq – H? –  H?  arrangement around 
the cyclohexane ring according to coupling constants. {Minch, 1994 #258;Karplus, 
1963 #257} The Karplus equation gives an estimation of 3JH-H proton coupling 
constants based on their dihedral angle, and vice versa. The strict relationship is 
only applied to unstrained, saturated unsubstituted hydrocarbons, however the 
equation and its more complicated variants can be applied to deduce the 
conformation of ring systems. E.g. cyclohexane,{Garbisch, 1968 #260;Karplus, 1963 
#257} monosubstituted cyclohexanes,{Jensen, 1969 #259} polyhydroxylated 
cyclohexanes.{McCasland, 1968 #261} In summary, larger 3JH-H proton coupling 
constants are observed between Hax – Hax protons (9 – 12 Hz) and values are 
typically less for Heq – Hax or Heq – Heq (3 – 4 Hz). 
 
Analysis of NMR spectra of isolated polyacetate indicates a large coupling constant 
of 10 Hz, between the resonances at 5.09 ppm and 4.29 ppm, indicating a Hax – Hax 
conformation. If 5.09 ppm is an axial position, within the proposed structure, this 
proton must be adjacent to the quaternary carbon, hence only coupling to one 
other proton, as we do not observe any smaller splitting due to Hax – Heq coupling. 
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Proton resonance at 4.29 ppm is split into a double doublet, coupling to 5.91 ppm 
with a coupling constant of 4.5 Hz, indicating a Hax – Heq interaction. All other peaks 
appear as singlets, suggesting the angle between Heq and subsequent protons is 
~90°, hence it cannot be stated with certainty whether the protons are in an axial or 
equatorial environment. Figure 15. 
 
In consideration of all possible conformations (simplified to be based on 
cyclohexane conformations) of all possible products, a Hax – Hax – Heq relationship 
needs to be present, with the first Hax adjacent to the quaternary carbon. Two 
possible conformers have been identified which display this pattern. Figure 17. 
(Assignments of acetate positions has been inferred later, substituents have been 
simplified to OR in this instance, where R = H or Ac) 
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Figure 17: Possible conformations. 
 
Conformer 289B has been discounted as NOESY 2D NMR spectroscopy indicates 
through space interaction between H1, (identified at 4.29 ppm as a doublet of 
doublets, displaying coupling to adjacent axial and equatorial protons) and CH2, 
which is only possible in the conformation of 290A. Figure 18. 
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Additionally Conformer 289B has been discounted as from proposed 
conformational order, 6Hax – 1Hax – 2Heq – 3Heq – 4Hax, expected coupling between 
3Heq – 4Hax with a coupling constant between 3 – 4 Hz is not observed.  
This argument further supports the choice of conformer 290A, as from proposed 
conformational order, 6Hax – 1Hax – 2Heq – 3Heq – 4Heq, no coupling between 3Heq – 
4Heq is observed; hence 3Heq and 4Heq appear as singlets.  
 
 
Figure 18: NOESY spectra of poly acetate, indicating through space interaction between 
H1 4.29 ppm and CH2.  
 
Further consideration of 2D spectroscopic assignments of carbons and other 
protons can be made, albeit not fully due to the two ambiguous singlet resonances 
which cannot be assigned as they both show NOESY through space correlation to 
5.08 ppm. Figure 18. Additional ambiguity arises, as regards the question of which 
alcohols are acetylated. It could be assumed that the most down field 1H 
resonances (5.91, 5.56, 5.09 ppm and the CH2) are acetylated. On this basis, 290A is 
tentatively assigned the structure shown in Figure 19. 
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Despite being able to fully characterise this compound, it is obvious that under 
these reaction conditions, multiple products form of similar polarity, and as a result 
are difficult to purify and separate. Additionally it is possible that neighbouring 
group participation could be in effect, as shown with Balci,{Baran, 2012 #246} which 
would further complicate mixture and lead to difficult chromographic separations.  
 
Future work would look at selective ring opening, with the use of larger 
nucleophiles to induce some selectivity.  At this point, no further work was carried 
out in this area. 
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4 Chapter 4: Bromine Substrates for BZDO 
4.1 Introduction: Halogenated Substrates MAO 134,135 
There are many examples within the literature of halogenated, substituted and 
polycyclic aromatic compounds which when subjected to MAO give ortho, meta 
substituted dienes 28. Scheme 67. This field has been reviewed in the earlier 
literature introduction.  
 
 
Scheme 67: Dioxygenase enzymes which metabolise substituted aromatics. 
 
Substituted benzoate substrates that may be elaborated via BZDO mediated 
dihydroxylation to give ipso, ortho substituted dienes are comparably less exploited. 
From the first report of A. eutrophus B9, Reiner & Hageman 1971, 21 identified 3,5 –
cyclohexadiene-1,2-diol-1-carboxylic acid 30 as the MAO product of benzoic acid. 
This preliminary study indicated that substituted benozates could be metabolised, 
albeit at appreciably slower rates. Scheme 68. 
 
 
Scheme 68:  Reiner & Hageman 1971, A. eutrophus B9 and substituted aromatics.  21 
 
Two years later, in 1973,26 Knackmuss and Reineke investigated mono, di-chloro 
and methyl- substituted benzoates, and although A. eutrophus B9 showed the 
ability to metabolise such substrates, again rates were 10-1000 times slower 
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depending on the specific substrate. This study was further expanded in 197827,28 to 
include bromo- and fluorobenzoates, and once again a decrease in rate was 
observed, which was attributed to the steric effects of the substituents. The relative 
rates of oxidation, according to the substituent were established to be F>Cl>Me>Br. 
Regarding regioselectivity, meta substituted benzoates were metabolised more 
readily than ortho or para. For meta-substituted substrates, a preference for 
formation of the 3-substitued diene product 38 over the 5-substituted isomer 39 
was reported. Scheme 69. 
 
 
Scheme 69: Knackmus 1978, preference for 3-substitued diene product 38 observed. 27,28 
 
Later Knackmuss in 1980136 found that A. eutrophus B9 had the ability to use 2-
fluorobenzoate 294 as a sole carbon source and produce 6-fluoro-3,5-
cyclohexadiene-1,2-diol-1-carboxylic acid 295 as a single product. Knackmuss 
attributed this to a defective DHB-dehydrogenase enzyme, preventing formation of 
3-fluoro catechol 296. Scheme 4.  
 
 
Scheme 70: Knackmuss 1980, identified that the reason for accumulation of diene 295 
was due to the defective enzyme. 136 
 
Other organisms expressing BZDOs have been show to metabolise substituted 
benzoates. For example, Pseudomonas mt-2. 137,138 and P. putida JT 10319 have been 
used for the biotransformation of fluorinated benzoates. BZDO has also been 
expressed in recombinant E.coli.139-141  
 
As highlighted above there is a plethora of research, dating back to the 1980’s, 
investigating whether substituted benzoates can be metabolised by dioxygenase-
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expressing bacteria. With a range of homochiral products identified and 
dioxygenase expression in stable recombinant strains, it is surprising that there is 
very little use of these substituted benzoate products in further synthetic 
applications. 
 
The sole literature example, displaying the synthetic use of substituted ipso, ortho 
cis-diols, was reported by Banwell et al. in their approach to vinblastine. Scheme 71. 
142 With access to P.putida BGXM1, which contains enzymes capable of oxidising 
toluenes to benzoic acids and TADO enzymes capable of the di-hydroxylation of 
toluates; Banwell utilised this in an elegant one pot microbial transformation of 
meta-ethyltoluene 297 via meta-ethylbenzoic acid 298 to targeted metabolite 299 
in >55% yield. This was then converted into its derivative 300 using conventional 
chemical techniques, for analysis and determination of absolute stereochemistry via 
single crystal X-ray analysis.    
 
 
Scheme 71: Banwell 2005, one pot synthesis of chiral diene 299 with P.putida BGXM1.142 
 
4.2 Aims and Previous work 
The work presented here completes a set of studies from our previous academic 
report143 which has since been compiled and published.144 
Previous studies sought to subject meta-bromo benzoic acid 301 to MAO, to 
identify and isolate enantiopure cis-diol diene 302. As substituted chiral diol dienes 
of this origin are underexploited in synthesis, it was sought to scope the synthetic 
viability of possible transformations of this building block.  
This present work goes further to expand the synthetic scope and viability of 302, 
specifically looking at formation of tricarbonyliron(0) complexes and cross-coupling 
reactions.  
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Scheme 72: m-bromo benzoic acid 301 to subjected to MAO, dihydrodiol diene 302 
isolated. 
 
Our previous work143 had successfully provided a route to bromo diene 304, which 
was used at the starting point for subsequent synthetic procedures. 
 
 
Scheme 73: Previous synthetic work 143,144 
4.3 Results and Discussion 
4.3.1 Iron complexes – Relevant Literature Reports 
Tricarbonyl (cyclohexadiene) iron complexes were first reported by Pauson in 
1958.145 They are commonly used as intermediates in synthesis as they can 1) 
protect reactive diene functionality to prevent re-aromatisation 2) impart a sense of 
stereo control in further synthetic transformations. 3) act to separate prochiral 
dienes.146 Rigid cyclohexadiene iron(0)tricarbonyl complexes have been shown to 
exhibit excellent stereo-induction, upon complexation.147-149 Scheme 74. 
 
Scheme 74: Complexation of dienes 305 with di-ironnonacarbonyl to give co-ordinated 
complexes 306. 
 
Previous work within the Lewis group found that on complexation of compound 121 
with di-ironnonacarbonyl a single product 136 was obtained whereby iron is co-
ordinated solely to the bottom face of the diene system. This is attributed to a 
favourable interaction between the electron donating hydroxyl groups and the 
incoming 16 valence-electron iron carbonyl fragment.68 In contrast, in an attempt to 
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Scheme 75: Previous iron work68,69 
 
It was thought that investigation of complexation of the bromo-diene compound 
304 with iron might give mechanistic insight into the previous findings. 
 
4.3.2 Iron complexes – This work 
Complexation of 304 with di-ironnonacarbonyl gave a mixture of 307, 308 and 
recovered starting material 304. Scheme 76. This suggests the bromodiene is less 
reactive than the unsubstituted diene analogues, which furnished products in 55% 
yield of 136 and 26% yield of 138 (under the same reaction conditions). This could 
be attributed to steric clash between the incoming iron fragment and the large 
bromine atom.  
 
The absolute structure of 307 was determined via X-ray crystallography. Figure 20. 
In contrast, compound 307 was not crystalline and proved unstable, attributed to 
the steric bulk of both the iron and the acetonide on the same face.  
 
 
Scheme 76: Complexation of 304 with di-ironnonacarbonyl gave a mixture of 307, 308 
and r.s.m.   
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Figure 20: Solid state structure of 307. Of two independent molecules in the unit cell, only 
one is shown for clarity. Ellipsoids are represented at 50% probability. H atoms are 
shown as spheres of arbitrary radius. 
 
Complexation products 307 and 308 were the only products observed; acetonide 
rearrangement was not observed. This supports the previously proposed 
mechanism for formation of 138, namely clockwise acetonide migration. Scheme 
77. 
 
Scheme 77: Proposed mechanism of acetonide migration. 69 
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In the present case, the meta–bromo substituent imparts steric bulk at the carbon 
which would be attacked by the oxygen lone pair in the acetonide migration 
process. The presence of the atom may play a role in blocking attack of the oxygen 
lone pair. 
4.3.3 Cross-coupling reactions – Relevant Literature Reports 
Palladium-catalysed cross-coupling reactions have been widely implemented with 
the more common ortho, meta cis-diol product from microbial oxidation, 312.  
 
Stille cross-coupling reactions are the most prevalent within the literature,45,150,151 
with more recent examples using Suzuki cross-coupling due to their cleaner reaction 
conditions, avoiding the use of tin.150-152 Songashira cross-coupling conditions have 
also been utilised.25,102,152-159 Compound 302 has not previously been synthesised 
for synthetic purposes, therefore this work aimed to scope the possibilities of using 
304 in cross-coupling reactions. Scheme 78. 
 
 
Scheme 78: Previous cross-coupling chemistry 
 
4.3.4 Cross-coupling reactions – This work 
Suzuki-Miyaura coupling160 was carried out in accordance with reported 
experimental procedure.152 The desired product 315 was not observed in the first 
instance; however the free acid 314 was isolated and subjected to treatment with 
TMS-diazomethane to form the methyl ester 315 in an overall yield of 30% over two 
steps. Scheme 79. The free acid 314 may have formed due to the 18 equivalents of 
potassium carbonate used, which may result in basic hydrolysis of ester 307 to form 
the acid 314.  
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Scheme 79: Suzuki reaction to form coupled methyl ester 315. 
 
Sonogashira coupling161 of 304 was carried out in accordance with literature 
procedure 87 to give methyl ester 316 in 98%. Scheme 80. 
 
 
Scheme 80: Sonogashira coupling. 
 
It was sought to exploit further the synthetic utility of the Sonogashira product 316. 
Deprotection of the TIPS silicon protecting group gave the terminal acetylene 317. 
This was then subjected to copper catalysed Huisgen162 cycloaddition with benzyl 
azide to form a 1,2,3-triazole, 318. These reactions, commonly referred to as an 
example of ‘click reactions’ are known to proceed in high yields. Scheme 81. 
 
Scheme 81: Azide click cycloaddition 
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4.3.5 Conclusions  
This expansion of previous work has shown that the bromo-diene 304, although less 
reactive than its un–substituted counterpart 121, can co-ordinate to form iron 
complexes. The bromo complex does not rearrange which supports the proposed 
mechanism from previous work.69 
This work has also demonstrated the synthetic utility of the bromine substituent as 
a synthetic handle in cross-coupling reactions. Both Suzuki and Sonogashira 
coulplings have proven successful with moderate to excellent yields. Further 
expansion with azide ‘click’ chemistry illustrates the synthetic utility and stability of 
the compound, enabling diversification to other chemical intermediates. 
 
The formation of cross-coupling products especially 315 is of particular significance, 
as these structures are arene dihydrodiol derivatives that would not be accessible 
by direct metabolism of the corresponding arene substrates. Scheme 82.  
 
 
Scheme 82: Dihydrodiol product 315 synthesised via this work, potentially inaccesible 
dihydroxylation product of 320. 
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5 Chapter 5: Introduction Asymmetric Epoxidations 
5.1 Background to Asymmetric Epoxidations 
 
Catalytic asymmetric epoxidations are an important class of chemical 
transformation as they enable the generation of up to two stereogenic centres and 
a reactive epoxide which can be further functionalised. This enables such 
methodology to be used towards the synthesis of enantiomerically pure chemical 
building blocks for the synthesis of complex biologically active molecules.163 The 
importance of this transformation was most notably recognised by the Nobel Prize 
in chemistry from 2001, awarded for asymmetric catalysis, where Sharpless (one of 
three winners) gained recognition for his work towards directed asymmetric 
epoxidation catalysis. Sharpless’ and Katsuki’s seminal work employed Ti(OiPr)4 as 
the transition metal catalyst precursor, TBHP (tert-butyl hydrogen peroxide) as the 
oxidant and DET (diethyltartrate) as the chiral additive, achieving >90% ee on allylic 
alcohol substrates 321. 164 Scheme 83. 
 
 
Scheme 83: Sharpless asymmetric epoxidation.164 
 
The use of chiral titanium complexes, developed by Sharpless has seen much 
innovation, development and progress since his initial work in the 1980s. This area 
has been extensively reviewed.165 This work has been followed by the next 
significant milestone, development of manganese-salen complexes by Katsuki et 
al.166 and Jacobsen et al.167 Scheme 84. 
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Scheme 84: Jacobsen and Katsuki’s catalyst.  
 
Jacobsen and Katsuki showed the enantioselective epoxidations of unfunctionalised 
alkyl- and aryl- substituted olefins. The catalysts show strong structural 
resemblance to porphyrin-metal complexes that are known in biological systems. 
The procedure showed excellent enantioselectivities for specific substrates with 
values 90 – 95% ee.166  
 
The advantages of the Jacobson-Katsuki epoxidation are: 168 
1. Chiral Schiff-base salen ligands are easily synthesised via the condensation 
of readily available C2 symmetric chiral diamines and substituted 
salicylaldehydes 
2. Expands the substrate scope from Sharpless’ allylic alcohols to a variety of 
conjugated, non-conjugated, substituted and functionalised alkenes. 
3. Cyclic and acyclic (Z)-1,2-disubstitued alkenes are epoxidised with almost 
100% enantioselectivity. 
4. (E)-1,2-disubstitued oelfins are poor substrates for Jacobsen’s catalyst 326, 
but work better with Katsuki’s 327. 
5. Cheap and readily available stoichiometric oxidants can be used e.g. NaOCl, 
mCPBA and PhIO. 
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5.2 Organocatalytic Asymmetric Epoxidation 
From a sustainability perspective organocatalysis can be viewed to be beneficial as 
it eliminates the use of metals, which (depending on the metal) could be scarce, 
toxic, and expensive or require extensive processing, mining or catalyst and ligand 
synthesis. 
A metal free epoxidation example is that from Corey and Chaykovsky,169 who in 
1962 developed methodology for the generation of epoxides from the 
corresponding aldehydes or ketones 328. A reactive sulfur ylide 329 is prepared in 
situ from deprotonation of the corresponding sulfonium salt.170 Development has 
shown that the use of chiral sulfides in asymmetric epoxidations is possible.171,172  
An example is from Metzner et al., who developed a new generation of 2,5-
dimethylthiolanes with a locked conformation to promote the asymmetric addition 
of chiral sulfonium ylides to aldehydes. The novel chiral sulfur derivative succeeded 
in the synthesis of trans-stilbene oxide derivatives with enantiomeric ratios ranging 
from 90 – 96% ee.171 Scheme 85. 
 
Scheme 85: Metzner et al.171 Asymmetric epoxidations using chiral sulfur ylides. 
 
5.2.1 Chiral Ketones 
The use of chiral ketones 331 in the presence of Oxone® (K2SO4, KHSO4 and KHSO5) 
generates chiral dioxiranes 332, which are capable of oxidising alkenes to form the 
corresponding epoxides 333, regenerating the chiral ketone 331. For this reason 
dioxiranes are considered to be environmentally friendly and versatile oxidizing 
agents.  Scheme 86. 
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Scheme 86: Generic oxidation of alkenes by chiral dioxiranes generated in situ from 
chiral ketone and Oxone.  
 
In the seminal publication of Curci et al.,  in 1984 173 the first chiral ketone catalysed 
asymmetric epoxidation was reported. Epoxidation of 1-methylcyclohexene and 
trans-β-methylstyrene with chiral ketone 335  and 336 in biphasic systems led to 
good yields and up to 12.5% ee. Later in 1996, Yang 174 exploited the use of 
binapthylene chiral ketones 337, with intention of the C2 symmetry aiding selectivity 
and activity of the catalyst. The electron withdrawing nature of 337 enabled it to be 
an effective catalyst, with high conversions obtained at 10 mol%. It was found that 
increasing the size of the para substituent of trans stilbenes substrates improved 
the selectivity from 47 to 87% ee. Following on from Yang’s work many other C2 
symmetric biphenyl ketones have been evaluated, including the work of Denmark et 
al.,175 who developed 7 membered biaryl ketone 338 to achieve good yields and 
selectivities up to 94% ee for trans stilbene. Scheme 87. 
 
Scheme 87: Examples of Chiral Ketones for Epoxidation of Alkenes 
 
In 1998, Armstrong and co-workers reported bicyclic ketones 339 – 341 to be used 
with Oxone to enantioselectivley epoxidise a variety of alkene substrates. Scheme 
88.176,177 Catalyst 339 achieved 83% ee for a variety of substrates. Replacing the 
nitrogen bridge head with oxygen, 340, lead to further improvements, up to 98% 
ee, with acetate substituents giving the best selectivities in both cases.  More 
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recently Armstrong has investigated a new class of tetrahydropyran-4-one 
catalysts.178 Catalyst 341 was considered to be more stable than the bicyclic 
counterparts, with as low as 10 mol% being used to obtain 100% conversion. 
Despite slightly lowered enantioselectivities (43 to 83% ee) compared to the 
bridged bicyclic systems, this suggests that this bridge within the structure does not 
contribute greatly to the observed enantioselectivity. However Armstrong 
concluded that the α-acyloxy group seemed to play an important role in reactivity 
and selectivity.   
 
Scheme 88: Armstrong’s catalysts.176-178 
 
Undoubtedly the most well-known organocatalytic asymmetric epoxidation is the 
work of Shi et al.173,179-181 Shi and co-workers developed a range of chiral ketones 
derived from sugars. The easily synthesised catalysts are now commercially 
available and have been employed in the synthesis of natural products.182 
 
Shi’s principal catalyst 344 was synthesised from ᴅ-fructose 342, with the other 
enantiomer easily accessible from L-sorbose which can be converted into L-fructose, 
this method avoids incurring excessive cost of using L-fructose directly.183 The 
catalyst 344 was designed based on three key principles179 
1. The stereogenic centres are close to the reacting centre, resulting in efficient 
stereochemical communication between substrate and catalyst. 
2. The presence of the fused ring and quaternary centre α to the carbonyl 
group minimises the epimerisation of the stereogenic centres.  
3. One face of the catalyst is sterically blocked to limit the possible competing 
approaches.  
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Scheme 89: Synthesis of Shi catalyst from fructose.  
 
It was found that pH has a large impact on the epoxidation reactions. 180 Earlier 
studies were carried out at pH 7 – 8 in an attempt to reduce the decomposition of 
Oxone, however this resulted in the decomposition of ketone catalyst 344, and 
formation of assumed byproducts 348 – 349, most likely due to Baeyer – Villiger 
oxidation. (N.B. byproducts 348 and 349 were never isolated from this reaction, 
attributed to their decomposition on work up and affinity to remain within the 
aqueous phase, identification of byproducts was investigated under controlled 
reaction conditions. Scheme 92.) The optimal pH of 10.5 was achieved with addition 
of K2CO3 and saw conversion increase from 5% to >80%, this was attributed to the 
improved formation of anion 346 and subsequent formation of the dioxirane 347 
within the catalytic cycle. 184 Scheme 90. 
 
 
Scheme 90: Mechanism of the Shi epoxidation, and possible decomposition products.  
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Exploring the substrate scope of Shi catalyst 344, unfuctionalised trans and tri 
substituted olefins, as well as allylic, homoallylic, conjugated dienes, silyl enol ethers and 
esters were investigated. This shows broad substrate scope and good functional group 
tolerances.  
Table 3.  
 
Entry Substrate Yield (%) ee (%) 














Table 3: Asymmetric epoxidation of trans and trisubstituted olefins with Shi catalyst 344. 
Reagents and conditions: Ketone (0.3 equiv), Oxone (1.38 equiv), K2CO3 (5.8 equiv), MeCN-DMM-0.5 
M Na2B4O7·10H2O of aq Na2EDTA (1:2:2 v/v). 
 
The high catalyst loadings are attributed to the competing Baeyer – Villiger 
decomposition pathways. Scheme 90. In attempts to reduce this, several different 
catalyst iterations and designs have been investigated. 184 Scheme 91. 
 
 
Scheme 91: Different generation of Shi chiral ketone catalyst.  
 
Catalyst 350 with the fused oxazolidinone imparted enhanced electron withdrawing 
characteristics, enabling catalyst loading to be reduced to 1 – 5 mol%. Since 
dioxiranes are electrophilic reagents acetate derived catalyst 351 proved to be an 
efficient catalyst for electron deficient α,β- unsaturated ketones, 57% – 96% yield 
and 82% – 97% ee, an improvement from the original catalyst 344. Scheme 91. 
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5.2.2 Chiral Carbocycles Ketone Catalysts 
As this thesis concerns carbocyclic compounds, (aminocarbasugars and cyclitol 
chapter) it is interesting to note the variety of carbocycle research which followed 
from Shi’s seminal publications. 
 
In 2001 Shi investigated carbocyclic chiral ketones derived in 10 steps from from (–)-
quinic acid; these included the carbocyclic analogue 352 to the original Shi catalyst 
344. 185 Scheme 92. Shi noted that the most dramatic effect of replacing the 
pyranose oxygen with CH2 was the decrease in reactivity. Catalyst 352 gave <10% 
conversion in 8 h of trans-stilbene, compared to 75% conversion in 1.5 h for the Shi 
Catalyst 344. This indicated that the pyranose oxygen is beneficial for the reactivity, 
the electron withdrawing nature inductively activates the carbonyl to attack from 
the Oxone, and further activates the electrophilic dioxiranes to attack from the 
alkene substrate. 
 
Additionally under controlled oxidative Baeyer – Villiger reactions, it was found that 
carbocycle ketone 352 formed substantial amounts of the corresponding lactones 




Scheme 92: Shi carbocyclic chiral ketone. 185 
 
Structural X-Ray analysis of 352 indicated slight differences in conformational shape 
compared to the original catalyst, destabilizing steric interactions were discussed as 
an explanation for decreased activity of catalyst 352. Figure 21. It was also noted 
that carbocyclic ketone 344 gave higher ee’s for cis-olefins indicating a different 
type of olefin requires different structural elements for stereoselectivity.  
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Figure 21: X-ray structures of ketone 344 and 352. Structures taken from 185 
 
Following this, in 2004 Shi presented a direct comparison and study on transition 
states for chiral ketones 355  and 356.186 Scheme 93. Ketone 356 was found to be 
an active catalyst for the styrenes, ((R)-styrene oxide was obtained with 20 mol% 
356 at -10 °C over 8 h which gave 100% conversion and 90% ee). Higher ee’s 
obtained with carbocycle 356 rather than 355 were attributed to the replacement 
of the pyranonse oxygen with CH2. Experiments probed the substrate structures 
and suggested favourable transition states and corresponding favourable orbital 
interactions to explain observed selectivities of this challenging class of styrene 
substrates.  
 
Scheme 93: Shi carbocyclic ketone 356, compariative study to pyranose 355. 
 
Further carbocyclic ketone structures have been investigated for their epoxidation 
capabilities, including structure 357, and its derivatives.187,188 Investigation into this 
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class of C2 symmetric ketones highlighted the importance of ketone conformation in 
reactivity and selectivity of the catalyst. Scheme 94. 
 
 
Scheme 94: Carbocyclic ketone catalysts. 
 
During investigations into the position of the spiro structural element in the 
carbocycle ketones, Shi evaluated the reactivity and selectivity of structures 358 – 
359.185 Results indicated lower enantioselectivities (12% – 72% ee) for a variety of 
test substrates, indicating that the chiral control element should be close and big 
enough to impart good ees but not too much so as to retard the reaction. Scheme 
94. 
 
Further investigations in 1998 by Yang et. al., 189 reported a series of ketones 360 
containing a quaternary carbon adjacent to the ketone and various substituents on 
the ring. The work aimed to investigate the remote substituent effect and electronic 
tuning potential as an important tool in catalyst design. Following Shi’s Oxone 
procedure, Yang reported epoxidation of various meta or para substituted trans-
stilbenes achieving selectivities 42% - 97% ee. Scheme 94. 
 
To conclude this section, it is obvious from the amount of literature available, that 
cyclic ketones provide viable asymmetric organocatalytic systems for the 
epoxidation of a range of alkene substrates.184,190 
5.3 Organocatalytic Asymmetric Epoxidations – with H2O2  
 
With an interest in organocatalytic asymmetric epoxidations which utilise hydrogen 
peroxide, this area has been extensively reviewed.163,184,191,192 Hydrogen peroxide as 
oxidant is becoming increasingly utilised as a reagent due to its environmental and 
economic benefits, thanks to high atom economy and formation of water as a by-
product.192 Organocatalysis has emerged as a convenient and effective tool for 
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stereoselective synthesis of either simple or complex molecular scaffolds. An 
organocatalyst presents many benefits as an alternative to traditional metal 
catalysed reactions – since generally they are easily available, generally derived 
from the chiral pool, and are less sensitive to moisture and aerobic conditions. 192 
 
Within this section key epoxidations which utilise hydrogen peroxide that have 
specific relevance to the work carried out within this thesis will be reviewed.  
5.3.1 Shi – Chiral ketones and H2O2 
 
From the previous section it has been shown that the most effective and widely 
employed ketone based catalysis methodology comes from Shi and Yang, whom 
developed original Oxone (K2SO4, KHSO4 and KHSO5) methodology of generating 
dioxiranes in situ for the epoxidation of alkenes. In more recent work, 1999 – 
2007,193-195 Shi developed the methodology to use peroxymic acid 361 formed in 
situ from hydrogen peroxide and acetonitrile. (analogous to the Payne oxidation 196) 
Scheme 95.  Under the hydrogen peroxide conditions the chiral Shi catalyst 344 was 
able to epoxidise trans–stilbene in 24 h with 90% yield and 98% ee. 
 
Scheme 95: Shi epoxidations Utilising hydrogen peroxide. 
 
These modified reaction conditions proved to be milder, reducing the amount of 
salts and solvents needed and eliminating the need for the use of parallel syringe 
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pumps and careful addition of reagents. Results were comparable to that of the 
Oxone based systems. Mixed solvent systems proved useful with substrates of poor 
solubility, with efficient mixing being noted as being influential in achieving good 
yields in the biphasic system. Various nitriles were evaluated, with acetonitrile 
being optimal. 193  
 
5.3.2 Juliá Colonna – Peptide Asymmetric Epoxidations 
The Juliá–Colonna epoxidations from the 1980s 197-199 is the peptide catalysed 
asymmetric epoxidations of enones. The methodology utilises a three phase system 
consisting of aqueous NaOH, hydrogen peroxide, toluene and insoluble peptide, 
typically poly-L-alanine or poly-L-leucine as catalysts to convert α,β-unsaturated 
ketones to their corresponding epoxides in good yields and high 
enantioselectivities.  
A recent review highlights the use of tBu-glycine in the enantioselective epoxidation 
of substrate 365.200 Scheme 96. 
 
 
Scheme 96: Juliá–Colonna epoxidations. 200 
 
5.3.3 Miller – Peptide Asymmetric Epoxidaitons. 
Following on from the peptide theme, Miller et al. 201-204 developed an N-Boc-
protected L-aspartate benzyl ester 367 in combination with DIC as a stoichiometric 
activator, DMAP as an acyl transfer catalyst and hydrogen peroxide. Reactions on 1-
phenylcyclohexene 368 were performed in order to optimise epoxidation conditions 
achirally with up to 15 catalytic turnovers (5 mol% cat. leading to 74% yield within 
3.5 h). Scheme 97. 
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Scheme 97: Miller’s optimised reaction conditions. 
 
Miller performed numerous experiments to establish the role of each of the 
components of the reaction mixture. As a result of the findings, a mechanism was 
proposed. Figure 22. 
 
Figure 22: Miller’s proposed mechanism. R* = chiral side chain. 
 
Miller suggested that as expected from the literature precedent205,206 diacyl 
peroxide byproduct 373 is formed under the reaction conditions. Formation of 373 
is obviously undesirable, as competes with the epoxidation process and is only 
slowly perhydrolysised back to 372. Miller found that addition of DMAP accelerates 
the perhydrolysis reaction. Critically Miller stated that no conversion of 368 to 369 
was observed until addition of peptide catalyst 367. 
 
To induce asymmetry, aspartic acid was incorporated into a peptide sequence 
which resulted in a β-turn-type structure as shown in peptide catalyst structure 374. 
To test the epoxidation capabilities of peptide 374 carbamate functionalised 
substrates 375 were chosen to facilitate potential catalyst–substrate interaction 
through hydrogen bonding. Scheme 98. 
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Scheme 98: Miller’s peptide catalyst and substrate reaction conditions. 
 
Results indicated that 374 was a suitable catalyst obtaining 17 catalytic turnovers at 
25 °C. Substrate (Ar = Ph, n = 1) could be epoxidised obtaining 97% yield and 89% ee 
at -10 °C. Various other carbamate substrates were tested the majority with high 
yields and selectivities, albeit in some examples at low temperature and over 
extended periods of time.  
 
In a follow up study, 204 catalyst analogues 377 – 379 were assessed for their 
catalytic activity, to give insight and mechanistic understanding.  
 
Scheme 99: Miller’s new catalysts 204 
 
Catalyst 377 gave insight into the importance of the NHBoc functionality; under 
standard test conditions catalyst gave 88% ee which is comparable to the original 
catalyst 374, which suggests the NHBoc group is not involved in the hydrogen 
bonding interaction with the substrate. Catalyst 378 evaluated the function of the 
Pro-ᴅ-Val amide, which in this case was replaced by an alkene, the reduction in 
selectivity was observed, 16% ee, under standard conditions, which suggests this 
structural feature contributes greatly to the observed enantioselectivity. This is also 
supported by the observed structural differences in the X-ray crystal structures. 
Finally fluorinated alkene catalyst 379 was used to imitate amide like character in an 
olefinic mimic. Enatioselectivities observed with 379 were 52% ee, explained by a 
slightly weaker hydrogen bonding effect, with ‘inbetween’ characteristics of the two 
previous catalysts 377 and 378.   
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5.4 Summary 
From this short yet specific literature review it is firstly obvious that there is a 
wealth of work and research in the area of asymmetric epoxidations. 
 
The majority of the asymmetric organocatalytic epoxidations – for this is the area of 
research interest – employ catalysts which are derived from natural sugars or chiral 
pool sources. 
 
We have seen in the preliminary introduction that MAO offers viable route to an 
abundant source of enantio-pure chiral material. It is therefore intuitive to explore 
the viability of MAO products to the application of asymmetric organocatalytic 
epoxidations. 
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6 Chapter 6: Peracid Epoxidations   
6.1 Introduction – Chiral peracids & epoxidations. 
This body of work takes its inspiration from Miller et al.201  who utilised hydrogen 
peroxide and a chiral peptide catalyst 374 to selectively epoxidise specific alkenes 
380 which contain a carbamate side chain. Their report presents varying 
enantiomeric excesses and conversions over a variety of time periods and 
temperatures, including some excellent results, and highlights the potential of a 
chiral acid, standard peptide coupling reagents and hydrogen peroxide to generate 





Figure 23: Miller’s chiral acid peptide acid method. 
 
With access to a sustainable source of a chiral acid 30, via the MAO of benzoic acid, 
we sought to scope its viability as a catalyst for the asymmetric epoxidations of 
alkenes with hydrogen peroxide. Figure 24. 
 
 
Figure 24: Aim of microbial derived acid to act in epoxidations reactions.  
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The initial aim of this work was to synthesise acid structure of type 382 to be used 
as catalysts for the enantioselective epoxidation of alkenes. It is necessary to 
protect the alcohol functionalities so they do not interfere with the coupling 
reagents and self-condense. Additionally removal of the reactive diene functionality 
is essential so the catalyst does not affect self-epoxidation. 
 
6.2 Results and Discussion: Catalyst Synthesis 
6.2.1 Acetonide protection of diol acid. 
Initially we sought to protect the diol 30 utilising standard acetal protection, a 
common technique used for this type of compounds, having precedent within the 
research group.68,69,72,75,76,144,207 Scheme 100. 
 
 
Scheme 100: Acetonide Protection hydrogenated diol acid.  
 
Starting with the product from MAO 30, hydrogenation with palladium on carbon 
gave the desired saturated acid diol 383, albeit obtained with varying yields, 33-
71%. Higher isolated yields were obtained with an adapted column chromatography 
purification procedure; addition of 10%, 50% v/v aqueous AcOH, to the 
corresponding eluting solvent prevented compounds adhering and retaining on the 
column resulting in higher isolated yields. Residual AcOH could be removed from 
the isolated final compound under reduced pressure and heating to obtain pure, 
white crystalline product 383.  
The diastereoisomer of 383 has been previously synthesised, with coincidentally 
consistent melting points to the product synthesised here. 208,209 
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Attempts to form the acetonide protected product 384 were unsuccessful. 
Conditions included both the standard 2,2-Dimethoxypropane and pTSA,207 Zerolit 
225 solid acid resin, heating and varying  solvents, all resulting in recovery of 
starting material 383. 
  
In an alternative approach, taking the known acetonide protected diene 206, under 
standard hydrogenation conditions, the desired product 384 was not formed, 
instead the product isolated, 383, indicated acetonide deprotection.  
We can attribute the instability of compound 384, and the inability to form the 
acetonide group to the inherent acid sensitivity of an acetal protecting group. With 
the presence of the free carboxylic acid functionality on the molecule itself, 
deprotection could plausibly be autocatalytic.   
6.2.2 Silicon protection of diol acid. 
With an abundance of the hydrogenated diol acid 383, silicon protection and 
formation of bicyclic systems were attempted. More rigid structures may possibly 
induce enhanced enantioselectivity if used as catalysts. Scheme 101. Following 
procedures common within the literature for silicon protection,210 attempts using 
Di-tert-butylsilyl bis(trifluoromethanesulfonate)  and 1,2-
bis(chlorodimethylsilyl)ethane under standard silylation conditions to form the 
corresponding desired products 385 and 386 were unsuccessful. Again this could 
conceivably be attributed to the acid lability of silacycles 385 and 386, especially 
steric strained disiloxane 385.  
 
Scheme 101: Silicon protection of diol acids. 
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6.2.3 Formation of acid catalysts via esters 
With problems of autocatalytic deprotection due to the presence of the free acid 
functionality we sought to transiently protect the acid as an ester. Esters are formed 
readily and are much simpler to purify.76,144 Scheme 102. 
6.2.4 Formation via methyl esters 
Formation of the methyl ester 387 using TMS diazomethane proceeded under 
quantitative conversion. Surprisingly, alternative use of dicyclocarbodiimide (DCC), 
avoiding both cost and toxicity of TMS diazomethane, proceeded well with yields 
53-73%. No self-coupled dimer products were observed, despite the alcohol 
functionality in the starting material. This could be attributed to the dilute reaction 
conditions; there is more chance of a compound coupling with methanol than with 
another molecule of itself.  
Methyl ester 387 has been previously synthesised albeit not in 100% ee, but as a 
scalemic mixture 211,212 
Acetonide protection of methyl ester 388 proceeded well with 61% yield to give the 
desired product. On a large scale repetition of this procedure a byproduct 389 was 
identified isolated in a 2% yield. This dimer formation, due to reaction with the 
starting material 387 with the desired product 388 highlights the potential 
unwanted reactivity of the secondary alcohol. 
 
Scheme 102: Formation of acids via methyl esters. 
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The final basic hydrolysis step of methyl ester 388 proved problematic. LiOH was 
unsuccessful and several attempts using NaOH and THF both at room temperature 
and heating gave inconsistent results with yields ranging from 5 to 10%. Under 
reflux both decomposition and rearrangement was observed giving acetonide 
migration product 390 13%, desired acid 384 10% and decomposition product diol 
acid 383 21%. Reduction in isolated mass could be attributed to loss of product in 
the aqueous acidification and workup. These results indicate the sensitive nature of 
the acetonide with regards to unwanted migration and cleavage. 
 
The Migration product 390 was fully assigned by detailed 2D-NMR spectroscopy 
studies, as described below. Analysis of 1H and 13C 1D-NMR spectra alone were 
insufficient, with only a few assignments being made. Figure 25. 
 
Figure 25: NMR spectroscopy assignments based on complete 2D data. 
 
Analysis of HSQC identified direct C-H bond interactions; this enabled the complex 
aliphatic region of the spectra to be split up to single proton environments. 
Additionally the OH region was identified. Figure 26. This technique alone was 
insufficient for further assignments to be made. 
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Figure 26: Compound 390 HSQC 2D-NMR Spectra, indicating which protons are bound to 




Figure 27: 390 HMBC 2D-NMR Spectra 
 
30.6 33.6 23.6 33.6 
20.1 
30.6 20.1 23.6 
Which carbon environmentals this chemical shift is bonded to.  
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Complete assignment was achieved with combined analysis of both HSQC and 
HMBC 2D-NMR spectra. HMBC indicated the carbonyl δc 174.0 interacted with 
saturated hydrogens at δH 1.92 and 1.73. HSQC could identify that these hydrogens 




Figure 28: Further assignments of compound 390 via interpretation of 2D-NMR spectra. 
 
Analysis of HMBC δH 3.75 interactions identified adjacent carbons at δc 31 and 24. 
Again HSQC identified the corresponding proton chemical shifts. The only un-
assigned carbon δc 20.1 could be assigned by matter of elimination. Further support 
for the assignment can be observed though negative interaction; peaks that are not 
present. δc 70.9 does not see any interaction with protons bound to δc 23.6 as well 
as δc 83.2 does not see any interaction with protons bound to δc 20.1. This is 
expected as HMBC interaction over four bonds is rarely observed due to weak 




Figure 29: Complete assignment of compound 290 via interpretation of 2D-NMR spectra. 
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Figure 30: NOESY 2D-NMR Spectra of compound 290 indicating through space proton-
proton interaction 
 
Finally via analysis of NOESY spectrum could suggest the conformation of the 
cyclohexane ring. Axial protons at δH 3.75, 1.88, 1.73, 1.38 showed through space 
interactions. Figure 31.  
 
 
Figure 31: NOESY correlations which indicated conformational structure of compound 
290. 
 
In further support for the structure, the polarity of the compound, Rf = 0.50 (50% 
EtOAc-petrol), this is much more a-polar than any of the previous isolated 
carboxylic acids, suggesting an ester functionality rather than acid. Furthermore, 
analysis of the ketal resonance in the carbon spectra at δc 110 is in support of a five 
membered ring, structure 390, rather than a possible six membered ring as shown 
in 391. This is supported by literature studies;106 five membered acetonides have 
characteristic quaternary carbon chemical resonances between 108 – 111 ppm, 
whereas six membered ketals have shifts between 97-101 ppm. Figure 32. 
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Figure 32: Five or Six membered acetonide? 
 
To summarise, formation of acetonide protected acid 384, via methyl esters, is 
possible via this route, although the basic hydrolysis step proves unreliable due to 
decomposition and rearrangement.  
6.2.5 Formation via Benzyl Esters 
We next investigated benzyl esters as their deprotection can be achieved without 
basic hydrolysis. Carboxylate alkylation of 383 was selective in formation of the 
ester 392 33-42% and no benzyl ethers were observed. Acetonide protection gave 
benzyl ester 393 in a considerably improved 91% yield. In contrast to the methyl 
ester 388 the benzyl ester hydrogenolysis was successful, to give 384 in a 63% yield. 
Scheme 103. 
 
Scheme 103: Benzyl ester route to acid catalyst 384. 
 
Telescoping the process resulted in an overall reduction in isolated yield. Scheme 
104. This indicates the sensitive nature of the desired acetonide protected acid, as 
telescoping would lead to a build-up of impurities.   
 
 
Scheme 104: Telescoped process. 
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The previous synthesis of the acetonide acid involved two hydrogenation steps, 
Scheme 103, one to reduce the alkenes in 30, one to deprotect the benzyl ester 
393. Combining the hydrogenation steps to form the acetonide acid 384 in three 
steps from the MAO product was successful. Scheme 105. From the known benzyl 
ester 394,76 facile acetonide protection achieved 395 in a 92% yield and the 
optimised hydrogenation to remove both diene and ester 384 was achieved in 80% 
in the first instance. 
 
 
Scheme 105: Combined hydrogenation steps. 
 
However, the final hydrogenation step to form 384, proved inconsistent; 
decomposition product diol acid 383, methylester diol 387, unidentifiable 
byproducts and significant loss of mass were observed on purification. This suggests 
autocatalytic deprotection. Scheme 106. 
 
 
Scheme 106: Decomposition products observed. 
 
Issues of decomposition upon purification were addressed by using a dry column 
chromatography method,213,214 being able to isolate up to 80% of 384 from 
hydrogenation of 395. At this stage we have a stabilised route through to the 
acetonide acid 384 in three steps from the product of MAO.  
6.2.6 Silicon protection of esters. 
With benzyl ester 394 in hand, we sought again to attempt silyl protection. Scheme 
107. This was achieved easily in 75 – 81% yield. This was followed by facile 
reduction/deprotection to give 385 in 53% yield.  
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Scheme 107: Silyl protection of esters to form silyl acids.  
 
However, again, disappointingly repetition of the final deprotection step, 
purification lead led to decomposition of the silyl acid 385 down to the diol acid 
383. Scheme 108. This again indicates the instability of this type of compounds with 
respect to both purification and autocatalytic deprotection.   
 
Scheme 108: Decomposition of silyl acid on purification. 
 
Starting with the methyl ester 387, silicon protection was successful to form 397 
with an 82% yield, however basic hydrolysis was not. Again this could be due to the 
acid sensitive nature of the product in the work up, which involves careful 
acidification of the basic hydrolysis mixture to neutral conditions. Scheme 109. 
 
Scheme 109: Silyl protection of methyl ester 
6.2.7 Methyl Ethers 
At this stage, it had been demonstrated how sensitive the most commonly applied 
hydroxyl protecting groups are to the presence of the acid side chain on the 
molecule.  A hydroxyl derived functional group that was not acid or base sensitive 
was needed; methyl ethers were considered appropriate. 215 
 
Unsurprisingly attempted formation of 398 from diene benzyl ester 394 was 
unsuccessful, and shows that this type of diene cis-diol is sensitive to acidic and 
basic conditions and readily rearomatises. Scheme 110. 
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Scheme 110: Attempted methyl ether formation.  
 
Diol acid 383 and 2 equivalents of methyl iodide, gave methyl ester 387 18% and 
desired product, protected ether 399 51 %, which could be separated. Scheme 111. 
 
 
Scheme 111: Attempted methylation 
 
Repeating the procedure with 3.4 equivalents of MeI, two inseparable esters were 
identified. Silicon protection of the mixture, 399 and 400, facilitated separation to 
give silyl compound 401 18% and di-ether 399 70% over two steps. Scheme 112. 
 
Scheme 112: bis(methyl ether) formation 
 
Upon optimisation and incorporating an excess of methyl iodide, 4 equivalents, the 
diether 399 was obtained, 69% as the sole product. Scheme 113. 
 
Scheme 113: Optimised methylether formation 
 
In order to obtain the desired chiral acids, basic hydrolysis of the methyl esters was 
required. Unfortunately hydrolysis of these methyl esters proved inconsistent. 
Hydrolysis of silicon ether 401, was unsuccessful and recovered small amounts of 
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starting material. Scheme 114.  More success was obtained with the di methyl ether 
399, where 36-75% isolated yields were obtained. Scheme 115. 
 
 
Scheme 114: methyl ester hydrolysis 
 
 
Scheme 115: methyl ester hydrolysis 
 
At this stage a reliable and reproducible route to di methyl ether acid 403, in three 
steps form the product of MAO was in hand. 
6.2.8 Other catalysts. 
It is commonly known that to enhance stereoselectivity of a catalyst the two most 
important factors are steric bulk and electronic properties of the catalyst,  as was 
shown by Miller and his carbamate – peptide interactions,202 and Shi and his 
pyranose ketones.184  
 
Thus synthesis of bicyclic acid catalysts was attempted in order to enhance any 
stereoselectivity observed. Following the Ley carbohydrate protection 
methodology216,217 we sought to protect the diol functionality using 2,3-
Butanedione and trimethyl orthoformate. Considering the double anomeric effect 
present in 405, this would be expected to be the favoured diastereomer. Figure 33. 
 
 
Figure 33: Expected product from ley protection. 
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Attempts on both the acid 383 and methyl ester 387 using methanol were 
unsuccessful. Very small amounts of product were identified when utilising a pTSA 
acid catalyst and CH2Cl2 as the solvent. The small mass isolated, complex NMR and 
the TLC showing multiple components with similar Rf, suggests different 
diastereoisomers had formed and would be difficult to isolate and purify. This was 
not pursued.  
 
 
Scheme 116: Ley protection. 
 
In a different approach with methylester 387, diastereomer formation with 
benzaldehyde was investigated. It was speculated that different diastereoisomers 
may result in different stereoselectivity. Attempts using CH2Cl2 at room 
temperature gave recovered starting material. Utilising THF at reflux resulted in THF 
being incorporated into the products. Success was finally obtained using toluene as 
the solvent and refluxing for 24 h. Scheme 117. 
 
Scheme 117: Benzyaldehyde acetal protection 
 
Diastereoisomers were separated by column chromatography; unfortunately they 
could not be separated completely and a 1:1 mix of 408 and 409 was obtained in a 
40% yield, in addition to 24% of 408 and 35% of 409.  
 
Identification of the diastereoisomers 408 and 409 could be achieved using NOESY 
NMR spectroscopy. Additionally the 3D modelling indicates that the lower yield in 
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408 could be due to steric clash of the aromatic ring with the carbonyl group.  















Figure 35: NOESY NMR spectroscopy of 409, to determine diasetereoisomer. 
  
NOESY 
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6.3 Conclusions – Catalyst Synthesis 
At this stage several different routes have been scoped for the viability of 
synthesising a range of chiral acid catalysts derived from the ipso, otho cis-diol MAO 
product of benzoic acid. 
Three chiral acids 384, 385 and 403 have been synthesised. Scheme 118  In the next 
section these chiral acids have been evaluated for their catalytic activity in 
asymmetric epoxidation reactions. 
 
Scheme 118: Chiral acids synthesised 
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6.4 Results and Discussion: Catalyst Testing 
6.4.1 Initial Catalyst testing 
Using Miller et al. 201 as a starting point for reaction optimisation, styrene 410 was 
chosen as a substrate, N,N'-Dicyclohexylcarbodiimide (DCC) was chosen as the 
available carbodiimide coupling agent and benzoic acid as the achiral acid catalyst 
for comparison to the synthesised chiral acids. Scheme 119. 
 
Scheme 119: Preliminary conditions used for catalyst testing. 
 
The subsequent reactions evaluated at many variables to predominantly achieve 
high conversions and investigate the roles of each of the components to gain 
greater insight into the reaction. Results of conversions and specific reaction 
conditions are graphically shown below. Table 4.Graph 1. 
 
Rxn H2O2 DCC DAMP Acid Other Conversion 
R1     No Acid 0.87 M 59% 
R2     Dilute Conditions 0.18 M 18% 
R3     Just H2O2 0% 
R4     Just H2O2 + DCC 21% 
R5     Alkene added last 48% 
R6     Chiral Acid 384 Alkene added last 12% 
R7     DCC last 51% 
R8     Alkene added after 1 h 19% 
R9     -22°C to r.t. DCC last 44% 
R10     Exact replicate R9 63% 
R11     Chiral Acid 385, DCC added last 11% 
Table 4: Initial Reaction optimisation conditions 
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An initial reaction R1 0.87 M in the absence of benzoic acid gave a conversion of 
59%, this suggests the benzoic acid is not essential for the reaction to take place, 
and that a background reaction is significant. A dilute reaction in the presence of 
benzoic acid R2 under dilute conditions for 20 h at 0.18 M resulted in a 
disappointing conversion of 18%.  (N.B. all subsequent reactions were carried out at 
0.87 M for consistency and comparability of results.) 
 
Further investigations into the specific roles of each of the components, R3 showed 
that hydrogen peroxide alone was insufficient, and only in the presence of DCC R4 
would the reaction proceed, albeit with a lower conversion, 21%. This result is of 
interest as the conversion is higher than that for the dilute reaction R1, suggesting 
the concentration plays a key role. The presence of DMAP R5 again improved 
conversions to 48%.   
Initial reactions using a chiral acetonide catalyst 384 under these standard 
conditions R6, at 0.87 M, and employing addition of the styrene after an hour, in an 
attempt to allow the peracid to form in situ, progressed with a disappointing 12% 
conversion.  
 
Following the Miller precedent, which added the diimide last, ‘added to start the 
reaction’, in reaction R7 DCC was added last in presence of benzoic acid gave a 51% 
conversion. Investigating further the order of addition, R8 involved no acid and 
styrene addition after an hour gave 19% conversion. 
 
Results to briefly scope the effect of temperature, in reactions R9 and R10 
components were added at ˗22 °C and allowed to warm to room temperature 
slowly over the course of the reaction.  R9 added DCC last and gave a 44% 
conversion; a repeat of this R10 to observe reproducibility of results gave a 63% 
which suggests poor reproducibility. Disappointingly R11 using chiral acid 385, 
achieved a meagre 11% conversion.  
 
Considering the length of reaction, R1 and R2 were left for 20 h, R3 to R8 were left 
for 90 h and R9 to R11 for 60 h. Firstly considering this length, conversions are low 
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and unimpressive, the significant difference in time does not result in a significant 
difference in conversion. It is worth noting Miller also reported some lengthy 
reaction times over several days. 
 
To summarise the above results, it is obvious there is little reproducibility and 
consistency between comparable reactions. Notably the use of DCC proved 
problematic in the aqueous work up and extraction, the DCC urea derived 
byproduct precipitated and caused poor phase separation.  Future reaction 
optimisations will consider other carbodiimides such as N,N'-
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6.4.2 Reaction Optimisation Using DIC 
Again using Miller201 as a starting point for reaction optimisation, N,N'-
Diisopropylcarbodiimide (DIC) was chosen as the available carbodiimide and 
benzoic acid as the achiral alternative for comparison to the latter synthesised chiral 
acids. Scheme 120. Considering the variety in reaction conditions investigated in the 
previous section, a more systematic approach was taken, results shown in Table 5 
and Graph 2. 
 
Scheme 120: Starting point for reaction optimisation using DIC. 
 
Rxn Investigation Outcome 
Max  
conversion 
R12 Solvent Screen Acetone 19% 
R13 Use of a carousel Acetonitrile – improved mixing 32% 
R14 Order of addition Very little difference 26% 
R15 Amount of DMAP 20 mol% beneficial 36% 
R16 Concentration H2O2  50%  H2O2 had no effect 27% 
R17 Concentration of reaction  4.0 M improved conversion  44% 
R18 Amount of H2O2 1.0 mL 12 equiv.  77% 
R19 Amount of DIC 4 equiv., 2 used for solubility 83% 
R20 Solvent screen Acetonitrile 66% 
R21 EDCI Water soluble diimide 2% 
R22 Chiral acids 384 and 385 Under optimised conditions 72% 
Table 5: Overview of reaction optimisation investigation and outcomes. 
 
Initial solvent screen of the reaction R12 and R13 scoped a variety of different 
solvents; Acetonitrile was the best performing solvent with 32% conversion, 
followed by MeTHF 23%, CH2Cl2 21% and 2-butanone 19%. As suspected polar 
aprotic solvents are beneficial for the reaction, and CH3CN being water miscible 
promotes the reaction.  
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Improved mixing and use of a carousel was implemented from R12 to R13. The 
benefits are shown noting R12.1 and R13.1 both use CH2Cl2, conversion of 13% to 
21% respectively indicates the importance of uniformed and good mixing in a 
biphasic reaction. Use of a phase transfer catalyst, tetrabutylammoniumbromide 
(TBAB), ceased the reaction and was not further investigated. R12.2 
 
R14 investigated order of addition of the reagents, using MeCN as the optimal 
solvent. In his work Miller presents two methods: 
General Procedure a: Acid + DMAP + Solvent + Alkene + H2O2 + DIC 
General Procedure b: Alkene + Acid + Solvent+ H2O2 + DIC + DMAP 
As it is obvious there are two possible pathways for epoxide formation, one using 
the acid catalyst, one not, 218 it would seem important that the active oxidant is the 
chiral peracid and not the DIC-peroxide complex. In order to promote peracid 
formation the procedure below was employed. The length of stirring was varied 0 
mins, 5 mins, 1 h.  
 Procedure c: Acid + DIC + DMAP + Solvent (Stir), then H2O2 (Stir), then Alkene 
Results indicated very little difference in conversions, 22-26%, which indicates that 
order of addition is not of primary importance.  
 
R15 investigated increasing the amount of DMAP, as this should improve the rate of 
formation of the peracid over the DIC-peroxide species.201 Results showed that 0.2 
equiv improved conversion to 36% however 0.4 equiv reduced conversion to 27%. 
Possibly due to competing reactions and formation of byproducts are indicated by 
the Miller report. 201 
 
The next set of experiments R16 and R17 evaluated concentration of the reaction 
and the peroxide concentration and equivalents. Again using the standard 
conditions and acetonitrile; the use of concentrated, 50% H2O2, 2.5 equiv R16 
showed slight improvement to 27%. Varying the concentration of the reaction, 
R17.1 from 0.8 M to 1.0 M in MeCN improved conversion to 35%, further 
concentration R17.2 to 4.0 M further improved conversion to 44%.  
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R18  kept the concentration constant at 0.8 M while varying the amount of H2O2 
added, from 0.4 – 1.0 mL, showed a dramatic increase in conversions, as 1 ml 
equates to 12 equivalents of oxidant, a 78% conversion was observed as the best 
achieved so far. 
 
Finally R19 investigated how equivalents of DIC affected conversions; as expected 
increasing the amount of diimide improves conversion, however not to the extent 
that varying quantity of the oxidant did. Conversion ranged between 80% to 83%. 
 
Finally a solvent screen R20 was performed for a second time to confirm that MeCN 
was the optimal solvent. Solvents chosen were previously tested CH2Cl2, MeTHF and 
Acetone, as these were the best performing solvents from previous screens. 
Conversions for these other solvents dropped dramatically which indicated 
unambiguously that MeCN is the solvent of choice. 
 
A drawback from all of the work carried out above is the presence of an insoluble 
urea byproduct, this can be filtered out however even after chromatography it 
sometime may persist. Use of a water soluble diimide EDCI219 was investigated as 
would be removed in aqueous work up. However reactions using EDCI did not 
proceed. No conversions were observed.  
 
To summarise, conditions have been optimised to greatly improve the conversion of 
the reaction over the 20 h given time frame.  Scheme 121. 
 
 
Scheme 121: Optimised conditions. 
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6.4.3 HPLC Methods 
Chiral HPLC methods were developed for styrene oxide 411 as the chosen substrate. 
The first: Chiralpak AS. 0.2 mlmin-1. 0.6% IPA/Hexane, 254nm. This gave good 
baseline separation and peaks of equal integration at t1 = 30 mins and t2 = 35 mins. 
Graph 3. The second shortened the method significantly: Chiralpak AS. 0.8 mlmin-1. 
0.2% IPA/Hexane, 254nm. This gave good baseline separation and peaks of equal 




Graph 3: Method 1. Styrne oxide, racemic, HPLC separation. Chiralpak AS. 0.2 mlmin-1. 





Graph 4: Method 2. Styrene oxide, racemic, HPLC separation. Chiralpak AS. 0.8 mlmin-1. 
0.2% IPA/Hexane, 254nm. t1 = 9.9 mins and t2 = 12.4 mins 
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6.4.4 Chiral Acid Epoxidations HPLC results – unoptimised 
conditions 
During the reaction optimisation process some chiral acids were evaluated and 
tested for their enantioselectivity, albeit under un-optimised reaction conditions. 
Scheme 119 & Graph 1. Using the chiral acetonide acid 384 in reaction R6, a 12% 
conversion and a 25% ee was calculated via HPLC method 1. Graph 5. 
 
Graph 5: R6 using  chiral acetonide acid 384 HPLC result. HPLC method 1. 
Reaction using the silicon protected acid 385 in reaction R11 gave a 11% conversion 
and a calculated selectivity of 6% ee, again using HPLC method 1. Graph 6. 
 
Graph 6: R11 using chiral silicon  acid 385 HPLC result. HPLC Method 1. 
 
At this stage of reaction screening, it is worth emphasizing that these are un-
optimised conditions, using an unfunctionalised substrate and a fairly minimally 
functionalised catalyst. Although the reactions are low yielding, the selectivity 
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observed is not zero. It is also worth noting that the HPLC quality is mediocre, this is 
due to samples being unpurified, residual styrene can be removed under reduced 
pressure, and most of the urea byproduct can be filtered off, however some still 
persists, often resulting in poor quality chromatograms. Nevertheless, at this early 
stage of catalyst screening, these resulting presented an excellent starting point for 
catalyst development an encouraged the work to continue.  
6.4.5 Chiral Acid Epoxidations HPLC results – optimised 
conditions 
After optimising the reaction conditions. Scheme 121 & Graph 2. Some more chiral 
acids were tested under the optimised reaction conditions and analysed using HPLC 
method 2.  
Repeating the chiral acetonide 384 under the optimised reaction conditions R22.1 
resulting in an increased conversion to 72%, however as a penalty selectivity 
reduced to 14% ee. Graph 7. 
  
Graph 7: R22 chiral acetonide acid under optimised conditions. HPLC method 2. 
 
Using the di-methyl ether acid 384 under the optimised conditions R22.2 again gave 
a sufficient conversion of 69%, however disappointingly a selectivity of only 4% ee, 
which could be attributed to error or variation in either integration, base line effects 
or sample preparation. Graph 8.  
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Graph 8: R19.2  Chiral di-methyl ether 403 under optimised conditions. HPLC method 2.  
 
At this stage, chiral HPLC’s are of singular reactions, to ensure validity of results it is 
essential that they are repeated. R22.1 was chosen to be replicated as showed the 
















Graph 9: R23.1 repeat of R22.1 HPLC Method 2. 
 
Reaction Conv. % ee 
R 22.1 72% 14% 
R 23.1 80% 6% A 
R 23.2 70% 6% B 
Table 6: Repeating chiral  acid reactions 
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Graph 10: R23.2 repeat of R22.1. HPLC Method2. 
 
Unfortunately these repeated chiral catalysts runs, not only show a reduction in the 
selectivity of 6% ee, which is small enough to be considered error, but additionally  
inversion of the selectivity was observed between runs. 
 
6.4.6 Summary HPLC results 
These results, despite optimisation, have shown that an increase in conversion has 
not enhanced the selectivity. It is worth considering whether the catalyst is playing 
a vital role. Under the optimised conditions reaction with benzoic acid gave a 79% 
conversion, and without benzoic acid gave 74%. This suggests the acid catalysed 
process has in effect has become the background reaction, and the known 
background reaction of di-imide and hydrogen peroxide218,220 to form the complex 
412 is actually performing the majority of the epoxidations. Figure 36. 
 
Figure 36: Epoxidation of styrene via di-imide and peroxide complex. 
 
To summarise the above chiral HPLC results – it has been shown that some 
selectivity has been observed, maximum 25% ee, other results have been much less, 
and even racemic. 
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The optimisation of the reaction conditions has led to the chiral catalyst playing 
little part in the reaction; this needs to be addressed.  
 
It is also worth noting the difficulty in obtaining good quality HPLC for styrene oxide, 
despite through optimisation and trials of many different columns, conditions and 
methods, DIC urea byproduct in samples leads to poor quality traces. 
 
From all the above and from the start, it has been aware that the epoxidaiton 
proceeds in the absence of acid, and since been shown that the background 
reaction, via intermediate 412, is now very much in the foreground. In an attempt 
to address this both varying urea source and coupling agent will be considered.  
 
6.4.7 Different coupling agents 
DIC, DCC are all common peptide coupling agents. Other coupling agents were 
identified and tested. Under the optimised reaction conditions EDCI and HATU, both 
on their own and with the addition of HOBt activating agents gave no reaction. The 
use of T3P® (Propane Phosphonic Acid Anhydride) did not give the desired epoxide, 
instead ring-opened to form the corresponding diol 413. 219  
 
The diol was analysed for its enantioselectivity by known methodology. 221 
Formation of an imine 416 with addition of boronic acid 414 and chiral amine 415 
was followed by NMR spectroscopy. Analysis and integration of the diastereotopic 
protons of the imine, showed a racemic mixture had been formed and hence no 
enantioselectivity was induced in the epoxidation.   
 
 
Scheme 122: Formation of chiral imine to calculate enantioselectivity. 
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Graph 11: Overlaid NMR spectra of imine diastereoisomers. 
6.4.8 Different urea source. 
Initially investigations used aqueous H2O2, however this is not the only possible 
oxidant and others are used in industry. Most commonly used is urea hydrogen 
peroxide, due to cost, ease of handling and safety.  
Under the optimised conditions, hydrogen peroxide urea gave a 13% conversion, 
which is a reduction to the 80% observed using the aqueous peroxide solutions. This 
reduction in conversion could be attributed to a solubility issue, to enable a direct 
comparison a solvent screen using urea hydrogen peroxide was carried out under 
un-optimised conditions, to enable a direct comparison to previous solvent screen 




Scheme 123: Conditions for urea H2O2 solvent screen. 
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Solvent Urea H2O2 Aqueous H2O2 
CH2Cl2 <1% 21% 
Me-THF 0% 23% 
Acetone 14% 15% 
Butanone <1% 19% 
MeCN 9% 32% 
 
Table 7: Solvent Screen Urea Hydrogen peroxide compared to aqueous peroxide.  
 
These results indicate that urea hydrogen peroxide is not a good candidate, as the 
aqueous peroxide performs better in all cases.  
6.4.9 Is the active catalyst actually being formed? 
 
All the above results suggest the known background reaction is significant. For 
absolute conformation, isolated and purified chiral peracid catalyst would need to 
be synthesised to evaluate its ability to directly epoxidise alkenes, rather than being 
generated in situ. However this is not possible due to the difficulty and risk 
associated in isolating potentially explosive peracid material. Additionally peracid 
synthesis often requires a strong acid, which is not viable for our acetonide acids, as 
would result in deprotection. Alternative analysis needs to be performed.  
 
It is known within the literature that oxidation of organic sulfides to sulfoxide occurs 
rapidly with peracids and proceeds very slowly with hydrogen peroxide. 
Methodology has been developed using GC to determine the amount of active 
peracid in the presence of an excess of hydrogen peroxide. 222 The same theory can 
be transferred to develop NMR spectroscopic method. Scheme 124. If the peracid is 
formed in situ, thioanisole 418 will be readily oxidized to methyl phenyl sulfoxide  
419 which can be analysed via NMR spectroscopy, as the chemical shifts of the 
methyl protons are distinctive from one another. Scheme 125. Results & NMR 
spectra shown below Table 3. 
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Scheme 124: Reaction Scheme for testing prescence of peracid formation. 
 
 











0.1 : 0.4 : 1.0 
 
0.1 : 0.4 : 1.0 
1.0 sulfoxide 
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  relative ratios 
1 Benzoic acid 15 min 1.0 1.0 0 
2 Chiral Acid 384 1 h 1.0 0.38 0.13 
3 No Acid 1hr 1.0 0.38 0.13 
4 Benzoic Acid 1hr 0 1.0 0 
 
Table 8:  1) Benzoic acid (94 mg, 0.78 mmol, 1 equiv), DIC (0.24 mL, 1.54 mmol, 2 equiv), DMAP (19 
mg, 0.16 mmol, 10 mol%) H2O2 (35 wt%, 0.79 mL, 12 equiv), thioanisole (484 mg, 3.9mmol, 5 equiv) 
MeCN (0.8 mL). Stirred r.t., 15 mins. Workup, add ice (5 mL), add NaHCO3(aq) extract CHCl3 (3 × 10 
mL), dry MgSO4 concentrate under reduced pressure. 2) Chiral acid 384 (68 mg, 0.34 mmol, 1 equiv), 
DIC (0.1 mL, 0.68 mmol, 2 equiv), DMAP (8 mg, 0.06 mmol, 10 mol%) H2O2 (35 wt%, 0.35 mL, 12 
equiv), thioanisole (217 mg, 1.75mmol, 5 equiv) MeCN (0.35 mL). Stirred r.t., 60mins. Standard 
workup.  3) DIC (0.1 mL, 0.68 mmol, 2 equiv), DMAP (8 mg, 0.06 mmol, 10 mol%) H2O2 (35 wt%, 0.35 
mL, 12 equiv), thioanisole (217 mg, 1.75mmol, 5 equiv) MeCN (0.35 mL). Stirred r.t., 60mins. 
Standard workup. 4) Benzoic acid (94 mg, 0.78 mmol, 1 equiv), DIC (0.24 mL, 1.54 mmol, 2 equiv), 
DMAP (19 mg, 0.16 mmol, 10 mol%) H2O2 (35 wt%, 0.79 mL, 12 equiv), thioanisole (484mg, 3.9mmol, 
5 equiv) MeCN (0.8 mL). Stirred r.t., 15mins. Standard workup. 
 
 
Experiment 1 indicated that, under the reaction conditions, benzoic acid was 
converted to perbenzoic acid resulting in 50% conversion of thioanisole to the 
sulfoxide in 15 mins.  
Experiment 2 utilised the synthesised chiral acetonide acid 384, under the same 
conditions as experiment 1 but instead over an extended period of 1 h, as we 
expect the catalyst could be less active. These results indicated a reduction in 
oxidative conversions, suggesting the chiral peracid is a poorer oxidative species. 
Experiment 3 utilised the same reaction conditions as experiment 2, over 1 h, 
containing no acid species. This reaction was performed to observe the background 
oxidation via H2O2. With almost identical conversion to experiment 2, it suggests 
the only conversion observed in experiment 2 is due to oxidation via H2O2, and 
suggest the chiral peracid isn’t being formed. 
Experiment 4 was carried out to complete this series of investigations. Benzoic acid 
was utilised under the same conditions as experiment 2 & 3 for direct comparison 
over 1 h reaction time. Complete conversion to the sulfide was observed. This 
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suggests under these conditions benzoic acid is able to form the perbenzoic acid. 
Whereas in comparisioon under these conditions the chiral acid 384 isn’t able to 






This final sulfide oxidation experiment, along with the unselectively and low 
conversions observed throughout the catalyst epoxidations optimisation process 
suggest that the chiral peracid isn’t being formed under these reaction conditions, 
and hence why we see very little, if no selectivity.  
 
It has been considered that this work will not be pursued further. 
 
Despite this this section shows a range of synthetic procedure through to novel 
chiral acids – future work would hope to find application of these, or use as 
synthons towards subsequent organic targets. 
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7 Chapter 7: Shi Catalyst Analogue  
As we have seen in the literature introduction to epoxidations Shi developed a 
range of catalysts of general type 344. The aim of this work is to synthesise a Shi 
catalyst analogue 421 derived from the MAO product 30. Notably similarities 
include the α-quaternary carbon. Differences include the lack of the endo cyclic 
oxygen and peripheral substituents around the cyclohexane ring.  
Many similar carbocyclic ketones have also been shown to be active epoxidation 
catalysts, as seen in the previous epoxidations literature section. 
 
Figure 38: Shi Catalyst and proposed MAO derived catalyst 
7.1 Shi Like Catalysts – Catalyst #1 
Within the previous chapter, in search for an asymmetric peracid epoxidation 
catalyst, compound 390 was isolated and fully characterised as a byproduct from 
the basic hydrolysis of methyl ester 388. Scheme 126. With a quaternary centre α to 
the alcohol, and the acetonide protected side chain, there are obvious structural 
similarities to the Shi catalyst 344. 
 
Scheme 126: Shi like by product identified via basic hydrolysis of 388. 
 
With 390 isolated and purified, oxidation to form the ketone, and direct Shi 
analogue 422 was evaluated. Scheme 127. Mild oxidative conditions were 
considered as deprotection or rearrangement of the acetonide was possible, as we 
have seen with compounds in the previous chapter.  
Use of pyridinium dichromate (PDC) was unsuccessful, recovering starting material. 
Dess Martin periodinane gave sufficient yield of 60% with the remaining isolated 
mass being recovered starting material.    
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Scheme 127: Synthesis of ketone 422, shi analogue.  
 
This new chiral ketone 422, has many structural similarities with, and prerequisites 
of the Shi catalyst, as reviewed by Shi 184 
- The chiral control element has to be placed close to the reacting 
carbonyl to enhance the stereochemical interaction between 
substrate and catalyst. 
- Fused rings and/or quaternary centre α to the carbonyl group 
being used to minimize epimerization of the stereogenic centres. 
- Approach of an olefin to the reacting dioxirane being directed by 
sterically blocking one face or by a C2 or pseudo–C2–symmetric 
element. 
- The carbonyl being inductively activated by introduction of an 
electron withdrawing element.  
 
Rather than obtaining the catalyst 422 as the low yielding byproduct of the basic 




Scheme 128: Synthetic route through to chiral ketone 422. 
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Previously synthesised benzyl ester diene diol 394 was subjected to TBDMS-OTf 
silylation, in order to form the desired singly protected silyl 423 in a 78% yield.  The 
di-silyl protected byproduct 424 was isolated and identified.  
 
Silyl benzyl ester 423 was subjected to hydrogenation to simultaneously reduce the 
alkenes and cleave the benzyl ester to give 425 in near quantitative yields. 
 
Attempts to form the acetonide protected compound 426 were unsuccessful on 
several attempts, utilising varying ratios of reagents and heating. The inability to 
form 426 could be attributed to the presence of the acid side chain. Acetonides are 
more commonly used to protect alcohols and diols, carboxylic acid protection is less 
precedented. Additionally autocatalytic deprotection could be preventing the 
reaction from occurring as we have seen reoccurring with compounds from the 
previous chapter. 
 
It was considered that this new chiral ketone 422 may be able to act in a similar 
mode to the Shi catalyst in the asymmetric epoxidations of alkenes. To evaluate 
this, trans-stilbene 427 was chosen as a substrate it gives good yields (77-91%) and 
enantioselectivity (94-98% ee) in Shi’s work.184,223 Additionally the substrate was 
chosen as stilbene oxide 428 is easily separable via chiral HPLC. Graph 12. This 
circumvents the issue encountered in the previous chapter of poor quality HPLC 
traces of styrene oxide.  
 
Graph 12: HPLC method for trans-stilbene oxide. Chiralcel OD. 1.0 mlmin
-1
. 10% IPA/Hexane, 
254nm. gave good baseline separation and peaks of equal integration at t1 = 5.9 mins and t2 = 10.2 
mins.  
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Chiral ketone catalyst 422 was evaluated under the conditions described in Shi’s 
most recent work224 following the Oxone procedure. 
 
Figure 39: Epoxidation of trans-stilbene with chiral ketone 422. Reagents and Conditions: 
trans-stilbene (90 mg, 0.5 mmol), ketone 422 (14 mg, 10 mol%), and tetrabutylammonium hydrogen 
sulfate (0.01 g, 0.03 mmol) in MeCN-DMM (v/v, 1/2) (9 mL) was added buffer (0.05 M aq Na2HPO4-
0.05 M aq KH2PO4, pH 7.0) (3 mL) with stirring. Upon cooling to 0 °C, a solution of Oxone (0.212 M in 
4 × 10
-4
 M aq EDTA, 4.8 mL) and a solution of K2CO3 (0.42 M in 4 × 10
-4
 M aq EDTA, 4.8 mL) were 
added dropwise over 1 h. The reaction was quenched by addition of pentane and extracted with 
pentane. The combined organic layers were dried over MgSO4, filtered and concentrated under 
reduced pressure.  
 
 
Disappointingly the above reaction was unsuccessful, with complete recovery of 
trans-stilbene. 
 
The Oxone methodology is known to be particularly sensitive to experimental 
procedure,  Shi states 184,225 that it is essential for the Oxone and K2CO3 to be added 
simultaneously and constantly, ideally via two separate syringe pumps, to control 
and maintain a constant pH to prevent decomposition of either the Oxone or the 
chiral catalyst.  
7.2 Catalyst Design #2 
 
As the above synthetic route is deemed implausible, we sought a new catalyst 
design, 429, for ease of synthesis and greater similarity to the Shi catalyst 344. 
Figure 40. 
 
Figure 40: New catalyst design.  
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Since silyl alcohol acid 427 was in hand, synthesis of reduced diol 430 was 
attempted. Attempts using LiAlH4 were unsuccessful with complete consumption of 
427 to form complex inseparable mixtures.  Scheme 129. 
 
 
Scheme 129: Attempted reduction of 427.  
 
As it has proven difficult to reduce the carboxylic acid 427, a new synthetic route 
was devised to form the reduced alcohol side chain from an ester, as this has 
literature precedent.68,69,72,75,144,207   Scheme 130. 
 
 
Scheme 130: Catalyst Synthesis. 
 
Known methyl ester 121 was converted to the desired singularly protected silyl 
methyl ester 431, in improved selectivity (98% yield) compared to the benzyl ester 
analogue 425 (78% yield). Diene 431 was subjected to standard hydrogenation 
conditions to give the desired product 433 in 42% and the deprotected diol 387 in 
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58% yield as the major product. Diol methyl ester 387 was easily converted back to 
the desired silicon protected ester 433 in near quantitative yields, 98%.  
 
Reduction of silicon protected methyl ester 433 was attempted under various 
conditions, DIBAL-H was unsuccessful, LiAlH4 proved too harsh as resulted in low 
yields, and formation of rearrangement product 434 , observed in varying ratios. 
Milder NaBH4 proved most successful and selective giving 91% yield of desired diol 
430. Now with the reduced side chain in hand, acetonide protection formed the 
expected acetonide 435. Silicon deprotection under standard TBAF conditions gave 
436 in 53% yield.  
 
Finally mild oxidation attempts to form the desired ketone using PDC were 
unsuccessful. Swern conditions proved to work, albeit in a 30% yield of 429. More 
successfully Dess Martin Periodinane gave high yields of 86% of 429, although over 
a 3 day period.  
 
The chiral ketone 429 has been synthesized in 20% overall yield in 7 steps from 
MAO product. 429 has been fully characterised and matches known literature data 
of the opposite enantiomer, which has never been evaluated as a catalyst; the 
enantiomer 429 synthesised here has not been previously reported.226  
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7.3 Catalyst Testing 
In order to minimise unnecessary waste of chiral catalyst 429 and to ensure well 
practiced experimental procedures, preliminary epoxidations reactions were carried 
out using cyclohexanone as an achiral analogue. Scheme 131, Table 9.  Findings are 
discussed below. 
 
Scheme 131: Epoxidation of trans-Stilbene under various conditions. 
 
Reaction Method Conversion Notes 
T 1227 A 9% Cyclohexanone – Oxone. 
T 2193 B 4% Cyclohexanone – H2O2  
T 3194 C 0% Cyclohexanone – H2O2 – nBuOH  
T 4193 D 13% Cyclohexanone – H2O2 – CH2Cl2 – cryostat used. 
Table 9: Method A: trans-stilbene (180 mg, 1.0 mmol), cyclohexanone (0.03 mL, 30 mol%), and 
tetrabutylammonium hydrogen sulfate (0.01 g, 0.04 mmol) in MeCN-DMM (v/v, 1:2) (15 mL) was 
added buffer (10 mL, 0.05 M aq Na2B4O7·10H2O in 4 × 10
-4
 M aq Na2(EDTA)). The mixture was cooled 
to 0 °C in an ice bath. A solution of Oxone (1.0 g, 1.6 mmol in 6.5 mL 4 × 10
-4
 M aq Na2(EDTA)), and a 
solution of K2CO3 (0.93 g, 6.74 mmol H2O 6.5 mL), were added dropwise separately and 
simultaneously via syringe pump over 2 h. The reaction was quenched by addition of pentane and 
extracted with pentane. The combined organic layers were dried over MgSO4, filtered and 
concentrated under reduced pressure. Method B: To a solution of trans-stilbene (180 mg, 1.0 mmol) 
and cyclohexanone (0.03 mL, 30 mol%) in MeCN-DMM (v/v, 1:2) (6 mL) was added buffer solution 
(1.5 mL, 2.0 M K2CO3 in 4 × 10
-4
 M aq Na2(EDTA)). Followed by H2O2 (30%, 0.25 mL, 3 mmol) at 0 °C.  
The reaction was left to room temperature over 48 h.  Reaction was quenched and extracted as per 
Method A. Method C: To a solution of trans-stilbene (180 mg, 1.0 mmol), cyclohexanone (0.03 mL, 
30 mol%), MeCN (0.2 mL, 3.8 mmol), n-BuOH (3.0 mL) was added buffer solution (3.5 mL, 0.3 M 
K2CO3 in 4 × 10
-4
 M aq Na2(EDTA)). Followed by H2O2 (35%, 0.25 mL, 3 mmol) at 0 °C and left to warm 
to room temperature over 24 h. Reaction was quenched and extracted as per Method A. Method D: 
To a solution of trans-stilbene (180 mg, 1.0 mmol) and cyclohexanone (0.03 mL, 30 mol%) in MeCN-
EtOH- CH2Cl2 (v/v, 1:1:2) (2.0 mL) was added buffer solution (1.5 mL, 2.0 M K2CO3 in 4 × 10
-4
 M aq 
Na2(EDTA)). Followed by H2O2 (30%, 0.25 mL, 3 mmol) at 0 °C for 24h.  Reaction was quenched and 
extracted as per Method A.    
 
T 1, Method A, followed the Shi precedent for the use of Oxone and K2CO3 to form 
insitu dioxiranes. In this instance solutions of Oxone and K2CO3 were added 
separately and simultaneously via syringe pump, as stipulated by Shi.227 Despite 
following this stringent procedure observed conversions were extremely low, 9%. 
This suggests that either cyclohexanone is not an active epoxidations catalyst or 
that the procedure is more sensitive to experimental error than originally 
considered. Considering this, subsequent reactions T 3 – T 4, methods B – D, 
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followed Shi’s hydrogen peroxide methodology. A more recent development, 1999 
– 2007,193-195,228 indicates that the hydrogen peroxide methodology is simpler and 
easier to perform, eliminating the use for syringe pumps, with effective mixing 
being highlighted as the only stipulated experimental requirement. Additionally as 
discussed in introductory sections, hydrogen peroxide is considered to be a green 
and sustainable oxidant. 
 
Comparing the hydrogen peroxide methods T 3 – T 4, differences includes the 
variations in solvent choice; this was found to have little effect on reactivity and 
conversions. The best conversion was observed with method D, where additionally 
the temperature of the reaction was maintained at 0 °C with use of a cryostat. This 
suggests that temperature is an extremely influential factor. 
 
In conclusion it seems that cyclohexanone, under the above reaction conditions, is 
an ineffective epoxidations catalyst. It was decided that commercial available Shi 
catalyst would be used to test the experimental reproducibility of the Shi 
methodology, and would be later used for a direct comparison to any epoxidations 
using synthesised chiral ketone 429. Table 10. 
 
Direct comparison of the Shi catalyst and cyclohexanone T 5 indicated that the 
correct experimental procedures were being followed, as the Shi catalyst showed 
complete conversion, as in accordance with the literature values.193  However 
cyclohexanone remained an inactive catalyst.  
 
Reaction Procedure Conversion Notes 
T 5.1 D 100% Shi 30 mol% 
T 5.2 D 0% Cyclohexanone 
    
T 6.1 E 38% Shi 15 mol% 
T 6.2 E 0% Catalyst 429 15 mol%  
    
T 7.1 F 0% Catalyst 429 1 equiv 
T 7.2 F 0% Cyclohexanone 1 equiv  
 
Table 10: Method D: To a solution of trans-stilbene (180 mg, 1.0 mmol) and catalyst (30 mol%) in 
MeCN-EtOH- CH2Cl2 (v/v, 1:1:2) (2.0 mL) was added buffer solution (1.5 mL, 2.0 M K2CO3 in 4 × 10
-4
 M 
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aq Na2(EDTA)). Followed by H2O2 (30%, 0.25 mL, 3 mmol) at 0 °C for 24h.  Reaction was quenched 
and extracted as Method A. Method E: To a solution of trans-stilbene (180 mg, 1.0 mmol) and 
catalyst (15 mol%) in MeCN-EtOH- CH2Cl2 (v/v, 1:1:2) (2.0 mL) was added buffer solution (1.5 mL, 2.0 
M K2CO3 in 4 × 10
-4
 M aq Na2(EDTA)). Followed by H2O2 (30%, 0.25 mL, 3 mmol) at 0 °C for 24h.  
Reaction was quenched and extracted as Method A. Method F: To a solution of trans-stilbene (180 
mg, 1.0 mmol) and catalyst (1 equiv) in MeCN-EtOH- CH2Cl2 (v/v, 1:1:2) (2.0 mL) was added buffer 
solution (1.5 mL, 2.0 M K2CO3 in 4 × 10
-4
 M aq Na2(EDTA)). Followed by H2O2 (30%, 0.25 mL, 3 mmol) 
at 0 °C for 72 h.  Reaction was quenched and extracted as Method A. 
 
T 6 directly compared the Shi catalyst and the synthesised chiral ketone catalyst 429 
at a 15 mol% catalyst loading (due to amount of material available). Disappointingly 
chiral ketone 429 displayed no conversion. Results either indicated that the chiral 
catalyst 429 is an inactive epoxidation catalyst, or is not as active as the Shi catalyst 
and higher catalyst loadings need to be considered. As is the case with the Shi 
catalyst, by reducing the catalyst loading by half, the conversion from T 5.1 – T 6.1 
has reduced from 100% – 38%, a significant reduction.   
Finally, T 7 reactions were performed for length (3 days), using excess catalyst (1 
equiv) and a maintained temperature (0 °C). These conditions should test whether 
chiral ketone 429 is in any way active. Cyclohexanone was also evaluated for 
comparison under these conditions. Disappointingly results indicated no conversion 
in either case.   
 
From all of the above results it can be suggested that chiral ketone catalyst 429 is an 
inactive catalyst under the Shi hydrogen peroxide conditions. For completeness 
original Oxone conditions should be re-evaluated. Table 11. 
 
Reaction Procedure Conversion Notes 
T8.1 A 65% Shi 30 mol% 
T8.2 A 0% Chiral Ketone 429 30 mol% 72 h 
 
Table 11: Method A: trans-stilbene (180 mg, 1.0 mmol), cyclohexanone (0.03 mL, 30 mol%), and 
tetrabutylammonium hydrogen sulfate (0.01 g, 0.04 mmol) in MeCN-DMM (v/v, 1:2) (15 mL) was 
added buffer (10 mL, 0.05 M aq Na2B4O7·10H2O in 4 × 10
-4
 M aq Na2(EDTA)). The mixture was cooled 
to 0 °C in an ice bath. A solution of Oxone (1.0 g, 1.6 mmol in 6.5 mL 4 × 10
-4
 M aq Na2(EDTA)), and a 
solution of K2CO3 (0.93 g, 6.74 mmol H2O 6.5 mL), were added dropwise separately and 
simultaneously via syringe pump over 2 h. The reaction was quenched by addition of pentane and 
extracted with pentane. The combined organic layers were dried over MgSO4, filtered and 
concentrated under reduced pressure. 
 
Chapter 7                                                                                               Shi Catalyst Analogue 
 
Page | 127  
 
The above results T 8 indicate that, as expected, the Shi catalyst epoxidises trans-
stilbene with comparable yields to the literature (63 – 85% yield).188 Chiral ketone 
reaction T 8.2 performed under the same conditions, with the exception of time (as 
literature precedent suggest carbocycles are less active catalysts, the reaction was 
left for 72h at 0 °C)185 gave no conversion. Interestingly, in comparison to the other 
chiral ketone hydrogen peroxide reactions, T 6.2 and T 7.1, in this instance no chiral 
catalyst or potential byproducts were recovered. This could indicate decomposition, 
and possible reason why the reaction did not work.  
7.4 Conclusion 
 
It can be concluded that the chiral catalyst 429 is an inactive epoxidations catalyst. 
Additionally it can be suggested that the endocyclic oxygen present within the Shi 
catalyst is important to its catalytic activity as indicated in many of Shi’s carbocyclic 
studies. 185 
Despite this novel chiral ketone 429 has been successfully synthesised in 8 steps in 
20% overall yield from the MAO product.  
Further elaboration and scope would intuitively follow adaption of the chiral ketone 
to make it a more active catalyst, including addition of electron withdrawing groups, 
potentially acetates or fluorine, as from the literature these have been shown to be 
viable. 
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8 Chapter 8: Conclusions and Future Work  
This thesis details the application of the underexploited ipso, ortho diene cis-diol 
from the fermentation of benzoic acid by mutant strains of bacteria which contain 
benzoate dioxygenase enzymes. 
 
Within Chapter 2 the synthesis of novel aminocyclitols architectures is detailed. 
Unfortunately the compounds synthesised proved to be biologically inactive for the 
specific application of glycosidase inhibition. Despite this the work details novel 
methodology through to compounds containing six contiguous stereocenters, all 
imparted via substrate control.  
 
The subsequent cyclitol section, Chapter 3, sought to synthesise the fully 
oxygenated counterparts. Despite a literature precedent the work led to complex 
mixtures of structurally similar compounds which proved difficult to isolate and 
purify. However a small quantity of one compound was isolated and structural 
identity and conformation alluded to.   
 
Further work in these two areas would involve the synthesis of further aminocyclitol 
and cyclitol analogues, with specific interest and investigation into the controlled 
ring opening of epoxides and aziridines to avoid the complex mixtures and 
purification issues. Targets would be tested for a range of biological activities, as we 
have seen many applications through the literature sections of this work. 
 
Chapter 4 completed and concluded some previous academic work, and highlights 
the synthetic utility of bromine substituted ipso, otho diene cis-diols. Further work 
in this area would explore the substrate scope and find the structural tolerances of 
the bacteria. It may be beneficial to engineer the bacteria so that it can tolerate 
different substrates, for example hetero-aromatics would be an interesting 
substrate (e.g. pyridine) as the nitrogen will already be present within the system, 
nitrogen insertion methodologies may be circumvented. 
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Finally the last section within this thesis, Chapter 6 and 7, investigated the viability 
of chiral acids and ketones derived from MAO as asymmetric epoxidation catalysts. 
Both the Miller203 and Shi184 precedent have been followed. There is vast scope for 
further investigation within this topic. Further manipulations and additions to the 
chiral substrates and further investigation into reaction conditions would, as the 
literature precedent suggests, yield comparative yields and selectivities. Structures 
438 – 440 would be interesting targets, as we have seen electron withdrawing 
substituents enhance catalyst activity towards Oxone reagents and formation of the 
dioxirane intermediate. Scheme 132.  
 
 
Scheme 132: Future chiral catalyst targets.  
 
Additional future work might scope the viability of oxidising azacarbasugar or 
cyclitol motifs towards chiral ketones such as 441 and 442 for the use in catalytic 
asymmetric epoxidations. 
 
Scheme 133:  Chiral ketones derived from azacarbasugars. 
 
Overall this thesis has scratched the surface of the proposed applications for the 
underexploited MAO product. Future work would continue these efforts.  
Overall this thesis has scratched the surface of the proposed applications for the 
underexploited MAO product. Future work would continue these efforts. 
  Experimental 
 





Reactions which required the use of anhydrous, inert atmosphere techniques were 
carried out under an atmosphere of nitrogen. In most cases, solvents were obtained 
by passing through anhydrous alumina columns using an Innovative Technology Inc. 
PS-400-7 solvent purification system. All other solvents were purchased as 
“anhydrous” grade from Fisher Scientific. “petrol” refers to petroleum spirit b.pt. 
40-60 °C. 
 
TLC was performed using aluminium backed plates precoated with Alugram®SIL 
G/UV 254nm. Visualization was accomplished by UV light and/or KMnO4 followed 
by gentle warming. Organic layers were routinely dried with anhydrous MgSO4 and 
evaporated using a Büchi rotary evaporator. When necessary, further drying was 
facilitated by high vacuum.  
 
Flash column chromatography was carried out using Davisil LC 60Å silica gel (35-70 
micron) purchased from Fisher Scientific. 
 
IR spectra were recorded on Perkin-Elmer 1600 FT IR spectrometer with only 
selected absorbances quoted as ν in cm-1. NMR spectra were run in CDCl3 (unless 
otherwise specified) on Bruker Avance 250, 300, 400 or 500 MHz instruments at 298 
K. The following abbreviations are used: s, singlet; d, doublet; t, triplet; q, quartet; 
dd, doublet of doublets; dq, doublet of quartets; td, triplet of doublets; m, multiplet 
and br, broad. J values are quoted to the nearest 0.5 Hz.  
 
A micrOTOF electrospray time-of-flight (ESI-TOF) mass spectrometer (Bruker 
Daltonik GmbH, Bremen, Germany) was used; this was coupled to an Agilent 1200 
HPLC system (Agilent Technologies, Waldbronn, Germany).  
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The HPLC system was used as an autosampler only. 10μl of sample was injected into 
a 30:70 flow of water:acetonitrile at 0.6mL/min to the mass spectrometer. For each 
acquisition 10μL of calibrant of 5mM sodium formate was injected after the sample. 
The observed mass and isotope pattern matched the corresponding theoretical 
values as calculated from the expected elemental formula.  
 
X-Ray crystallography was recorded on a Nonius Kappa CCD diffractometer with 
Mo-Kα radiation (λ=0.71074Å). All structures were solvent by direct methods and 
refined on all F2 data using SHELX-97 suite of programs. Enantiomeric excess was 
measured using a Perkin Elmer 200 Series HPLC machine fitted with a Chiralcel AS 
column (25 cm), eluting with HPLC grade hexane and isopropylalcohol. 
  
  Experimental 
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9.2 Chapter 1 Aminocyclitols Experimental 
9.2.1 (1S,6R)-methyl 1,6-dihydroxycyclohexa-2,4-dienecarboxylate 
 
 
To a stirred solution of the microbial oxidation cis – diol acid 30 (982 mg, 6.3 mmol, 
1 equiv) in MeOH/benzene (1:1, 30 mL) (trimethylsilyl)diazomethane (8 mL, 2.0 M in 
hexanes) was added dropwise until the yellow colour persisted and effervescence 
ceased. The solution was stirred for 2 h at room temperature then concentrated 
under reduced pressure to give crude 121 (1.06 g, 99%) as pale brown crystals, 
sufficiently pure to be used without further purification. 
121 has been reported previously; spectroscopic data are in agreement with 
published values.18 
 
Rf = 0.25 (50 % EtOAc-petrol); δH (250 MHz, CDCl3) 6.10 (1H, dd, J = 10.0, 5.0 Hz, 
C=CH), 5.85 – 5.95 (1H, m, C=CH), 5.72 – 5.81 (2H, m, HC=CH), 4.81 (1H, s, CH(O)), 
3.83 (3H, s, OCH3); 
  
  Experimental 
 





To diol acid 30 (1.77 g, 11.3 mmol, 1 equiv) and para-toluenesulfonic acid (5 mg, 0.3 
mmol, 4 mol%) in acetone (50 mL), 2,2-dimethoxypropane  (8.5 mL, 68.0 mmol, 6 
equiv) was added dropwise. The reaction mixture was stirred at room temperature 
for 24 h, transferred to a separating funnel, washed with saturated NaHCO3(aq) then 
extracted with EtOAc (3 × 20 mL). The organic phase was dried over MgSO4 and 
filtered. The filtrate was concentrated under reduced pressure and purified via 
column chromatography (50% EtOAc–petrol) to give 206 (2.08 g, 94%) a pale yellow 
oil. 
206 has been reported previously; spectroscopic data are in agreement with 
published values.17 
 
Rf = 0.35 (50 % EtOAc-petrol); δH (250 MHz, CDCl3) 6.21 – 6.11 (2H, m, C=CH), 6.05 – 
5.98 (1H, m, C=CH), 5.83 – 5.78 (1H, m, C=CH), 4.94 (1H, d, J = 4.5 Hz (CH(O)), 1.49 
(3H, s, CH3), 1.43 (3H, s, CH3); 
  
  Experimental 
 
Page | 134  
 




To acetonide protected acid 206 (443 mg, 2.25 mmol, 1 equiv), N,N′-
Dicyclohexylcarbodiimide (465 mg, 2.25 mmol, 1 equiv), in methanol (30 mL), N,N-
Dimethylpyridin-4-amine (13 mg, 0.11 mmol, 5 mol %) was added. The resulting 
mixture was stirred at room temperature for 48 h. The reaction mixture was 
transferred to a separating funnel, diluted with EtOAc and washed with saturated 
brine. The organic phase was dried over MgSO4 and filtered. The filtrate was 
concentrated under reduced pressure and purified via column chromatography 
(15% EtOAc–petrol) to give 113 (268 mg, 56%) as a pale yellow oil. 
Or: 
To methyl ester diol  121 (1.09 g, 6.45 mmol, 1 equiv) and para-toluenesulfonic acid 
(50 mg, 0.3 mmol, 4 mol%) in acetone (70 mL) 2,2-dimethoxypropane  (5.5 mL, 40.0 
mmol, 6 equiv) was added dropwise. The reaction mixture was stirred at room 
temperature for 24 h, transferred to a separating funnel, washed with saturated 
NaHCO3(aq) then extracted with EtOAc (3 × 30 mL). The organic phase was dried over 
MgSO4 and filtered. The filtrate was concentrated under reduced pressure and 
purified via column chromatography (15% EtOAc–petrol) to give 113 (1.30 g, 95%) 
as a pale yellow oil. 
113 has been reported previously; spectroscopic data are in agreement with 
published values.75 
 
Rf = 0.70 (60 % EtOAc-petrol); δH (250 MHz, CDCl3) 5.85 – 6.02 (3H, m, C=CH), 5.66 – 
5.74 (1H, m, C=CH), 4.84 (1H, d, J 2.5 Hz CH(O)), 3.66 (3H, s, OCH3), 1.31 (3H, s, CH3), 
1.28 (3H, s, CH3); 
  
  Experimental 
 






To methyl ester 113 (612 mg, 2.9 mmol, 1 equiv), lithium borohydride, 2M in THF, 
(1.45 mL, 2.91 mmol, 1 equiv) was added at -78 °C. The reaction mixture was stirred 
at -78 °C for 8 h, then left to warm to room temperature overnight. The reaction 
mixture transferred to a separating funnel, washed with saturated brine then 
extracted with EtOAc (4 × 25 mL). The organic phase was dried over MgSO4 and 
filtered. The filtrate was concentrated under reduced pressure and purified via 
column chromatography (15% EtOAc–petrol) to give 207 (548 mg, 96 %) a pale 
yellow oil. 
207 has been reported previously; spectroscopic data are in agreement with 
published values. 75 
 
Rf = 0.30 (50 % EtOAc-petrol); δH (250 MHz, CDCl3) 5.91 – 6.06 (3H, m, C=CH), 5.63 
(1H, d, J = 5 Hz, C=CH), 4.42 (1H, d, J = 5 Hz, CH(O)), 3.52 (1H, d, J = 10.0 Hz, CHH), 
3.29 (1H, d, J = 10.0 Hz, CHH),  1.38 (3H, s, CH3), 1.30 (3H, s, CH3); 
  
  Experimental 
 






To alcohol 207 (548 mg, 3.0 mmol, 1 equiv) dissolved in dichloromethane (30 mL), 
triethylamine (1.0 mL, 7.5 mmol, 2.5 equiv) was added and stirred at 0 °C. tert-
Butyldimethylsilyl trifluoromethanesulfonate (0.83 mL, 3.6 mmol 1.2 equiv) was 
added dropwise at 0 °C over 5 mins. The resulting mixture was stirred at 0 °C for 1 
h. The reaction mixture was transferred to a separating funnel. Saturated brine (10 
mL) was added, then extracted with EtOAc (3 × 10 mL). The organic phase was dried 
over MgSO4 and filtered. The filtrate was concentrated under reduced pressure and 
purified via column chromatography (15% EtOAc-petrol) to give 47 (636 mg, 72%) as 
a colourless oil. 
208 has been reported previously; spectroscopic data are in agreement with 
published values. 75 
 
Rf = 0.90 (10 % EtOAc-petrol); δH (250 MHz, CDCl3) 6.10 – 5.94 (3H, m, C=CH), 5.67 
(1H, d, J = 10.0 Hz, C=CH), 4.52 (1H,  J = 5.0 Hz, CH(O)), 3.55 (1H, d, J = 12.0 Hz, CHH),  
3.44 (1H, d, J = 12.0 Hz, CHH), 1.43 (3H, s, CH3), 1.36 (3H, s, CH3), 0.87 (9H, s, 
C(CH3)3), 0.05 (3H, s, SiCH3), 0.04 (3H, s, SiCH3);  
  
  Experimental 
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To a solution of diene 208 (446 mg, 1.5 mmol, 1 equiv) and tetrabutylammonium 
periodate (1.3 g, 3.0 mmol, 2 equiv) in dichloromethane (30 mL) at -78 °C was 
added N-(benzyloxycarbonyl)hydroxylamine (503 mg, 3.0 mmol, 2 equiv) in 
dichloromethane (10 mL) dropwise via cannula over 5 min. The reaction mixture 
was stirred at -78 °C under N2 for 20 h, then diluted with EtOAc (10 mL) and washed 
with saturated aqueous sodium thiosulfate solution (5 mL) and then saturated brine 
(5 mL). The organic layer was separated and dried over MgSO4, then concentrated 
under reduced pressure and purified by column chromatography (5% EtOAc-petrol) 
to give 214 (217 mg, 31%) as a colourless oil and 215 (403 mg, 58%) as a colourless 
oil.  
 
214: Rf = 0.19 (15% EtOAc-petrol); *α+D
25 +1.53 (c 0.66 in CH2Cl2); δH (300 MHz, 
CDCl3) 7.28 – 7.23 (5H, m), 6.46 (1H, br t, J = 5.0 Hz), 6.28 (1H, ddd, J = 7.5, 2.5, 1.5 
Hz), 5.10 (1H, d, JAB = 10.0 Hz), 5.06 (1H, dd, J = 6.0, 3.0 Hz)  5.02 (1H, d, JAB = 10.0 
Hz), 4.82 (1H, ddd, J = 6.0, 3.0, 1.5 Hz), 4.07 (1H, d,  J = 3.0 Hz), 3.80 (1H, d, J = 12.0 
Hz), 3.76 (1H, d, J = 12.0 Hz), 1.30 (3H, s), 1.21 (3H, s), 0.08 (9H, s), 0.01 (3H, s), -0.01 
(3H, s); δC (75 MHz, CDCl3) 158.2, 135.5, 132.4, 129.0, 128.4, 128.2, 128.0, 112.3, 
84.0, 75.7, 72.2, 68.0, 66.2, 53.6, 28.0, 27.0, 25.9, 18.4, -5.5, -5.6; νmax (film) 3515, 
2929, 2857, 1747, 1713, 1497, 1455, 1379, 1312, 1284, 1248, 1211, 1184, 1151, 
1097, 1061, 1024, 984, 929, 910, 776, 751, 731, 696, 616 cm–1; HRMS (ESI+) m/z 
calcd for  (C24H35NO6Si+Na)
+, 484.2131; found 484.2140.  
  Experimental 
 
Page | 138  
 
 
215: Rf = 0.28 (15% EtOAc-petrol); *α+D
25 +12.6 (c 0.87 in CH2Cl2); δH (300 MHz, 
CDCl3) 7.37 – 7.29 (5H, s), 6.53 (1H, ddd, J = 7.5, 2.5, 1.5 Hz), 6.42 (1H, br t, J = 5.0 
Hz), 5.22 (1H, d, JAB = 12.0 Hz), 5.19 (1H, d, JAB = 12.0 Hz), 5.06 (1H, ddd, J = 5.0, 5.0, 
1.5 Hz), 4.89 (1H, dd, J = 5.0, 2.5 Hz), 4.18 (1H, d, J = 2.5 Hz), 3.90 (2H, s), 1.39 (3H, 
s), 1.28 (3H, s), 0.90 (9H, s), 0.09 (3H, s), 0.08 (3H, s); δC (75 MHz, CDCl3) δ 157.5, 
135.5, 131.1, 129.8, 128.4, 128.3, 128.1, 112.5, 84.1, 75.1, 71.5, 68.1, 65.6, 53.6, 
28.3, 27.1, 26.0, 18.5, -5.3, -5.4; νmax (film) 2930, 2857, 1748, 1709, 1498, 1462, 
1380, 1370, 1327, 1295, 1248, 1214, 1170, 1150, 1096, 1080, 1065, 1026, 1005, 
934, 904, 836, 776, 736, 696, 683, 670 cm–1;  HRMS (ESI+) m/z calcd for 
(C24H35NO6Si+Na)
+, 484.2131; found 484.2108. 
  
  Experimental 
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To alkene 214 (195 mg, 0.43 mmol, 1 equiv) in acetone:water (4:1, 20 mL) was 
added N-methylmorpholine N-oxide (57 mg, 0.43 mmol, 1.0 equiv) as a solid. 
Osmium tetroxide (2.5% in tert-butanol, 60 μL, 0.008 mmol, 2 mol%) was added via 
syringe and the reaction mixture was stirred at room temperature for 48 h. A colour 
change from colourless to pale yellow was observed. The reaction mixture was 
transferred to a separating funnel, diluted with EtOAc (15 mL) and washed with 
saturated aqueous sodium thiosulfate (5 mL) and saturated – (5 mL). The organic 
phase was separated and dried over MgSO4, concentrated under reduced pressure 
and purified by column chromatography (50% EtOAc-petrol) to give 216 (172 mg, 
81%), as a colourless oil.  
 
Rf = 0.38 (40% EtOAc-petrol); []D
25 -27 (c 8.2 in CHCl3); δH (250 MHz, CDCl3) 7.36-
7.30 (5H, m), 5.18 (2H, s), 4.66 (1H, br s), 4.38 (1H, br s), 4.24-4.17 (3H, m), 3.82 (1H, 
d, J = 12.5 Hz), 3.75 (1H, d, J = 12.5 Hz) 3.75-3.63, (2H, m), 1.43 (3H, s), 1.40 (3H, s), 
0.87 (9H, s), 0.04 (6H, s); δC (75 MHz, CDCl3) 156.8, 135.4, 128.2, 128.1, 127.9, 
111.1, 82.0, 78.0, 76.4, 72.3, 67.9, 64.9, 61.8, 61.2, 26.5, 26.4, 25.7, 18.2, -5.6, -5.7; 
max (film) 3419, 2959, 2929, 2886, 2857, 1708, 1553, 1498, 1460, 1408, 1384, 1258, 
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To alkene 215 (489 mg, 1.06 mmol, 1 equiv) in acetone:water (4:1, 20 mL) in a 
round-bottomed flask (50 mL) was added N-methylmorpholine N-oxide (143  mg, 
1.06 mmol, 1 equiv) as a solid. Osmium tetroxide (2.5% in tert-butanol, 130 μL, 0.02 
mmol, 2 mol%) was added via syringe and the reaction mixture was stirred at room 
temperature for 48 h. A colour change from colourless to pale yellow was observed 
and reaction mixture was transferred to a separating funnel, diluted with EtOAc (10 
mL) and washed with saturated aqueous sodium thiosulfate (5 mL) then saturated 
brine (5 mL). The organic phase was separated and dried over MgSO4, concentrated 
under reduced pressure and purified by column chromatography (50% EtOAc-
petrol) to give 217 (230 mg , 44%) and 220 (70 mg, 17%) both as colourless oils. Also 
isolated was recovered starting material 215 (97 mg, 19%).  
 
217: Rf = 0.36 (50 % EtOAc-petrol); []D
25 +17 (c 11.5 in CHCl3); δH (250 MHz, CDCl3) 
7.38 – 7.32 (5H, m), 5.20 (2H, s), 4.67 (1H, br s), 4.39 (1H, br s), 4.25 – 4.21 (3H, m), 
3.84 (1H, d, J = 10.0 Hz), 3.78 (1H, d, J =10.0 Hz) 3.54 (1H, br s), 3.32 (1H, d, J = 5.0 
Hz) 1.44 (3H, s), 1.42 (3H, s), 0.89 (9H, s), 0.06 (6H, s); δC (75 MHz, CDCl3) 158.9, 
135.5, 128.5, 128.3, 128.3, 111.7, 83.1, 76.2, 73.2, 68.3, 66.0, 62.5, 61.4, 58.9, 26.7, 
26.6,  25.9, 18.4, -5.5, -5.6; max (film) 3428, 2929, 2856, 1710, 1498, 1454, 1383, 
1256, 1102, 1064, 835, 777 cm–1; HRMS (ESI+) m/z calcd for (C24H37NO8Si+Na)
+, 
518.2186; found 518.2210. 
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220: Rf = 0.57 (50 % EtOAc-petrol); []D
25 -6.5 (c 3.5 in CHCl3); δH (250 MHz, CDCl3)  
6.06 (1H, br s), 5.03-5.02 (2H, m), 4.33 (1H, d, J = 6.0 Hz), 4.21 (1H, d, J = 6.0 Hz), 
4.08 (1H, d, J = 12.0 Hz), 3.90 (1H, d, J = 12.0 Hz), 3.67 (1H, br s) 1.45 (3H, s), 1.44 
(3H, s), 0.90 (9H, s), 0.09 (3H, s), 0.08 (3H, s); δC (75 MHz, CDCl3) 154.4, 110.9, 81.8, 
73.7, 71.7, 69.9, 68.3, 66.2, 53.4, 26.9, 26.6, 25.8, 18.3, -5.4, -5.5; max (film) 3270, 
2955, 2930, 2857, 1808, 1463, 1361, 1254, 1166, 1077, 836, 779 cm–1; HRMS (ESI+) 
m/z calcd for (C17H29NO7Si+Na)
+, 410.1611; found 410.1664. 
 
  
  Experimental 
 







To silyl ether 216 (165 mg, 0.33 mmol, 1 equiv.) in THF (20 mL) at 0 °C was added 
tetrabutylammonium fluoride (0.3 mL, 1.0 M in THF, 1.0 equiv) dropwise over 5 
min. The reaction mixture was stirred at 0 °C for 12 h, then transferred to a 
separating funnel and diluted with EtOAc (20 mL) and washed with water (2 x 10 
mL). The organic phase was then washed further with saturated brine (5 mL), dried 
over MgSO4, concentrated under reduced pressure and purified by column 
chromatography (50% EtOAc-petrol) to give 222 (34 mg, 24%), as a colourless oil. 
 
Rf  = 0.20 (50% EtOAc-petrol); []D
25 -1.5 (c 1.7 in CHCl3); δH (250 MHz, (CD3)2CO) 
6.88 (1H, br s), 5.16 (1H, dd, J = 8.0, 4.0 Hz), 5.09 (1H, d, J = 8.0 Hz), 4.42 (1H, d, J = 
4.0 Hz), 4.27 (1H, t, J = 4.0 Hz), 4.19 (1H, br s), 3.97 – 3.84 (3H, m), 1.50 (3H, s), 1.48 
(3H, s);  δC (75 MHz, (CD3)2CO) 154.5, 110.1, 81.7, 73.7, 72.0, 70.6, 69.4, 64.5, 51.6, 
25.8, 25.6; max (film) 3268, 2992, 2923, 1800, 1780, 1454, 1369, 1165, 1067, 770 
cm–1; HRMS (ESI+) m/z calcd for (C11H16NO7+Na)
+, 296.0746; found 296.0787. 
 
  
  Experimental 
 






To alkene 214 (61 mg, 0.13 mmol, 1 equiv) in EtOAc (20 mL) was added palladium 
on carbon (6 mg, 10 wt%). The reaction mixture was stirred under an atmosphere of 
H2 at room temperature for 24 h then filtered through celite. The filtrate was 
concentrated under reduced pressure and purified by column chromatography 
(50% EtOAc-petrol) to give 223 as a colourless oil (43 mg, 99%). 
 
Rf = 0.85 (50% EtOAc-petrol); []D
25 -15 (c 0.55 in CHCl3); δH (300 MHz, CDCl3) 4.05 
(1H, d, J = 3.0 Hz), 3.97 (1H, d, J = 12.0 Hz), 3.83 (1H, d, J = 12.0 Hz), 3.80 (1H, app q, 
J = 3.0 Hz), 3.46-3.42 (1H, m, 1H), 2.76 (3H, br s), 2.02 – 1.87 (1H, m), 1.83 – 1.72 
(2H, m), 1.61 – 1.51 (1H, m), 1.46 (3H, s), 1.37 (3H, s), 0.91 (9H, s), 0.10 (3H, s), 0.09 
(3H, s); δC (75 MHz, CDCl3) 108.1, 83.6, 80.1, 73.2, 65.1, 47.4, 28.1, 26.7, 25.9, 25.4, 
24.5, 18.3, -5.5, -5.6; max (film) 2961, 2927, 2854, 1590, 1519, 1463, 1392, 1300, 
1251, 1215, 1151, 1033, 747 cm–1; HRMS (ESI+) m/z calcd for (C16H33NO4Si+Na)
+, 
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To alkene 215 (253 mg, 0.55 mmol, 1 equiv) in EtOAc (20 mL) was added palladium 
on carbon (26 mg, 10 mass%). The reaction mixture was stirred under an 
atmosphere of H2 at room temperature for 24 h then filtered through celite. The 
filtrate was concentrated under reduced pressure and purified by column 
chromatography (20% MeOH-79% EtOAc-1% Et3N) to give 224 as a colourless oil 
(179 mg, 98%).  
 
Rf = 0.43 (20% MeOH-79% EtOAc-1% Et3N); []D
25 -37 (c 3.5 in CHCl3); δH (300 MHz, 
CDCl3) 4.03 (1H, br s), 3.96 – 3.93 (2H, m), 3.70 (1H, d,  J = 11.0 Hz), 3.36 (3H, br s), 
3.12 (1H, br s), 2.00 – 1.88 (1H, m), 1.82 – 1.72 (2H, m), 1.62 – 1.58 (1H, m), 1.41 
(3H, s), 1.32 (3H, s), 0.88 (9H, s), -0.09 (6H, s); δC (75 MHz, CDCl3) 108.4, 83.1, 79.8, 
67.3, 65.8, 52.3, 27.5, 26.3, 26.0, 25.9, 23.7, 18.3, -5.3, -5.5; max (film) 3282, 2898, 
2930, 2856, 1472, 1378, 1250, 1216, 1087, 963, 835 cm–1;  HRMS (ESI+) m/z calcd for 
(C16H33NO4Si+Na)
+, 354.2076; found 354.2076. 
  
  Experimental 
 






To diol 216 (28 mg, 0.06 mmol, 1 equiv) in EtOAc (20 mL) was added palladium on 
carbon (5 mg, 20 mass%). The reaction mixture was stirred under an atmosphere of 
H2 at room temperature for 24 h then filtered through celite. The filtrate was 
concentrated under reduced pressure and purified by column chromatography 
(10% MeOH-89% chloroform-1% Et3N) to give 225 as a colourless oil (11 mg, 50%).  
 
Rf = 0.25 (15% MeOH-84% EtOAc-1% Et3N); []D
25 +43 (c 0.6 in H2O); ); δH (300 MHz, 
D2O) 4.46 – 3.93 (10H m), 1.45 (3H, s), 1.39 (3H, s), 0.92 (9H, s), 0.12 (6H, s); δC (75 
MHz, CDCl3) 108.9, 83.8, 74.3, 70.6, 67.6, 65.3, 64.7, 51.9, 29.6, 27.9, 26.6, 26.0, 
25.9, 18.4, -5.3, -5.4; max (film) 3324, 3256, 2965, 2813, 2787, 1432, 1376, 1244, 
1156, 1020, 978, 836, 774 cm–1; HRMS (ESI+) m/z calcd for (C16H33NO6Si+Na)
+, 
386.1907; found 386.1968. 
  
  Experimental 
 






To diol 217 (120 mg, 0.24 mmol, 1 equiv) in EtOAc (20 mL) was added palladium on 
carbon (12 mg, 10 mass%). The reaction mixture was stirred under an atmosphere 
of H2 at room temperature for 24 h then filtered through celite. The filtrate was 
concentrated under reduced pressure and purified by column chromatography 
(50% EtOAc-petrol) to give 226 as a colourless oil (39 mg, 45%).  
 
Rf = 0.35 (50% EtOAc-petrol); []D
25 +33 (c 0.39 in CHCl3); δH (300 MHz, CDCl3) 4.25 – 
4.20 (2H, m), 4.18 – 4.15 (2H, m), 4.03 (1H, d, J = 15.0 Hz), 3.91 (1H, d, J  = 15.0 Hz), 
3.30 (1H, s), 1.46 (3H, br s), 1.43 (3H, s), 0.92 (9H, s), 0.11 (3H, s), 0.10 (3H, s); δC (75 
MHz, CDCl3) 110.3, 81.9, 73.8, 72.9, 66.7, 62.7, 60.2, 58.3, 26.8, 26.8, 25.9, 
18.4, -5.3, -5.4; max (film) 3404, 2958, 2930, 2857, 1463, 1382, 1255, 1210, 1101, 
1060, 863, 779 cm–1;  HRMS (ESI+) m/z calcd for (C16H33NO6Si+H)




  Experimental 
 








225 (38 mg, 0.1 mmol, 1 equiv) dissolved in THF (20 mL) was added TBAF (0.1 mL 
1M in THF) was added at 0°C and stirred for 24 h. The resulting solution was 
extracted with water. The aqueous layer was concentrated down and contained the 
alcohol product and quaternary ammonium salts which could not be separated. The 
resulting oil was dissolved into acetone (20 mL) to which was added 2,2-
dimethoxypropanol (2 mL, 16 mmol, 160 equiv), and para-toluenesulfonic acid (20 
mg, 0.1 mmol, 1 equiv). The resulting solution was stirred at room temperature for 
24 h. The reaction mixture was transferred to a separating funnel, diluted with 
EtOAc, washed with saturated brine, dried over MgSO4, concentrated under 
reduced pressure to give intermediate 228 a yellow oil (26 mg, 10%). 
 
δH (300 MHz, CDCl3) 4.98 (1H, d, J = 12.0 Hz ), 4.42 – 4.65 (5H, m), 3.65 – 3.69 (2H, 
m), 1.36 – 1.44 (18H, m, CH3); δC (75 MHz, CDCl3); 101.5 (C(CH3)2), 109.6 (C(CH3)2), 
90.2 (NC(CH3)2), 76.5 (CHO), 73.0 (CHO), 69.6 (CHO), 69.4 (CHO), 67.2 (CHN), 55.5 
(CH2), 29.8 (C(CH3)2), 26.7 (C(CH3)2), 26.5 (C(CH3)2), 26.1 (C(CH3)2), 25.7 (C(CH3)2), 
20.6 (C(CH3)2); max (film) 2994, 2933, 2864, 1459, 1381, 1252, 1211, 1072, 868 cm
-1; 
HRMS (ESI+) m/z calcd for (C16H27NO6+H)
+, 330.1917; found 330.1796. 
 
  Experimental 
 






228 (26 mg, 0.08 mmol) was stirred in 1M HCl (20 mL) for 24 h at room 
temperature. The resulting mixture was concentrated under reduced pressure to 
give 229 (15 mg, 89%) a yellow oil unpurified. 
 
[]D
25 -32 (c 0.5, H2O); δH (300 MHz, D2O) 4.43 (1H, d,  J = 6.0 Hz), 4.25 (1H, d, J = 9.0 
Hz), 4.06 (1H, d, J = 6.0 Hz), 3.97 (1H, d, J = 6.0 Hz), 3.85 (1H, br s), 3.60 – 3.71 (2H, 
m); δC (75 MHz, D2O) 76.3, 76.0, 72.8, 67.7, 66.6, 66.5, 60.3; max (film) 3349, 2506, 
1631, 1433, 1258, 1063 cm-1; HRMS (ESI+) m/z calcd for (C7H15NO6+H)
+, 210.0978; 
found 210.0965.  
  
  Experimental 
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9.2.18 (1S,2R,3S,4R)-2,3,4-trihydroxy-3-(hydroxymethyl) cyclo 
hexanaminium chloride 
 
Hydroxyamine 223 (43 mg, 0.13 mmol) was stirred in aqueous hydrochloric acid 
(1.0 M, 20 mL) at room temperature for 24 h. The aqueous phase was washed with 
EtOAc (2 x 10 mL) to remove the silanol byproduct. The aqueous phase was 
concentrated under reduced pressure to give 230 as a colourless oil (26 mg, 94%). 
 
[]D
25 +22 (c 1.3 in H2O); δH (300 MHz, D2O) 3.85 (1H, s), 3.64 (1H, d, J = 12.0 Hz), 
3.57 (1H, d, J = 12.0 Hz), 3.55 (1H, d, J = 9.0 Hz), 3.37 – 3.18 (1H, m), 1.80 – 1.55 (4H, 
m); δC (75 MHz, D2O) 76.0, 69.9, 68.6, 63.5, 52.1, 25.8, 22.7; max (film) 3336, 2981, 
2482, 1602, 1383, 1233, 1156, 1069, 1021, 956, 797 cm–1; HRMS (ESI+) m/z calcd for 
(C7H15NO4+Na )
+, 200.0898; found 200.0906.  
  
  Experimental 
 





Hydroxyamine 224 (30 mg, 0.09 mmol) was stirred in aqueous hydrochloric acid (1.0 
M, 20 mL) at room temperature for 24 h. The aqueous phase was washed with 
EtOAc (2 × 10 mL) to remove the silanol byproduct. The aqueous phase was 
concentrated under reduced pressure to give 231 as a pale yellow oil (17 mg, 88%).  
 
[]D
25 +35 (c 0.85 in H2O); δH (300 MHz, D2O) 3.86 (1H, d, J = 12.0 Hz), 3.81 (1H, td, J 
= 7.5, 4.0 Hz), 3.55 (1H, d, J = 12.0 Hz), 3.49 (1H, d, J = 6.0 Hz), 3.38-3.34 (1H, m), 
1.92 – 1.63 (3H, m), 1.52 – 1.40 (1H, m); δC (75 MHz, D2O) 74.1, 72.3, 69.8, 63.4, 
54.0, 26.0, 22.8; max (film) 3317, 2940, 2508, 1400, 1071, 1027, 972, 799 cm
–1;  
HRMS (ESI+) m/z calcd for (C7H15NO4+H)
+, 179.1157; found 179.1129. 
  
  Experimental 
 





Aminotriol 225 (11 mg, 0.03 mmol) was stirred in aqueous hydrochloric acid (1.0 M, 
20 mL) at room temperature for 24 h. The aqueous phase was washed with EtOAc 
(2 × 10 mL) to remove the silanol byproduct. The aqueous phase was concentrated 
under reduced pressure to give 232 as a colourless oil (8 mg, 99%).  
 
[]D
25 -47 (c 0.4 in H2O); δH (300 MHz, D2O) 4.24 (1H, q, J = 3.0 Hz), 4.04 – 3.99 (3H, 
m), 3.89 (1H, d, J = 12.0 Hz), 3.75 (1H, d, J = 12.0 Hz), 3.57 (1H, dd, J = 10.5, 3.0 Hz); 
δC (75 MHz, D2O) 75.5, 72.6, 70.4, 65.6, 65.1, 62.8, 53.3; max (film) 3302, 2958, 
2511, 1629, 1508, 1077, 1028, 808, 723 cm–1; HRMS (ESI+) m/z calcd for 
(C7H15NO6+Na)
+, 232.0797; found 232.0783. 
  
  Experimental 
 






Triol 226 (35 mg, 0.1 mmol) was stirred in aqueous hydrochloric acid (1.0 M, 20 mL) 
at room temperature for 24 h. The aqueous phase was washed with EtOAc (2 × 10 
mL) to remove the silanol byproduct. The aqueous phase was concentrated under 
reduced pressure to give 233 as a pale yellow oil (21 mg, 80%).  
 
[]D
25 +32 (c 0.5 in H2O); δH (250 MHz, D2O) δ 4.16 – 4.14 (2H, m), 3.91 (1H, d, J = 
12.0 Hz), 3.83 – 3.70 (3H, m), 3.59 – 3.56 (1H, br t, J = 2.5 Hz); δC (75 MHz, D2O) 
75.9, 75.6, 72.4, 69.3, 66.3, 66.1, 59.9;  max (film) 3272, 2943, 2507, 1622, 1496, 
1398, 1184, 1155, 1074, 1025, 928, 892, 814, 712 cm–1; HRMS (ESI+) m/z calcd for 
(C7H15NO6+H)
+, 210.0978; found 210.0965. 
 
  
  Experimental 
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To a stirred solution of 207 (637 mg, 3.50 mmol, 1 equiv) in CH2Cl2 (20 mL) was 
added triethylamine (0.48 mL, 3.49 mmol, 1 equiv), DMAP (42 mg, 0.35 mmol, 10 
mol%) and Ac2O (0.33 mL, 3.50 mmol, 1 equiv). TLC indicated reaction was complete 
after 30 mins. Water (20 mL) was added to the reaction mixture and extracted with 
EtOAc (4 x 20 mL). The organic layers were combined and dried over MgSO4 and 
concentrated under reduced pressure. The resulting oil was purified via flash 
column chromatography (15% EtOAc-petrol) to yield pure 274 (600 mg, 77%) as a 
yellow oil.  
 
Rf = 0.45 (15% EtOAc-petrol); []D
25 -81.6 (c 1.20, CH2Cl2); δH (300 MHz, CDCl3) 6.13 
– 6.08 (1H, m, C=CH), 6.03 – 5.98 (2H, m, C=CH), 5.72 (1H, d, J = 10.0 Hz, C=CH), 4.41 
(1H, d, J = 4.5 Hz, C(H)OC(CH3)2), 4.15 (1H, d, JAB = 11.5 Hz, CH2), 3.94 (1H, d, JAB = 
11.5 Hz CH2), 2.07 (3H, s, OAc), 1.44 (3H, s, CH3), 1.37 (3H, s, CH3); δc (75 MHz, CDCl3) 
170.6 (C=O), 128.1, 125.4, 124.3, 123.1 (C=C), 106.6 (C(CH3)2), 78.3 (CO(CH2)), 71.8 
(C(H)OC(CH3)2), 66.1 (CH2), 27.1, 26.4 (C(CH3)2), 20.8(C=OCH3); vmax (film) 2991, 
2937, 1741, 1415, 1372, 1239, 1172, 1043, 906, 728, 648 cm-1; HRMS (ESI+) m/z 
calcd for (C12H16O4+Na)
+, 247.0946; found 247.0931.  
  Experimental 
 








      
 
To a stirred solution of 274 (94 mg, 0.42 mmol, 1 equiv) in CH2Cl2 (20 mL) was added 
a solution of 5,10,15,20-Tetraphenyl-21H,23H-porphine (10 mg, 0.016 mmol, 4 
mol%) in CH2Cl2 (50 mL) dropwise over a period of 18 h, while the solution 
irradiated with 150 W halogen lamps, and being continually sparged with oxygen. 
After 18 h no more conversion was observed; the solution was concentrated under 
reduced pressure and purified via flash column chromatography (15% EtOAc-petrol) 
to yield pure 275 (52 mg, 48%) as a colourless oil, by product 276 a pale pink oil (10 
mg, 9%) and r.s.m 274 (11 mg, 12%). 
 
275: Rf = 0.35 (15% EtOAc-petrol); *α+D
25 -16.9 (c 0.83, CH2Cl2); δH (400 MHz, CDCl3) 
6.65 (1H, t, J = 8.0 Hz, C=CH), 6.55 (1H, t, J = 8.0 Hz, C=CH), 4.88-4.91 (2H, m, C(H)O), 
4.55 (1H, d, JAB = 12 CH2), 4.31 (1H, d, JAB = 12 CH2), 4.25 (1H, d, J = 4.8 Hz, 
C(H)OC(CH2)3), 2.13 (3H, s, C=OCH3), 1.39 (3H, s, CH3), 1.30 (3H, s, CH3); δc (100 MHz, 
CDCl3) 170.4 (C=O), 131.5 (C=C), 130.3 (C=C), 122.3 (C(CH3)2), 79.9 (CO(CH2), 74.6 
(C(H)OC(CH3)2), 72.1 (CHO-O), 71.8 (CHO-O), 65.9 (CH2), 27.8 (C(CH3)2), 26.8 
(C(CH3)2), 20.8 (COCH3); vmax (film) 2995, 2988, 2928, 1736, 1348, 1372, 1450, 1244, 
1204, 1144, 1039, 919, 743, 712, 644 cm-1; HRMS (ESI+) m/z calcd for 
(C12H16O6+Na)
+, 279.0844; found 279.0829.  
 
Byproduct 276: Rf = 0.40 (15% EtOAc-petrol); *α+D
25 –14.3 (c 0.28, CH2Cl2); δH (300 
MHz, CDCl3) 6.09 (1H, dd, J = 10.0, 4.0 Hz, HC=CHCO), 5.70 (1H, dt, J = 10.0 1.5 Hz, 
HC=CHCO), 4.65 (1H, t, J = 1.0 Hz, CHOC(CH3)2), 4.33 (1H, JAB = 11.0 Hz, CH2), 3.83 
(1H, JAB = 11.0 Hz, CH2), 3.64 (1H, dd, J = 3.5, 2.5 Hz, CH(O)), 3.35 – 3.38 (1H, m, 
  Experimental 
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CH(O)), 2.09 (3H, s), 1.41 (3H, s), 1.37 (3H, s); δc (75 MHz, CDCl3) 170.4 (C=O), 132.5 
(C=CC(O)CH2, 124.1 (C=CCH(O)), 110.5 (C(CH3)2) , 79.0 (CO(CH2), 71.3 (C(H)OC(CH3)2), 
66.8 (CH2), 50.3 (CH(O-O)CH(O)), 46.5 (CH(O-O)CH=CH), 27.8, 26.6 (CH3), 20.8 
(C=OCH3); vmax (film) 2989, 2943, 1745, 1455, 1379, 1236, 1181, 1162, 1089, 1060, 




  Experimental 
 




yl)methyl acetate  
 
 
To a stirred solution of 275 (755 mg, 2.94 mmol, 1 equiv) in CH2Cl2 (50 mL) was 
added 5,10,15,20-Tetraphenyl-21H,23H-porphine cobalt(II) (11 mg, 0.01 mmol, 6 
mol%). The solution was stirred for 30 mins, until TLC indicated full conversion of 
275. The solution was concentrated under reduced pressure and purified via flash 
column chromatography (15% EtOAc-petrol) to yield pure 281 (724 mg, 96%) as a 
colourless oil. 
 
Rf = 0.15 (15% EtOAc-petrol); *α+D
25 -33.8 (c 0.80, CH2Cl2); δH (300 MHz, CDCl3) 4.35 
(1H, d, JAB = 11.0 Hz, CH2), 4.32 (1H, d, J = 2.0 Hz, C(H)OC(CH2)3), 4.02 (1H, d, JAB = 
11.0 Hz, CH2), 3.58 (1H, t, J = 3.0 Hz), 3.52 (1H, t, J = 3.0 Hz), 3.39 (1H, dd, J = 3.0, 2.0 
Hz), 3.04 (1H, d, J = 3.5 Hz), 2.11 (3H, s, C=OCH3), 1.43 (3H, s, CH3), 1.42 (3H, s, CH3); 
δc (75 MHz, CDCl3) 170.4 (C=O), 110.4 (C(CH3)2), 78.3 (CO(CH2), 71.9 (C(H)OC(CH3)2), 
65.5 (CH2), 51.5 (C(H)O), 50.9 (C(H)O), 47.6 (C(H)O), 47.5 (C(H)O), 28.0 (C(CH3)2), 
26.3 (C(CH3)2), (C(CH3)2), 20.8(C=OCH3); vmax (film) 2991, 2938, 1742, 1455, 1435, 
1380, 1231, 1175, 1063, 1043, 992, 964, 803, 630 cm-1; HRMS (ESI+) m/z calcd for 
(C12H16O6+Na)
+, 279.0844; found 279.0861.  
 
  
  Experimental 
 







To a stirred solution of 281 (23 mg, 0.089 mmol, 1 equiv) in MeOH (10 mL), NH3 was 
continuously bubbled through the solution for 10 h. After TLC indicated 
consumption of all starting material the solution was concentrated under reduced 
pressure and purified via flash column chromatography (50% EtOAc-petrol) to yield 
pure 272 (18 mg, 95%) as a colourless oil. 
 
Rf = 0.20 (50 % EtOAc-petrol); *α+D
25 -46 (c 1.02, CH2Cl2); δH (250 MHz, CDCl3) 4.41 
(1H, d, J = 2.0 Hz, C(H)OC(CH2)3), 3.77 (1H, d, JAB = 11.0 Hz, CH2), 3.61 (1H, d, JAB = 
11.0 Hz, CH2), 3.57 (1H, d, J = 3.0 Hz C(H)O), 3.53 (1H, d, J = 3.5 Hz, C(H)O), 3.41 (1H, 
dd, J = 3.5, 2.0 Hz, C(H)O), 3.04 (1H, dd, J = 3.5, 2.0 Hz, C(H)O), 2.09 (3H, br s, OH), 
1.44 (6H, s, CH3); δc (100 MHz, CDCl3) 110.0 (C(CH3)2), 79.4 (CO(CH2), 71.5 
(C(H)OC(CH3)2), 64.4 (CH2), 51.7 (C(H)O), 51.4 (C(H)O), 47.6 (C(H)O), 47.5 (C(H)O), 
28.1 (CH3), 26.5 (CH3); vmax (film) 3491, 2982, 2253, 1457, 1383, 1247, 1219, 1080, 
1063, 907, 726, 647 cm-1; HRMS (ESI+) m/z calcd for (C10H14O5+Na)
+, 237.0734; 
found 237.0792.  
 
  
  Experimental 
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9.3.6 Compound 290A 
 
281 (94 mg, 0.36 mmol, 1 equiv) was refluxed for 24 h in HCl (30 mL, 1M, excess). 
The resulting solution was carefully neutralised with NaHCO3(aq) and concentrated 
under reduced pressure. To the resulting solid was added Ac2O (1.0 mL, excess) and 
pyridine (0.7 mL excess) and stirred at room temperature for 24 h. The resulting 
solution was acidified with 1.0 M HCl to pH 4, then extracted with EtOAc (4 x 20 
mL). The organic layers were combined and dried over MgSO4 and concentrated 
under reduced pressure. The resulting oil was purified via flash column 
chromatography (5% EtOAc-petrol) to a complex mixture of inseparable compounds 
and pure 290A (3 mg, 2%) as a colourless oil.  
 
Rf = 0.70 (50% EtOAc-petrol); δH (500 MHz, CDCl3) 5.91 (1H, d, J = 4.5 Hz), 5.56 (1H, 
s), 5.09 (1H, d, J = 10.0 Hz), 4.54 (1H, d, JAB = 10.0 Hz), 4.29 (dd,  J = 10.0, 4.5 Hz), 
4.23 (1H, s), 3.97 (1H, d, JAB = 10.0 Hz), 2.20 (3H, s), 2.15 (3H, s), 2.13 (3H, s), 1.99 
(3H, s); δc (100 MHz, CDCl3) 169.9 (C=O), 169.8 (C=O), 169.7 (C=O), 169.4 (C=O), 83.4 
(CH(O)), 78.3 (CH(O)), 75.2 (CH(O)), 72.1 (CH(O)), 69.9 (CH(O)), 69.7 (CH(O)), 
55.4(CH2), 20.8 (CH3), 20.7 (CH3), 20.6 (CH3), 20.5 (CH3); HRMS (ESI+) m/z calcd for 
(C15H22O11+Na)
+, 401.1055; found 401.0615.  
 
  
  Experimental 
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To a flask containing 304 (185 mg, 0.59 mmol, 1 equiv) in a glovebox was added 
nonacarbonyldiiron (440 mg, 1.21 mmol, 2 equiv). THF (40 mL) was added and the 
reaction mixture was stirred at room temperature for 7 d. The reaction mixture was 
then concentrated under reduced pressure (Care! Toxic pentacarbonyliron distilled 
over at this point) and purified by column chromatography (10% EtOAc-petrol) to 
give 307 as fine brown needles (43 mg, 17%) and 308 as a brown oil (36 mg, 14%). 
Unreacted 304 (100 mg, 60%) was also isolated. 307 was crystallized using EtOAc-
petrol to obtain crystals suitable for X-Ray crystal structure analysis. 
 
307: m.p 95-97 °C (EtOAc-petrol); Rf = 0.32 (10% EtOAc-petrol); *α+D
25 ˗10 (c 0.20, 
CH2Cl2); δH (300 MHz, CDCl3) 5.95 (1H, dt, J = 4.5, 1.5 Hz, CBr=CH), 5.47 (1H, dd, J = 
6.5, 4.5 Hz CBr=CH˗CH=), 5.36 (1H, d, J = 1.5 Hz CH˗O˗), 3.88 (3H, s, O˗CH3), 3.06 (1H, 
dd, J = 6.5, 1.0 Hz CBr=CH˗CH=CH), 1.45 (3H, s, C-CH3), 1.23 (3H, s, C˗CH3); δc (75 
MHz, CDCl3) 171.3 (˗COOMe), 117.8 (˗O˗C˗O˗), 89.9 (CBr=CH), 87.0 (C-COOMe), 86.7 
(CH-O-), 83.6 (CBr=CH-CH=), 70.2 (CBr), 54.0 (CBr=CH-CH=CH), 53.3 (O˗CH3), 28.1 
(C˗CH3), 27.3 (C˗CH3); vmax (film) 2981, 2068, 2003, 1730, 1437, 1375, 1261, 1214, 
1162, 1062, 1027, 978, 865, 752, 687, 636 cm-1; HRMS (ESI+) m/z calcd for 
(C14H13BrFeO7+Na)
+, 450.9092, 452.9071; found 450.9106, 452.9164.   
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308: Rf = 0.26 (10% EtOAc-petrol); *α+D
25 -90 (c 0.6, CH2Cl2); δH (500 MHz, CDCl3) 5.76 
(1H, d, J = 3.5 Hz, CBr=CH), 5.15 (1H, dd, J = 6.0, 4.5 Hz, CBr=CH ˗ CH=), 4.60 (1H, s, 
CH˗O˗), 3.75 (3H, s, O˗CH3), 2.97 (1H, d, J = 6.5 Hz, CBr=CH˗CH=CH), 1.71 (3H, s, 
C˗CH3), 1.20 (3H, s, C-CH3); δc (75 MHz, CDCl3) 207.1 (Fe C=O), 173.3 (˗COOMe), 
109.7 (˗O˗C˗O˗), 89.3 (CBr=CH), 85.4 (C˗COOMe), 84.8 (CH-O-), 80.5 (CBr=CH-CH=), 
73.6 (CBr), 61.2 (CBr=CH-CH=CH), 53.1 (O˗CH3), 25.0 (C-CH3), 24.2 (C˗CH3); vmax (film) 
2980, 2061, 1995, 1729, 1460, 1380, 1252, 1207, 1168, 1070, 1030 cm-1; HRMS 
(ESI+) m/z calcd for (C14H13BrFeO7+Na)
+, 450.9092, 452.9071; found 450.9091, 
452.9073. 
  
  Experimental 
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Bromodiene 304 (25 mg, 0.096 mmol, 1 equiv), 
tetrakis(triphenylphosphine)palladium (2 mg, 2 μmol, 2 mol %), para-tolylboronic 
acid (105 mg, 0.78 mmol, 8 equiv) and potassium carbonate (238 mg, 1.73 mmol, 18 
equiv) were dissolved in DMF˗H2O 5:1 (30 mL) and stirred at room temperature for 
72 h. The reaction mixture was diluted with EtOAc (20 mL) and washed with water 
(20 mL). The organic layer was devoid of product; thus, the aqueous layer was 
concentrated under pressure to afford crude free acid cross-coupling product 314. 
The crude acid 314 was then dissolved in MeOH˗benzene 1:1 (35 mL) and 
(trimethylsilyl)diazomethane (1.5 mL, 2.0 M in hexane) was added dropwise with 
stirring until the yellow colour persisted and effervescence ceased. The solution was 
stirred for 2 h then concentrated under reduced pressure. Purification by column 
chromatography (10% EtOAc-petrol) to give 315 (8 mg, 30% over two steps) as a 
colourless oil:  
 
Rf = 0.36 (5% EtOAc-petrol); *α+D
25 ˗156 (c 0.3, CH2Cl2);  δH (250 MHz, CDCl3) 7.50 
(2H, d, J = 8.0 Hz, Ar˗H), 7.18 (2H, d, J = 8.0 Hz, Ar˗H) 6.48 (1H, d, J = 6.0 Hz, 
Ar˗C=CH), 6.23 (1H, dd, J = 9.5, 6.0 Hz, Ar˗C=CH˗CH), 5.83 (1H, d, J = 9.5 Hz, 
Ar˗C=CH˗CH=CH), 5.26 (1H, s, CH˗O˗C), 3.77 (3H, s, O˗CH3), 2.36 (3H, s, Ar˗CH3), 1.53 
(3H, s, C˗CH3), 1.42 (3H, s, C˗CH3); δc (75 MHz, CDCl3) 171.8 (C=O), 138.2 , 135.3, 
134.6, 129.4 , 125.8, 124.8 (Ar˗C=CH˗CH), 124.5 (Ar˗C=CH˗CH=CH), 119.7 (Ar˗C=CH), 
107.6 (˗O˗C˗O˗), 81.2 (C˗COOMe), 74.6 (CH˗O˗), 53.1 (O-CH3), 27.1 (C˗CH3), 25.4 
(C˗CH3), 21.4 (Ar˗CH3); vmax (film) 2973, 2937, 2888, 1741, 1469, 1381, 1308, 1163, 
1131, 1105, 951, 821 cm-1; HRMS (ESI+) m/z calcd for (C18H20O4+Na)
+, 323.1259; 
found 323.1258.  
 
  Experimental 
 






To a solution of bromodiene 304 (81 mg, 0.28 mmol, 1 equiv), 
tetrakis(triphenylphosphine)palladium (16 mg, 0.014 mmol, 5 mol %), copper(I) 
iodide (3.7 mg, 0.0196 mmol, 7 mol%) dissolved in THF (20 mL), was added by 
syringe n-butylamine (110 μL, 1.12 mmol, 4 equiv) and (triiso-propyl)acetylene (100 
μL, 0.45 mmol, 1.6 equiv). The reaction mixture was stirred at room temperature 
for 24 h, then diluted with EtOAc (20 mL) and washed with NH4Cl(aq) (20 mL) and 
saturated brine (20 mL). The organic phase was dried over MgSO4 and filtered. The 
filtrate was concentrated under reduced pressure and purified by column 
chromatography (10% EtOAc-petrol) to give 316 (108 mg, 98%) as a yellow oil:  
 
Rf = 0.45 (10% EtOAc-petrol);  *α+D
25 -176 (c 0.9, CH2Cl2);  δH (250 MHz, CDCl3) 6.37 
(1H, d, J = 6.0 Hz, SiC≡C˗C=CH), 6.12 (1H, dd, J = 9.5, 6.0 Hz, SiC≡C˗C=CH-CH), 5.85 
(1H, dd, J = 9.5, 0.5 Hz, SiC≡C˗C=CH-CH=CH), 4.91 (1H, d, J = 0.5 Hz, CH˗O˗), 3.78 (3H, 
s, O˗CH3), 1.45 (3H, s, C˗CH3), 1.39 (3H, s, C˗CH3), 1.08 (21H, br s, Si˗CH and 
Si˗CH˗CH3); δc (75 MHz, CDCl3) 171.7 (C=O), 129.0 (C=C), 125.0 (C=C), 124.4 (C=C), 
120.7 (C=C), 108.2 (˗O˗C˗O˗), 105.5 (C≡C), 96.7 (C≡C), 80.0 (C˗COOMe), 75.6 (CH˗O˗), 
53.0 (O˗CH3), 26.9 (C˗CH3), 25.6 (C˗CH3), 18.6 (Si˗C˗CH3), 11.3 (Si˗C˗CH3); vmax (film) 
2943, 2865, 2158, 2032, 1741, 1462, 1381, 1243, 1039, 883, 677 cm-1; HRMS (ESI+) 
m/z calcd for (C22H34O4Si+Na)
+, 413.2124; found 413.2127. 
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To a stirred solution of silylacetylene 316 (9.6 mg, 0.03 mmol, 1 equiv) in THF (30 
mL) at room temperature was added tetra-n-butylammonium fluoride (1.0 M 
solution in THF, 0.05 mL, 0.05 mmol, 1.1 equiv). The reaction mixture was stirred for 
24 h, then diluted with EtOAc (10 mL) and washed with saturated brine (10 mL). The 
organic layer was dried over MgSO4 and filtered. The filtrate was concentrated 
under reduced pressure and purified by column chromatography (15% EtOAc-
petrol) to give 317 (4.4 mg, 0.015 mmol, 76%) as a pale white gum:  
 
Rf = 0.24 (15% EtOAc-petrol); *α+D
25 ˗184 (c 0.34, CH2Cl2); δH (400 MHz, CDCl3) 6.46 
(1H, d, J = 6.0 Hz, HC≡C˗C=CH), 6.14 (1H, dd, J = 9.5, 6.0 Hz, HC≡C˗C=CH˗CH), 5.90 
(1H, d, J = 9.5 Hz, HC≡C˗C=CH˗CH=CH), 4.92 (1H, s, CH˗O˗), 3.80 (3H, s, O˗CH3), 3.23 
(1H, s, C≡CH), 1.48 (3H, s, C˗CH3), 1.43 (3H, s, C˗CH3); δc (75 MHz, CDCl3) 171.5 
(C=O), 130.6 (HC≡C˗C=CH), 126.1 (HC≡C-C=CH-CH=CH), 123.8 (HC≡C-C=CH-CH), 
118.8 (HC≡C-C=), 108.1 (˗O˗C˗O˗), 82.6 (HC≡C), 81.8 (HC≡C), 80.1 (C˗COOMe), 75.0 
(CH˗O), 53.3 (O˗CH3), 27.0 (C˗CH3), 25.4 (C˗CH3); vmax (film) 2981, 2889, 1737, 1462, 
1382, 1251, 1152, 954, 807 cm-1; HRMS (ESI+) m/z calcd for (C13H14O4+Na)
+, 





  Experimental 
 







To a stirred solution of terminal alkyne 317 (13.0 mg, 0.05 mmol, 1 equiv) in 
EtOH˗H2O 5:1 (25 mL) were added benzyl azide (7.9 mg, 0.06 mmol, 1.2 equiv), 
CuSO4 (1.1 mg, 1 mol %) and ascorbic acid (5.9 mg, 10 mol%). The solution was 
stirred at room temperature for 48 h, then diluted with saturated brine and 
extracted with EtOAc (3 × 10 mL). The organic layer was dried over MgSO4 and 
filtered. The filtrate was concentrated under reduced pressure and purified by 
column chromatography (10% to 50% EtOAc-petrol) to give unreacted 317 (7.8 mg, 
66%) and 318 (6.3 mg, 34%) as a pale brown oil:  
 
Rf = 0.48 (50% EtOAc-petrol); *α+D
25 -40 (c 0.18, CH2Cl2); δH (300 MHz, CDCl3) 7.62 
(1H, s, HetAr–H), 7.37 – 7.29 (5H, m, Ph–H) 6.94 (1H, d, J = 6.0 Hz, HetAr–C=CH–), 
6.28 (1H, dd, J = 9.0, 6.0 Hz, HetAr–C=CH–CH=), 5.92 (1H, d, J = 9.0 Hz, HetAr–C=CH–
CH=CH), 5.61 (1H, d, J = 15.0 Hz, Ph–CHH–), 5.49 (1H, d, J = 15.0 Hz, Ph–CHH–) 5.27 
(1H, s, CH–O–), 3.78 (3H, s, O–CH3), 1.48 (3H, s, C–CH3), 1.34 (3H, s, C–CH3); δc (75, 
CDCl3 MHz) 172.0 (C=O), 134.8, 129.3, 128.8, 128.1, 127.8, 126.1, 124.9, 124.5, 
121.0 (3º HetAr), 119.7 (HetAr–C=CH–), 108.7 (–O–C–O–), 80.6 (C–COOMe), 74.2 
(CH–O–), 54.3 (Ph–CH2–), 53.2 (O–CH3), 27.1 (C–CH3), 25.8 (C–CH3); vmax (film) 2995, 
2917, 1857, 1739, 1496, 1457, 1258, 1066, 887, 799, 727 cm-1; HRMS (ESI+) m/z 
calcd for (C20H21N3O4+Na)
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9.5 Chapter 5: Peracid epoxidation experimental 




A stirred solution of 30 (65 mg, 0.33 mmol) and Pd/C (10 mg, 10 wt. % loading, 
matrix activated carbon support) in MeOH (20 mL) was exposed to a hydrogen 
atmosphere at room temperature. After 24 h the solution was filtered and washed 
through a plug of celite and concentrated under reduced pressure. The resulting oil 
was purified via flash column chromatography (60% EtOAc 35% petrol 2.5% H2O 
2.5% AcOH) to yield pure 383 (20mg, 38%) as a white crystalline solid.  
Or 
A stirred solution of 206 (857 mg, 5.48 mmol) and Pd/C (50 mg, 10 wt. % loading, 
matrix activated carbon support) in MeOH (20 mL) was exposed to a hydrogen 
atmosphere at room temperature. After 24 h the solution was filtered and washed 
through a plug of celite and concentrated under reduced pressure. The resulting oil 
was purified via flash column chromatography (60% EtOAc 35% petrol 2.5% H2O 
2.5% AcOH) to yield pure 383 (625mg, 71%) as a white crystalline solid.  
383 has been reported previously; spectroscopic data are in agreement with 
published values.208,209 
 
m.p = 112-115 °C (EtOAc:petrol); Rf = 0.10 (60% EtOAc 35% petrol, 2.5% H2O, 2.5% 
AcOH); *α+D
25 + 13.3 (c 0.3, H2O); δH (300 MHz, D2O) 3.76 (1H, dd,  J = 11.5, 3.5 Hz, 
CH(OH)), 1.60 – 1.56 (4H, m, CH), 1.40 – 1.08 (4H, m, CH); δc (125 MHz, MeOD) 
180.1 (C=O), 79.5 (C(OH)CO2H), 73.7 (CH(OH)), 35.0, 30.8, 25.3, 21.1 (CH2); vmax 
(film) 3445, 3086, 2924, 2858, 1736, 1439, 1199, 1138, 1023, 948, 821 cm-1; HRMS 
(ESI-) m/z calcd for (C7H12O4-H)
-, 159.0657; found 159.0672.  
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9.5.2 (1S,2R)-methyl 1,2-dihydroxycyclohexanecarboxylate 
 
 
To a stirred solution of 383 (47 mg, 0.29 mmol) dissolved in MeOH:C6H6 (6 mL 1:1 
ratio), was added TMS-CHN2 (0.2 mL, 2.0 M solution in THF, 0.4 mmol, 1.4 equiv) 
until a yellow colour persisted. Solvent was removed under reduced pressure 
[CAUTION - TMS-CHN2 diazomethane extremely toxic, removed under reduced 
pressure in fume hood, with acetic acid in solvent trap to quench any unreacted 
reagent] Pure 387 was obtained (52 mg, 100%) as a yellow oil.  
 
387 has been reported previously; spectroscopic data are in agreement with 
published values.211,212 
 
Rf = 0.05 (30% EtOAc-petrol); *α+D -10.0 (c 0.3, CHCl3); δH (250 MHz, CDCl3) 3.82 –
3.74 (1H, m, CH(OH)), 3.77 (3H, s, CH3), 2.86 (2H, br s, OH), 1.83 – 1.22 (8H, m, CH); 
δc (75 MHz, CDCl3) 176.3 (C=O), 76.8 (C(OH)(CO2CH3)), 72.2 (CH(OH)), 52.9 (OCH3), 
34.2 (CH2), 30.0 (CH2), 23.9 (CH2), 19.7 (CH2); vmax (film) 3453, 2938, 2861, 1729, 
1438, 1272, 1238, 1207, 1149, 1079, 998, 923 cm-1; HRMS (ESI+) m/z calcd for 
(C8H14O4 +H)
+, 175.0970; found 175.0981.  
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9.5.3 (3aS,7aR)-methyl 2,2-dimethylhexahydrobenzo[d][1,3] 
dioxole-3a-carboxylate 
and 





To a stirred solution of 387 (53 mg, 0.30 mmol) dissolved in acetone (10 mL, freshly 
distilled), was added 2,2-Dimethoxypropane ( 0.45 mL, 3.65 mmol, 12 equiv) and 
para-toluenesulfonic acid (6 mg, 0.03 mmol, 10 mol %). The solution was stirred at 
room temperature under N2 for 20 h. The resulting solution was diluted with EtOAc 
(10 mL) followed by the addition of water (20 mL). The biphasic system was 
extracted with EtOAc (4 × 10 mL) and the organic layers combined and washed with 
saturated brine, dried over MgSO4 and concentrated under reduced pressure. The 
resulting oil was purified via flash column chromatography (0-20% EtOAc-petrol) to 
yield 388 a colourless oil (40 mg, 61%). 
 
Rf = 0.70 (30% EtOAc-petrol); *α+D
25 -37.8 (c 0.65, CHCl3); δH (300 MHz, CDCl3) 4.35 
(1H, t, J = 3.5 Hz, CH(OC(CH3)2), 3.75 (3H, s, OCH3), 2.06 – 1.93 (2H, m, C-H), 1.50 
(3H, d, J = 0.5 Hz, CH3) 1.35 (3H, d, J = 0.5 Hz, CH3), 1.85 – 1.23 (6H, m, C-H); δc (75 
MHz, CDCl3) 173.2 (C=O), 108.9 (C(CH3)2), 81.0 C(OC(CH3)2)(CO2CH3), 74.9 
(CH(OC(CH3)2), 52.5 (OCH3), 32.3, 28.0, 25.9, 25.8, 20.5, 18.7; vmax (film) 2997, 2941, 
2873, 1733, 1450, 1383, 1217, 1160, 1054, 1025, 905, 725 cm-1; HRMS (ESI+) m/z 
calcd for (C11H17NaO4+H)
+, 237.1102; found 237.1079.  
 
 
On repeating this previous experimental procedure, small amounts. (20 mg, 2%) of 
byproduct 389 were isolated: 
 
  Experimental 
 
Page | 168  
 
Rf = 0.85 (50% EtOAc-petrol); *α+D
25 -21 (c 1.6, CHCl3); δH (500 MHz, CDCl3) 5.08 (1H, 
dd, J = 10.0, 6.0 Hz, CH(OC=O)), 4.26 (1H, t, J = 3.2 Hz, CH(O)), 3.73 (3H, s, OCH3), 
3.24 (1H, s, OH), 2.06 – 1.24 (16H, m, CH), 1.50 (3H, s, CH3), 1.35 (3H, s, CH3); δc (125 
MHz, CDCl3) 175.3 (CO2CH3), 171.8 (C=O), 108.9 (C(CH3)3), 80.7, 75.6, 75.3, 74.9, 
53.0 (OCH3), 34.1, 32.2, 27.7, 26.1, 25.7, 25.6, 23.6, 20.2, 19.6, 18.3; vmax (film) 3523, 
2987, 2938, 2865, 1733, 1449, 1381, 1370, 1243, 1216, 1152, 1124, 1046, 1003, 
874, 735 cm-1; HRMS (ESI+) m/z calcd for (C18H28O7+H)
+, 357.1908; found 357.1929. 
 
  
  Experimental 
 










388 (253 mg, 1.18 mmol) was dissolved in THF (10 mL) and NaOH (6 mL, 2M in H2O, 
12 mmol, 10 equiv) and refluxed overnight. The resulting solution washed with 
EtOAc (3 x 10 mL) to remove any unreacted starting material, the remaining 
aqueous layer was acidified to pH 2.0 and extracted with EtOAC (3 x 10 mL) and 
combined organic layers were washed with saturated brine and dried over MgSO4. 
The resulting oil was purified via flash column chromatography (50% EtOAc-petrol) 
to yield three compounds, acetonide migration product  390 (30 mg, 13%), acid 384 
(20 mg, 8%) and diol acid 383 (40 mg, 21%). 
Or 
A stirred solution of benzyl ester 393 (32 mg, 0.11 mmol) and Pd/C (10 mg, 10 wt. % 
loading, matrix activated carbon support) in MeOH (20 mL) was exposed to a 
hydrogen atmosphere at room temperature. After 24 h the solution was filtered 
through a plug of celite and concentrated under reduced pressure. The resulting oil 
was purified via flash column chromatography (0-50 % EtOAc-petrol) to yield pure 
384 (14 mg, 63 %) as a colourless oil.  
 
384: Rf = 0.40 (50% EtOAc-petrol); *α+D
25 -40.0 (c 0.70, CHCl3); δH (300 MHz, CDCl3) 
4.31 (1H, t, J = 3.5 Hz, CH(OC(CH3)2), 2.12-1.97 (2H, m, C-H), 1.90-1.78 (1H, m, C-H), 
1.54 (3H, s, CH3), 1.43 (3H, s, CH3), 1.71-1.51 (4H, m, C-H), 1.28-1.21 (1H, m, C-H); δc 
(75 MHz, CDCl3) 175.6 (C=O), 109.6 (C(CH3)2), 80.7 C(OC(CH3)2)(CO2H), 74.9 
(CH(OC(CH3)2), 32.3, 27.9, 25.9, 25.6, 20.7, 18.5; vmax (film) 2994, 2939, 2873, 2714, 
1450, 1371, 1383, 1217, 1174, 905, 725 cm-1; HRMS (ESI-) m/z calcd for (C10H16O4)
-, 
199.0970; found 199.0975.  
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390 rearrangement: Rf = 0.83 (50% EtOAc-petrol); *α+D
25 +2.0 (c 1.5, CHCl3); δH (500 
MHz, CDCl3) 3.75 (1H, dd, J = 11.5, 4.6 Hz, CH(OH)), 1.95 – 1.93 (1H, m, CH), 1.92- 
1.89 (1H, m, CH), 1.88 (1H, brs, OH), 1.77-1.80 (1H, m, CH), 1.73 (1H, td, J = 14.0, 4.5 
Hz, CH), 1.66 (3H, s, CH3), 1.63 (1H, m, CH), 1.63 (3H, s, CH3), 1.49 – 1.55 (1H, m, 
CH), 1.44 – 1.48 (1H, m, CH), 1.38 (1H, tt, J = 13.0, 3.5 Hz, CH); δc (125 MHz, CDCl3) 
174.0 (C=O), 110.1 (C(CH3)3), 83.2 (C(O)(C=O), 70.9 (C(OH)H), 33.6 (CH2), 30.6 (CH2), 
29.0 (C(CH3)3), 27.9 (C(CH3)3), 23.6 (CH2), 20.1 (CH2); vmax (film) 3484, 2991, 2939, 
2863, 2774, 1448, 1385, 1291, 1262, 1060, 1036, 908, 860, 626 cm-1; HRMS (ESI+) 
m/z calcd for (C10H16O4+H)
+, 201.1127; found 201.1113. 
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To a stirred solution of 383 (43 mg, 0.26 mmol) and triethylamine (0.10 mL, 0.91 
mmol, 3.4 equiv) dissolved in CH2Cl2 (10 mL), was added Benzyl Bromide (0.12 mL, 
0.91 mmol, 3.4 equiv). Solution was stirred for 3 h. The resulting solution was 
washed with water (10 mL) then the aqueous layer extracted with EtOAc (3 x 20 
mL). The combined organic layers were dried over MgSO4 and concentrated under 
reduced pressure. The resulting oil was purified via flash column chromatography 
(10-50% EtOAc-petrol) to yield 392 a colourless oil (28 mg, 42%). 
 
Rf = 0.10 (30%  EtOAc-petrol); *α+D
25 -2.35 (c 0.4, CHCl3); δH (250 MHz, CDCl3) 7.36 
(5H, s, Ar-H), 5.27 (1H, d,  JAB = 12.0 Hz, CH2), 5.21 (1H, d,  JAB = 12.0 Hz, CH2), 3.86 
(1H, dd, J = 11.3, 4.5, CH(OH)), 1.88 – 1.20 (8H, m, CH);  δc (75 MHz, CDCl3) 176.0 
(C=O), 125.3, 128.6, 128.4, 127.9 (Ar-C), 76.8 (C), 72.2 (C(OH), 67.6 (OCH2Bn), 34.2 
(CH2), 30.2 (CH2), 23.9 (CH2), 17.8 (CH2); vmax (film) 3465, 2937, 2860, 1728, 1498, 
1449, 1232, 1148, 1066, 951, 909, 735 cm-1; HRMS (ESI+) m/z calcd for 
(C14H17O4+H)
+, 251.1283; found 251.1267.  
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To a stirred solution of 392 (28 mg, 0.11 mmol) dissolved in acetone (10 mL, freshly 
distilled), was added 2,2-Dimethoxypropane (0.16 mL, 1.34 mmol, 12 equiv) and 
para-toluenesulfonic acid (2 mg, 0.01 mmol, 10 mol %). The solution was stirred at 
room temperature under N2 for 20 h. The resulting solution was diluted with EtOAc 
(10 mL) followed by the addition of water (20 mL). The biphasic system was 
extracted with EtOAc (4 × 10 mL) and the organic layers combined and washed with 
saturated brine and dried over MgSO4. The solution was concentrated under 
reduced pressure to obtain 393 (30 mg, 92%) as a colourless oil. Material was taken 
forward unpurified.  
 
Rf = 0.75 (30% EtOAc-petrol); *α+D
25 –23.3 (c 1.25, CHCl3); δH (300 MHz, CDCl3) 7.36-
7.33 (5H, m, Ar-H), 5.21 (2H, s, CH2), 4.38 (1H, t, J = 3.5 Hz, CH(O)), 2.05-1.97 (2H, m, 
CH), 1.83-1.25 (6H, m, CH), 1.52 (3H, s, CH3), 1.36 (3H, s, CH3); δc (75 MHz, CDCl3) 
172.7 (C=O), 135.7, 128.7, 128.4, 128.2 (Ar-C), 109.1 (C(CH3)2), 81.0 
C(OC(CH3)2)(CO2Bn), 75.1 (CH(OC(CH3)2), 66.9 (CH2), 32.2, 28.0, 25.9, 25.8, 20.3, 
18.6; vmax (film) 2994, 2935, 2865, 1731, 1498, 1455, 1337, 1244, 1215, 1021, 998, 
874, 742, 696 cm-1; HRMS (ESI+) m/z calcd for (C17H24O4+H)
+, 291.1591; found 
291.1574.  
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Benzyl bromide (0.93 mL, 7.83 mmol, 1.1 equiv) was dissolved in acetone (50 mL) 
containing triethylamine (1.10 mL, 7.83 mmol, 1.1 equiv) to which was added 
dropwise a solution of microbial diol acid 30 (1.12 g, 7.12 mmol, 1 equiv) in acetone 
(50 mL). The resulting solution was stirred for 4 h. The resulting solution was diluted 
with EtOAc (50 mL), and extracted with LiCl (2 × 15 mL). The organic layer was dried 
over MgSO4 to yield pure 394, a colourless oil. (1.10 g, 61%). 
 
Rf = 0.29 (40% EtOAc-petrol); []D
25 -135.6 (c 1.6, CH2Cl2); δH (300 MHz, CDCl3); 7.36 
(5H, br.s, Bn), 6.13 (1H, dddd, J 9.5, 4.0, 1.0, 0.5 Hz C=CH), 5.94 (1H, dddd, J 9.5, 5.0, 
2.5, 0.5 Hz, C=CH), 5.82 (1H, ddd, J 9.5, 2.0, 1.0 Hz, C=CH), 5.76 (1H, ddd, J 9.5, 2.0, 
1.0 Hz,  C=CH), 5.29 (1H, s, CO2-CH2-Ar), 4.87 (1H, m, C(O)H); δC (75 MHz, CDCl3); 
175.0 (C=O), 134.9 (Ar), 131.9 (C=C), 128.7, 128.6, 128.1, (Ar) 126.8, 124.6, 122.7 
(C=C), 74.0 (C(OH)C=O) , 70.9 (C(OH)-H), 68.3 (O-CH2); max (film) 3451, 3038, 1731, 
1660, 1455, 1378, 1234, 1168, 1077, 1020, 909, 753, 695 cm-1; HRMS (+ve ESI-TOF) 
m/z calculated for (C14H14O4+Na)
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To a stirred solution of 394 (335 mg, 1.37 mmol) dissolved in acetone (10 mL, 
freshly distilled), was added 2,2-Dimethoxypropane (2.0 mL, 16.46 mmol, 12 equiv) 
and para-toluenesulfonic acid (26 mg, 0.03 mmol, 10 mol %). The solution was 
stirred for 20 h. The resulting solution was diluted with EtOAc (10 mL) followed by 
the addition of water (20 mL). The biphasic system was extracted with EtOAc (4 × 10 
mL) and the organic layers combined and washed with saturated brine, dried over 
MgSO4 and concentrated under reduced pressure. The resulting oil was purified via 
flash column chromatography (10-20% EtOAc-petrol) to yield 395 a colourless oil 
(358 mg, 92%). 
 
395 has been reported previously; spectroscopic data are in agreement with 
published values.76 
 
Rf = 0.60 (30% EtOAc-petrol); δH (250 MHz, CDCl3) 7.28 – 7.25 (5H, m, Ar-H), 6.08 – 
5.94 (3H, m, C=CH), 5.86 – 5.79 (1H, m, C=CH), 5.18 (2H, s, CH2), 4.97 (1H, d,  J = 4.0 
Hz, CH(O)), 1.38 (3H, s, CH3), 1.37 (3H, s, CH3). 
 
  
  Experimental 
 
Page | 175  
 





To a stirred solution of 394 (48 mg, 0.195 mmol) dissolved in CH2Cl2 (2 mL) was 
added triethylamine (60 μL, 0.46 mmol, 2.4 equiv) and tert-Butyldimethylsilyl 
trifluoromethanesulfonate (70 μL, 0.21 mmol, 1.1 equiv). The solution was stirred at 
room temperature for 9 h. The resulting solution was diluted with EtOAc (10 mL) 
followed by the addition of water (20 mL). The biphasic system was extracted with 
EtOAc (4 × 10 mL) and the organic layers combined and washed with saturated 
brine, dried over MgSO4 and concentrated under reduced pressure. The resulting oil 
was purified via flash column chromatography (0-5% EtOAc-petrol) to yield 396 a 
colourless oil (61 mg, 81%). 
 
Rf = 0.65 (10% EtOAc-petrol); *α+D
25 -327.0 (c 3.31, CHCl3); δH (300 MHz, CDCl3) 7.35 
– 7.31 (5H, m, Ar-H), 6.03 – 5.94 (3H, m, C=CH), 5.75 – 5.71 (1H, m, C=CH), 5.25 (1H, 
d, J = 12.0 Hz, HAB), 5.18 (1H, d, J = 12.0 Hz, HAB), 4.97 (1H, d, J = 1.8 Hz, CH(OSi)), 
0.99 (9H, s, CH3) 0.98 (9H, s, CH3); δc (75 MHz, CDCl3) 172.2 (C=O), 135.5, 128.6, 
128.4, 128.3, 126.3, 125.8, 123.8, 122.3, 78.6 (C(OSi)(C=O)), 71.5 (CH(OSi), 67.3 
(CH2), 27.0 (CH3), 26.9 (CH3), 21.1 (C(CH3)3), 20.2 (C(CH3)3); vmax (film) 3045, 2966, 
2934, 2891, 2859, 1733, 1473, 1229, 1091, 1031, 1012, 1000, 875, 825, 696 cm-1; 
HRMS (ESI+) m/z calcd for (C22H30O4Si+H)
+, 387.1991; found 387.1993.  
  
  Experimental 
 






A stirred solution of 396 (61 mg, 0.16 mmol) and Pd/C (10 mg, 10 wt. % loading, 
matrix activated carbon support) in MeOH (20 mL) was exposed to a hydrogen 
atmosphere at room temperature. After 24 h the solution was filtered through a 
plug of celite and concentrated under reduced pressure. The resulting oil was 
purified via flash column chromatography (10-70% EtOAc-petrol) to yield pure 385 
(25 mg, 53%) as a colourless oil.  
 
Rf = 0.30 (30% EtOAc-petrol); *α+D
25 -17.0 (c 0.18, CHCl3); δH (300 MHz, CDCl3) 4.36 
(1H, dd, J = 11.0, 4.5 Hz, CH(OSi)), 1.99 – 1.20 (8H, m, CH), 1.02 (9H, s, CH3), 0.98 
(9H, s, CH3); δc (75 MHz, CDCl3) 179.1 (C=O), 77.9 ((C(OSi)(C=O)), 73.9 (CH(OSi), 33.0 
(CH2), 30.1 (CH2), 27.7 (CH3), 27.5 (CH3), 23.6, 20.5, 20.3, 19.6; vmax (film) 3070, 
2935, 2894, 2859, 1717, 1448, 1472, 1094, 827 cm-1; HRMS (ESI+) m/z calcd for 
(C15H28O4Si+H)
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To a stirred solution of 387 (25 mg, 0.15 mmol) dissolved in CH2Cl2 (5 mL) was 
added triethylamine (50 μL, 0.34 mmol, 2.4 equiv) and tert-Butyldimethylsilyl 
trifluoromethanesulfonate (50 μL, 0.16 mmol, 1.1 equiv). The solution was stirred at 
room temperature under N2 for 9 h. The resulting solution was diluted with EtOAc 
(10mL) followed by the addition of water (20mL). The biphasic system was 
extracted with EtOAc (4 × 10 mL) and the organic layers combined and washed with 
saturated brine, dried over MgSO4 and concentrated under reduced pressure. The 
resulting oil was purified via flash column chromatography (0-5% EtOAc-petrol) to 
yield 397 a colourless oil (37 mg, 82%). 
 
Rf = 0.50 (50% EtOAc-petrol); *α+D
25 -27.0 (c 0.14, CHCl3); δH (250 MHz, CDCl3) 4.26 
(1H, dd, J = 9.0, 4.0 Hz), 3.74 (3H, s), 1.95-1.16 (8H, m), 0.99 (9H, s), 0.95 (9H, s); δc 
(75 MHz, CDCl3) 176.8 (C=O), 77.6, 74.5, 52.5, 33.4, 30.1, 27.5, 27.4, 23.8, 20.5, 20.3, 
19.6; vmax (film) 2934, 2892, 2858, 1731, 1472, 1438,1278, 1092, 768 cm
-1; HRMS 
(ESI+) m/z calcd for (C16H30O4Si+H)
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383 (133 mg, 0.83 mmol) dissolved in DMF (1 mL), was added dropwise to a 
suspension of NaH (109 mg, 2.74 mmols, 3.3 equiv of 60 % in mineral oil) in DMF (2 
mL) at -22 °C. MeI (0.17 mL, 2.83 mmols, 3.4 mmols) was dropwise over 5 mins. The 
resulting solution was stirred at -22 °C and allowed to warm to room temperature 
over 19 h. The solution was cooled to -22 °C, NH4Cl(aq) (10 mL) was added to the 
solution dropwise, then transferred into a separating funnel.  EtOAc (20 mL) was 
added to the solution and the organic layers  washed (3 × 10 mL) LiCl(aq),, dried over 
MgSO4 and concentrated under reduced pressure. The resulting oil was purified via 
flash column chromatography (5-20% EtOAc-petrol) to yield a mixture of two 
products 399  and 400 as a colorless oil (99 mg). 
The inseparable mixture was dissolved in CH2Cl2 (3 mL), addition of triethylamine 
(40 μL, 0.32 mmol) followed by Trimethylsilyl trifluoromethanesulfonate (50 μL, 
0.29 mmol) stirred at room temperature for 30 h. The resulting mixture was diluted 
with EtOAc (20 mL) and washed with saturated brine (20 mL) dried over MgSO4 and 
concentrated under reduced pressure. The resulting oil was purified via flash 
column chromatography (1-20% EtOAc-petrol) to yield a mixture of two purified 
products 401 (20 mg, 18%) 399 (40 mg, 42%). 
 
401: Rf = 0.85 (20% EtOAc-petrol); *α+D
25 -1.4 (c 0.73, CHCl3); δH (250 MHz, CDCl3) 
3.73 (3H, s, CO2CH3), 3.47 (1H, dd, J = 11.0, 4.5 Hz, CH(OCH3)), 3.29 (3H, s, OCH3), 
1.85-0.84 (8H, m, CH), 0.15 (9H, s, Si(CH3)3); δc (75 MHz, CDCl3) 175.6 (C=O), 82.2, 
76.1, 56.7, 51.8, 36.2, 25.1, 24.0, 20.3, 2.2;  vmax (film) 2949, 2860, 1753, 1446, 1366, 
1279, 1244, 1156, 1062, 1041, 837, 760, 734 cm-1; HRMS (ESI+) m/z calcd for 
(C12H24O4Si+H)
+, 261.1522; found 261.1515.  
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399: Rf = 0.20 (20 % EtOAc-petrol); *α+D
25 -26.9 (c 2.23, CHCl3); δH (250 MHz, CDCl3) 
3.73 (3H, s, CO2CH3), 3.44 (1H, dd, J = 11.0, 4.0 Hz, CH(OCH3)), 3.36 (3H, s, OCH3), 
3.26 (3H, s, OCH3), 2.04-0.80 (8H, m, CH); δc (75 MHz, CDCl3) 174.1 (C=O), 82.9, 81.7, 
57.0, 52.1, 51.8, 29.6, 24.7, 23.6, 20.3;  vmax (film) 2938, 2861, 1730, 1446, 1373, 
1275, 1227, 1099, 1061, 997 cm-1; HRMS (ESI+) m/z calcd for (C10H18O4+H)
+, 
203.1283; found 203.1289.  
 
  
  Experimental 
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9.5.15 (1S,2R)-1,2-dimethoxycyclohexanecarboxylic acid 
 
 
399 (67 mg, 0.33 mmol) was dissolved in THF (1.0 mL) and NaOH (1.0 mL, 2M in 
H2O, 20 μmol, 60 equiv) and refluxed overnight. The resulting solution extracted 
with EtOAC (3 x 10 mL) to remove any unreacted starting material, the remaining 
aqueous layer was acidified to pH 2.0 and extracted with EtOAC (3 × 10 mL), 
combined organic layers  washed with saturated brine and dried over MgSO4. The 
resulting oil was purified via flash column chromatography (50% EtOAc, 45% petrol, 
2.5% AcOH, 2.5% H2O) to yield 403 a colorless oil (22 mg, 35%). 
 
Rf = 0.25 (50% EtOAc, 45% petrol, 2.5 % AcOH, 2.5% H2O); *α+D
25 -20.5 (c 0.73, 
CHCl3); δH (500 MHz, CDCl3) 3.40-3.37 (1H, m, CH(OCH3)), 3.38 (3H, s, OCH3), 3.35 
(3H, s, OCH3), 2.18 (1H, dd, J = 15.0, 2.0 Hz, CH), 1.96 (1H, m, CH), 1.82-1.81 (1H, m, 
CH), 1.68-1.53 (3H, m, CH), 1.37-1.25 (2H, m, CH); δc (125 MHz, CDCl3) 175.3 (C=O), 
82.7, 81.2, 57.1, 52.0, 28.1, 24.8, 23.7, 20.0;  vmax (film) 3143, 2940, 2860, 2838, 
1721, 1464, 1448, 1308, 1196, 1099, 1077, 973, 939 cm-1; HRMS (ESI-) m/z calcd for 
(C9H16O4-H)
-, 187.0970; found 187.0972. 
 
  
  Experimental 
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9.5.16 (2S,3aS,7aR)-methyl 2-phenylhexahydrobenzo[d] [1,3] 
dioxole-3a-carboxylate  
and  





387 (30 mg, 0.27 mmol) dissolved in toluene (15 mL). Benzaldehyde (0.03 mL, 0.34 
mmol, 2 equiv) and para-toluenesulfonic acid (4 mg, 0.02 mmol, 10 mol%) was 
added. The resulting solution was refluxed for 24 h and monitored by TLC. The 
resulting cooled solution was quenched with NaHCO3 (15 mL) and extracted with 
EtOAC (3 × 10 mL). Combined organic layers were dried over MgSO4. The resulting 
oil was purified via flash column chromatography (5-10% EtOAc-petrol) to yield both 
diastereoisomers 408 (10 mg, 24%) 408 + 409 (17 mg, 40%), 409 (15 mg, 35%). 
Overall 99% yield. 
 
408: Rf = 0.53 (10% EtOAc-petrol); *α+D
25 -1.6 (c 0.08, CHCl3); δH (300 MHz, CDCl3) 
7.49-7.45 (2H, d, J = 7.6 Hz, Ar-H), 7.39-7.32 (3H, m, Ar-H), 6.21 (1H, s, CH(O)(O)), 
4.53 (1H, t, J = 5.5 Hz, CH(O)), 3.70 (3H, s, OCH3), 2.03-1.89 (4H, m, CH), 1.75 – 1.39 
(4H, m, CH); δc (75 MHz, CDCl3) 173.0 (C=O), 138.9, 129.0, 128.3, 126.4 (Ar-C), 102.8 
(CH(O)(O)(Ar)), 81.9 (C(O)(C=O)), 75.9 (C(O)H), 52.3 (OCH3), 30.6, 26.1, 20.8, 20.4; 
vmax (film) 2938, 2863, 1735, 1451, 1247, 1162, 1093, 698 cm
-1; HRMS (ESI+) m/z 
calcd for (C15H18O4+H)
+, 263.1283; found 263.1268. 
 
409: Rf = 0.49 (10% EtOAc-petrol); *α+D
25 -31 (c 0.7, CHCl3); δH (300 MHz, CDCl3) 7.56 
– 7.52 (2H, m, Ar-H), 7.40 – 7.37 (3H, m, Ar-H), 5.97 (1H, s, CH(O)(O)), 4.41 (1H, t, J = 
4.0 Hz, CH(O)), 3.82 (3H, s, OCH3), 2.13 – 1.81 (4H, m, CH), 1.76 – 1.45 (4H, m, CH); 
δc (75 MHz, CDCl3) 173.4 (C=O), 137.2, 129.3, 128.3, 126.6 (Ar-C), 103.2 
(CH(O)(O)(Ar)), 81.4 (C(O)(C=O)), 77.3 (C(O)H), 52.5 (OCH3), 31.1, 26.1, 19.4, 18.5; 
vmax (film) 2951, 2869, 1734, 1451, 1247, 1163, 1088, 1024, 697 cm
-1; HRMS (ESI+) 
m/z calcd for (C15H18O4+H)
+, 263.1283; found 263.1267. 
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A stirred solution of 390 (25 mg, 0.12 mmol) in CH2Cl2 (10 mL) was added Dess 
Martin Periodinane (131 mg, 0.31 mmol, 2.5 equiv). The resulting solution was 
heated to reflux for 24 h. To the cooled solution was added NaHCO3(aq) (20 mL). The 
biphasic system was extracted with EtOAc (4 × 10 mL) and the organic layers 
combined and washed with saturated brine, dried over MgSO4 and concentrated 
under reduced pressure. The resulting oil was purified via flash column 
chromatography (0-20% EtOAc-petrol) to yield 422 a colourless oil  (15 mg, 60%). 
 
Rf = 0.25 (10% EtOAc-petrol); *α+D
25 -50.0 (c 2.2, CHCl3); δH (500 MHz, CDCl3) 2.81 
(1H, ddd, J = 13.9, 10.9, 5.5 Hz), 2.63 (1H, ddd, J = 13.9, 10.9, 5.5 Hz), 2.32-2.17 (2H, 
m), 2.08 – 1.97 (2H, m), 1.86 –1.73 (2H, m), 1.62 (3H, s, CH3), 1.57 (3H, s, CH3); δc 
(125 MHz, CDCl3) 203.1 (C=O), 169.3 (C=O), 111.4 (C(CH3)2), 85.2, 39.5, 38.7, 28.4, 
27.5, 26.5, 21.0; vmax (film) 2996, 2941, 2921, 2872, 2851, 1784, 1732, 1394, 1380, 
1283, 1254, 1130, 1077, 1045, 930 cm-1; HRMS (ESI+) m/z calcd for (C10H14O4+Na)
+, 
221.0789; found 221.0787.  
  
  Experimental 
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9.6.2 (1S,6R)-benzyl 1,6-bis((tert-butyldimethylsilyl)oxy) 
cyclohexa-2,4-dienecarboxylate 
and 





To a stirred solution of 394 (170 mg, 0.69 mmol) dissolved in CH2Cl2 (10 mL) was 
added triethylamine (0.07 mL, 0.47 mmol, 1.1 equiv) and tert-Butyldimethylsilyl 
trifluoromethanesulfonate (0.17 mL, 0.76 mmol, 1.1 equiv). The solution was stirred 
at room temperature for 4 h. The resulting solution was diluted with EtOAc (10 mL) 
followed by the addition of water (20 mL). The biphasic system was extracted with 
EtOAc (4 × 10 mL) and the organic layers combined and washed with saturated 
brine, dried over MgSO4 and concentrated under reduced pressure. The resulting oil 
was purified via flash column chromatography (1-10% EtOAc-petrol) to yield a 
colourless oil 423 (68 mg, 21%), 424 (195 mg, 78%). 
 
423: Rf = 0.80 (10% EtOAc-petrol); *α+D
25 +41.4 (c 2.1, CHCl3); δH (300 MHz, CDCl3) 
7.38 – 7.32 (5H, m, Ar-H), 6.02 (1H, ddd, J = 9.5, 4.5, 1.0 Hz), 5.88 – 5.82 ( 1H, m, 
C=CH), 5.79-5.75 (2H, m, C=CH), 5.22 (1H, d,  JAB = 12.0 Hz), 5.13 (1H, d,  JAB = 12.0 
Hz), 5.08 (1H, m), 0.88 (9H, s, CH3), 0.82 (9H, s, CH3), 0.08 (9H, s, CH3), 0.01 (9H, s, 
CH3), -0.01 (3H, s, CH3), -0.02 (3H, s, CH3); δc (75 MHz, CDCl3) 174.3 (C=O), 135.5 (Ar-
C), 135.2 (C=C), 128.6, 128.5, 128.3 (Ar-C), 127.0, 125.9, 121.6 (C=C), 77.7 (COSi), 
73.8 (CH(OSi)),  67.3 (CH2), 25.7, 25.7 (SiC(CH3)3), 18.7, 17.9 (SiC(CH3)3), -3.0, -3.1, -
4.4, -4.9 (SiCH3); vmax (film) 2954, 2929, 2893, 2856, 1752, 1462, 1361, 1250, 1138, 
1058, 905, 836, 777, 696 cm-1; HRMS (ESI+) m/z calcd for (C26H42O4Si2+Na)
+, 
497.2515; found 497.2580.  
 
424: Rf = 0.45 (10% EtOAc-petrol); *α+D
25 -84.6 (c 6.3, CHCl3); δH (300 MHz, CDCl3) 
7.39 – 7.32 (5H, m, Ar-H), 6.12 (1H, dd, J = 9.5, 5.5 Hz), 5.92 (1H, dddd, J = 9.8, 5.5, 
  Experimental 
 
Page | 184  
 
2.5, 1.0 Hz), 5.80 (1H, dd, J = 9.5, 1.0 Hz), 5.69 (1H, dt, J = 9.8, 1.0 Hz), 5.28 (1H, d, 
J = 12.0 Hz, HAB), 5.15 (1H, d, J = 12.0 Hz, HAB), 5.00 (1H, t, J = 2.5 Hz), 0.88 (9H, s, 
CH3), 0.09 (3H, s, CH3), -0.01 (3H, s, CH3); δc (75 MHz, CDCl3) 174.5 (C=O), 135.1 
(Ar-C), 131.7 (C=C), 128.6, 128.4, 128.3 (Ar-C), 126.5, 124.7, 122.5 (C=C), 74.5 (COH), 
72.5 (CH(OSi)), 67.6 (CH2), 25.6 (SiC(CH3)3), 17.8 (SiC(CH3)3), -4.4, -5.3 (SiCH3); vmax 
(film) 3546, 3050, 2954, 2929, 2886, 1737, 1498, 1408, 1250, 1106, 1044, 1026, 939, 
886, 777 cm-1; HRMS (ESI+) m/z calcd for (C20H28O4Si+Na)




  Experimental 
 






A stirred solution of 424 (177 mg, 0.49 mmol) and Pd/C (20 mg, 10 wt.% loading, 
matrix activated carbon support) in MeOH (20 mL) was exposed to a hydrogen 
atmosphere. After 24 h the solution was filtered through a plug of celite and 
concentrated under reduced pressure. The resulting oil was pure 425 (136 mg, 99%) 
as a colourless oil.  
 
Rf = 0.20 (50 % EtOAc-petrol); *α+D
25 -19.5 (c 4.5, CHCl3); δH (300 MHz, CDCl3) 4.05 
(1H, dd, J = 11.0, 4.5 Hz), 1.91 (1H, dq, J = 14.0, 3.0 Hz), 1.78-1.67 (3H, m), 1.58-1.45 
(3H, m), 1.37-1.21 (3H, m), 0.84 (9H, s, SiC(CH3)3), 0.06 (3H, s, SiCH3), 0.02 (3H, s, 
SiCH3); δc (75 MHz, CDCl3) 179.4 (C=O), 77.8 (C(OH)), 73.9 (CH(OSi)), 32.8, 30.3 (CH), 
25.6 (SiC(CH3)3), 23.6, 19.5 (CH2), 17.8 (SiC(CH3)3), -4.3, -5.2 (SiCH3); vmax (film) 3546, 
2957, 2930, 2887, 2857, 1735, 1498, 1472, 1462, 1251, 1099, 1045, 896, 835, 777, 
695 cm-1; HRMS (ESI+) m/z calcd for (C13H26O4Si+Na)
+, 297.1492; found 297.1519.  
  
  Experimental 
 
Page | 186  
 
9.6.5 (1S,6R)-methyl 1,6-bis((tert-butyldimethylsilyl)oxy) 
cyclohexa-2,4-dienecarboxylate 
and 




To a stirred solution of 121 (639 mg, 3.7 mmol) dissolved in CH2Cl2 (20 mL) was 
added triethylamine (0.71 mL, 5.8 mmol, 1.4 equiv) and tert-Butyldimethylsilyl 
trifluoromethanesulfonate (0.86 mL, 3.7 mmol, 1 equiv). The solution was stirred at 
room temperature for 4 h. The resulting solution was diluted with EtOAc (10 mL) 
followed by the addition of water (20 mL). The biphasic system was extracted with 
EtOAc (4 × 10 mL) and the organic layers combined and washed with saturated 
brine, dried over MgSO4 and concentrated under reduced pressure. The resulting oil 
was purified via flash column chromatography (10-20% EtOAc-petrol) to yield a 
colourless oil 432 (40 mg, 3%), 431 (1.00 g, 95%). 
432: Rf = 0.85 (20 % EtOAc-petrol); *α+D
25 +54 (c 1.62, CHCl3); δH (250 MHz, CDCl3) 
6.03 (1H, ddd, J = 9.5, 4.5, 1.0 Hz), 5.74 – 5.89 (3H, m), 5.01 (1H, t, J = 1.0 Hz), 3.75 
(3H, s), 0.88 (9H, s), 0.85 (9H, s), 0.08 (3H, s), 0.06 (3H, s), 0.01 (3H, s), 0.00 (3H, s); 
δc (75 MHz, CDCl3) 175.1 (C=O), 135.2, 127.1, 125.8, 121.6 (C=C), 77.6 (COSi), 73.9 
(CH(OSi)), 52.1 (OCH3), 25.7, 25.6, 18.7, 17.9, -3.10, -3.15, -4.39, -5.05 (SiCH3); vmax 
(film) 2953, 2929, 2890, 2850, 1756, 1472, 1389, 1250, 1134, 1060, 1039, 809, 834, 
775 cm-1; HRMS (ESI+) m/z calcd for (C20H38O4Si2+Na)
+, 421.2201; found 421.2265.  
431: Rf = 0.50 (20 % EtOAc-petrol); *α+D
25 -46 (c 1.3, CHCl3); δH (250 MHz, CDCl3) 6.14 
(1H, dd, J = 9.5, 5.0 Hz), 5.93 (1H, dddd, J = 6.0, 5.0, 4.0, 2.5 Hz), 5.81 (1H, dd, J = 9.5, 
1.0 Hz), 5.69 (1H, dquint, J = 9.5, 1.0 Hz), 4.97 (1H, quint, J = 2.0 Hz), 3.81 (3H, s), 
3.41 (1H, s), 0.90 (9H, s), 0.12 (3H, s), 0.03 (3H, s); δc (75 MHz, CDCl3) 175.3 (C=O), 
131.9, 126.4, 124.8, 122.6 (C=C), 74.6 (COH), 72.7 (CH(OSi)), 52.9 (OCH3), 25.6 
(SiC(CH3)3), 17.9(SiC(CH3)3), -4.4, -5.2 (SiCH3); vmax (film) 3516, 2959, 2929, 2863, 
1736, 1494, 1453, 1252, 1111, 889, 777, 698 cm-1; HRMS (ESI+) m/z calcd for 
(C14H24O4Si+Na)
+, 307.1337; found 307.1389.  
  Experimental 
 







A stirred solution of 431 (1.00 g, 3.5 mmol) and Pd/C (50 mg, 10 wt.% loading, 
matrix activated carbon support) in MeOH (50 mL) was exposed to a hydrogen 
atmosphere at room temperature. After 24 h the solution was filtered through a 
plug of celite and concentrated under reduced pressure. The resulting oil was 
purified via flash column chromatography (10-50% EtOAc-petrol) to yield a 
colourless oil 433 (375 mg, 42%), 387 (360 mg, 58%). 
 
433: Rf = 0.60 (20% EtOAc-petrol); *α+D
25 -7.0 (c 1.3, CHCl3); δH (250 MHz, CDCl3) 3.94 
(1H, dd, J = 10.5, 5.0 Hz), 3.72 (3H, s), 3.05 (1H, d, J = 1.5 Hz), 1.91 – 1.14 (8H, m), 
0.83 (9H, s) 0.04 (3H, s), -0.03 (3H, s); δc (75 MHz, CDCl3) 176.1 (C=O), 77.5 (C(OH)), 
73.8 (CH(OSi)), 33.1, 30.1 (CH), 25.6 (SiC(CH3)3), 23.8, 19.6 (CH), 17.8 (SiC(CH3)3),  
-4.1, -5.2 (SiCH3); vmax (film) 3555, 3027, 2928, 1705, 1494, 1453, 1281, 908, 732, 
699 cm-1; HRMS (ESI+) m/z calcd for (C14H28O4Si+H)
+, 289.1835; found 289.1831.  
  
  Experimental 
 









To a stirred solution of 433 (375 mg, 1.3 mmol) in THF at -78 °C was added dropwise 
LiAlH4 (0.54 mL, 2.4 M solution, 1.3 mmol, 1 equiv) over 20 mins. The resulting 
solution was left to warm to room temperature for 12 h. Solution was quenched 
with addition of H2O (0.05 mL) followed by NaOH (10% aq. sol. 0.09 mL) followed by 
H2O (0.14 mL). The solution was filtered through MgSO4 and concentrated under 
reduced pressure. The resulting oil was purified via flash column chromatography 
(5-20% EtOAc-petrol) to yield a colourless oil 434 (19 mg, 5%), 430 (45 mg, 13%).   
 
To a stirred solution of 433 (465 mg, 1.6 mmol) in THF at -78 °C was added dropwise 
LiBH4 (0.8 mL, 4.0 M solution, 3.22 mmol, 2 equiv) over 20 mins. The resulting 
solution was left to warm to room temperature for 12 h. Solution was quenched 
with addition of Et2O (10 mL) followed by H2O (10 mL).  The mixture was separated, 
and the aqueous layer extracted with EtOAc (4 × 10 mL), the organic layers were 
combined and dried with MgSO4 and concentrated under reduced pressure. The 
resulting oil was purified via flash column chromatography (5-20% EtOAc-petrol) to 
yield a 430 (400 mg, 91%).   
 
434: Rf = 0.55 (20 % EtOAc-petrol); *α+D
25 +10 (c 0.5, CHCl3); δH (500 MHz, CDCl3) 
3.66 (1H, d, J = 10.0, Hz), 3.64 (1H, dd, J = 10.0, 4.5 Hz), 3.52 (1H, d, J = 10.0 Hz), 
1.73-1.63 (3H, m), 1.60-1.50 (2H, m), 1.45-1.39 (1H, m), 1.22-1.08 (2H, m), 0.90 (9H, 
s), 0.09 (3H, s), 0.08 (3H, s); δc (125 MHz, CDCl3) 73.7, 71.9, 71.8, 31.8, 29.5, 25.8 
(SiC(CH3)3), 23.5, 20.3, 18.1  (SiC(CH3)3), -5.5, -5.6 (SiCH3); vmax (film) 3555, 3027, 
2929, 1494, 1453, 1218, 908, 732, 699 cm-1; HRMS (ESI+) m/z calcd for 
(C13H28O3Si+H)
+, 261.1886; found 261.1858.  
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430: Rf = 0.45 (20 % EtOAc-petrol); *α+D
25 -18 (c 0.5, CHCl3); δH (500 MHz, CDCl3) 3.65 
(1H, br s), 3.56 (1H, d, J = 10.0 Hz), 3.37 (1H, d, J = 10.0 Hz), 2.51 (2H, br s, OH), 1.82 
(1H, d, J = 13.0 Hz), 1.63 (3H, m), 1.52 (1H, m), 1.40 (1H, m), 1.29 (1H, m), 1.19-1.14 
(1H, m); δc (125 MHz, CDCl3) 73.2, 72.9 (CH), 68.3 (OCH2), 31.7, 30.7, 25.8 
(SiC(CH3)3), 23.1, 20.7, 17.9 (SiC(CH3)3), -4.0, -4.9 (SiCH3); vmax (film) 3443, 2930, 
2857, 1463, 1389, 1261, 1252, 1079, 835, 777 cm-1; HRMS (ESI+) m/z calcd for 
(C13H28O3Si+H)
+, 261.1886; found 261.1886.  
 
  
  Experimental 
 






To a stirred solution of 430 (1.81 g, 6.59 mmol) dissolved in acetone (10 mL, freshly 
distilled), was added 2,2-Dimethoxypropane (12 mL, 100 mmol) and para-
toluenesulfonic acid (13 mg, 0.06 mmol, 10 mol %). The solution was stirred at room 
temperature for 20 h. The resulting solution was diluted with EtOAc (10 mL) 
followed by the addition of water (20 mL). The biphasic system was extracted with 
EtOAc (4 × 10 mL) and the organic layers combined and washed with saturated 
brine, dried over MgSO4 and concentrated under reduced pressure. The resulting oil 
was purified via flash column chromatography (10-20% EtOAc-petrol) to yield 435 a 
colourless oil (1.72 g, 86%). 
 
Rf = 0.80 (10% EtOAc-petrol); *α+D
25 -20 (c 0.3, CHCl3); δH (300 MHz, CDCl3) 3.88 (1H, 
d, J = 8.0 Hz), 3.70 (1H, d J = 8.0 Hz), 3.53 (1H, dd, J = 7.0, 3.0 Hz), 1.95-1.86 (1H, m), 
1.75-1.56 (3H, m), 1.51-1.18 (4H, m) 1.39 (6H, s, CH3), 0.90 (9H, s), 0.07 (3H, s), 0.05 
(3H, s); δc (75 MHz, CDCl3) 109.2, 83.4, 72.8, 70.8, 34.0, 32.3, 27.8, 26.9, 25.9, 22.6, 
21.6, 18.2, -4.5, -4.6; vmax (film) 2988, 2933, 2894, 2856, 1472, 1462, 1377, 1368, 
1251, 1212, 1141, 1094, 1056, 988, 898, 773 cm-1; HRMS (ESI+) m/z calcd for 
(C16H32O3Si+Na)
+, 323.2018; found 323.2015. 
  
  Experimental 
 






To a stirred solution of 435 (1.72 g, 5.72 mmol) in THF (50 mL) at -78 °C, was added 
dropwise Tetrabutylammonium fluoride hydrate (1M solution in THF, 5.72  mL, 2 
equiv) over 5 mins. The resulting solution was allowed to warm to room 
temperature over 16 h. The resulting solution was quenched with Et2O (10 mL) and 
NH3Cl(aq) (10 mL). The organic layer was extracted with EtOAc (4 × 10 mL) and the 
organic layers combined and washed with saturated brine, dried over MgSO4 and 
concentrated under reduced pressure. The resulting oil was purified via flash 
column chromatography (5% EtOAc-petrol) to yield 436 a colourless oil (591 mg, 
55%). 
 
Rf = 0.30 (20% EtOAc-petrol); *α+D
25 -4.0 (c 0.9, CHCl3); δH (250 MHz, CDCl3) 3.99 (1H, 
d, J = 8.5 Hz), 3.71 (1H, d,  J = 8.5 Hz), 3.49 (1H, m), 2.11 (1H, br s, OH), 1.99 – 1.23 
(8H, m), 1.40 (3H, s), 1.39 (3H, s); δc (100 MHz, CDCl3) 109.4, 83.2, 71.5, 71.3, 33.7, 
33.2, 29.7, 27.2, 27.1, 22.6; vmax (film) 3204, 2930, 2855, 1563, 1406, 1371, 1184, 
903, 729 cm-1; HRMS (ESI+) m/z calcd for (C10H18O3+Na)
+, 209.1149; found 
209.1104. 
  
  Experimental 
 






Oxalyl chloride (0.10 mL, 1.18 mmol, 2 equiv) followed by Dimethyl sulfoxide (0.08 
mL, 1.18 mmol, 2 equiv) was added to a flask containing CH2Cl2 (2 mL) and stirred at 
-78 °C for 15 mins. Alcohol 436 (110 mg, 0.59 mmol) dissolved in CH2Cl2 (5 mL) was 
added dropwise to the cooled solution and left to stir at -78 °C for 1 h. 
Triethylamine (0.5 mL, 3.54 mmol, 6 equiv) was added dropwise at -78 °C  and left 
to stir for 20 mins, before allowing to slowly warm to room temperature. The 
reaction was quenched with the addition of water (20 mL) and EtOAc (20 mL). The 
aqueous layer was extracted with EtOAc (4 x 10 mL) and the organic layers 
combined and washed with saturated brine, dried over MgSO4 and concentrated 
under reduced pressure. The resulting oil was purified via flash column 
chromatography (5% EtOAc-petrol) to yield 429 a colourless oil (32 mg, 30%). 
Or 
To alcohol 436 (591 mg, 3.17 mmol) dissolved in CH2Cl2 (50 mL) was added Dess–
Martin periodinane (2.69 g, 6.3 mmol, 2 equiv) the solution and left to stir at room 
temperature for 72 h. The reaction was quenched with the addition of water (20 
mL) and EtOAc (50 mL). The aqueous layer was extracted with EtOAc (5 x 10 mL) 
and the organic layers combined and washed with saturated brine, dried over 
MgSO4 and concentrated under reduced pressure. The resulting oil was purified via 
flash column chromatography (10% EtOAc-petrol) to yield 429 a colourless oil (517 
mg, 86%). 
 
Rf = 0.50 (20% EtOAc-petrol); *α+D
25 -6.0 (c 1.6, CHCl3); δH (400 MHz, CDCl3) 4.42 (1H, 
d, J = 8.5), 3.65 (1H, d,  J = 8.5 Hz), 2.78 (1H, ddd, J = 15.0, 9.0, 5.0 Hz), 2.34 – 2.27 
(1H, m), 2.04 – 1.86 (3H, m), 1.80 – 1.59 (3H, m), 1.40 (3H, s), 1.33 (3H, s); δc (100 
MHz, CDCl3) 209.1, 110.5, 85.6, 69.1, 39.7, 28.5, 27.4, 26.9, 26.1, 22.3; vmax (film) 
2986, 2937, 2865, 1723, 1452, 1431, 1380, 1371, 1050, 858, 811 cm-1; HRMS (ESI+) 
m/z calcd for (C10H16O3+Na)
+, 207.0997; found 207.0995.  
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9.7 Chapter 6 Experimental. 
9.7.1 General Method for epoxidation of styrene. 
Any variations from this general procedure, reaction optimisation etc, are detailed 
in Chapter 6.  
Styrene (0.1 mL, 0.87 mmol, 1 equiv) in CH3CN (0.8 mL) was added N,N-
Dimethylpyridin-4-amine (18 mg, 0.16 mmol, 20 mol%), H2O2 (1.0 mL, 35 wt%, 12 
equiv), N,N′-Diisopropylcarbodiimide (219 mg, 1.74 mmol, 2 equiv) and acid catalyst 
(0.1 equiv). The resulting solution was stirred at r.t, for 20 h.  At this point the 
reaction was quench with the addition of Na2S2O3 (10 mL) and extracted with EtOAc 
(3 × 20 mL). The combined organic layers were dried over MgSO4 and concentrated 
under reduced pressue. The crude mixture was analysed via NMR spectroscopy to 
obtain conversion to styrene oxide, and chiral HPLC to calculate any 
enantioselectivity.  
Chiral HPLC methods were developed for styrene oxide: Method 1: Chiralpak AS. 0.2 
mlmin-1. 0.6% IPA/Hexane, 254nm. t1 = 30 mins and t2 = 35 mins. Method 2: 
Chiralpak AS. 0.8 mlmin-1. 0.2% IPA/Hexane, 254nm. t1 = 9.9 mins and t2 = 12.4 
mins.  
9.7.2 Sulfide oxidation to test for prescence of peracid 
 
Experiment 1: Benzoic acid (94 mg, 0.78 mmol, 1 equiv), DIC (0.24 mL, 1.54 mmol, 2 
equiv), DMAP (19 mg, 0.16 mmol, 10 mol%) H2O2 (35 wt%, 0.79 mL, 12 equiv), 
thioanisole (484 mg, 3.9mmol, 5 equiv) MeCN (0.8 mL). Stirred r.t., 15 mins. 
Workup, add ice (5 mL), add NaHCO3(aq) extract CHCl3 (3 × 10 mL), dry MgSO4 
concentrate under reduced pressure.  
Experiment 2: Chiral acid 384 (68 mg, 0.34 mmol, 1 equiv), DIC (0.1 mL, 0.68 mmol, 
2 equiv), DMAP (8 mg, 0.06 mmol, 10 mol%) H2O2 (35 wt%, 0.35 mL, 12 equiv), 
thioanisole (217 mg, 1.75mmol, 5 equiv) MeCN (0.35 mL). Stirred r.t., 60mins. 
Standard workup.   
Experiment 3: DIC (0.1 mL, 0.68 mmol, 2 equiv), DMAP (8 mg, 0.06 mmol, 10 mol%) 
H2O2 (35 wt%, 0.35 mL, 12 equiv), thioanisole (217 mg, 1.75mmol, 5 equiv) MeCN 
(0.35 mL). Stirred r.t., 60mins. Standard workup.  
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Experiment 4: Benzoic acid (94 mg, 0.78 mmol, 1 equiv), DIC (0.24 mL, 1.54 mmol, 2 
equiv), DMAP (19 mg, 0.16 mmol, 10 mol%) H2O2 (35 wt%, 0.79 mL, 12 equiv), 
thioanisole (484mg, 3.9mmol, 5 equiv) MeCN (0.8 mL). Stirred r.t., 15mins. Standard 
workup. 
 




Epoxidation of trans-stilbene with chiral ketone 422. trans-stilbene (90 mg, 0.5 
mmol), ketone 422 (14 mg, 10 mol%), and tetrabutylammonium hydrogen sulfate 
(0.01 g, 0.03 mmol) in MeCN-DMM (v/v, 1/2) (9 mL) was added buffer (0.05 M aq 
Na2HPO4-0.05 M aq KH2PO4, pH 7.0) (3 mL) with stirring. Upon cooling to 0 °C, a 
solution of Oxone (0.212 M in 4 × 10-4 M aq EDTA, 4.8 mL) and a solution of K2CO3 
(0.42 M in 4 × 10-4 M aq EDTA, 4.8 mL) were added dropwise over 1 h. The reaction 
was quenched by addition of pentane and extracted with pentane. The combined 






Method A: trans-stilbene (180 mg, 1.0 mmol), cyclohexanone (0.03 mL, 30 mol%), 
and tetrabutylammonium hydrogen sulfate (0.01 g, 0.04 mmol) in MeCN-DMM (v/v, 
1:2) (15 mL) was added buffer (10 mL, 0.05 M aq Na2B4O7·10H2O in 4 × 10
-4 M aq 
Na2(EDTA)). The mixture was cooled to 0 °C in an ice bath. A solution of Oxone (1.0 
g, 1.6 mmol in 6.5 mL 4 × 10-4 M aq Na2(EDTA)), and a solution of K2CO3 (0.93 g, 6.74 
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mmol H2O 6.5 mL), were added dropwise separately and simultaneously via syringe 
pump over 2 h. The reaction was quenched by addition of pentane and extracted 
with pentane (4 × 10 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated under reduced pressure.  
Method B: To a solution of trans-stilbene (180 mg, 1.0 mmol) and cyclohexanone 
(0.03 mL, 30 mol%) in MeCN-DMM (v/v, 1:2) (6 mL) was added buffer solution (1.5 
mL, 2.0 M K2CO3 in 4 × 10
-4 M aq Na2(EDTA)). Followed by H2O2 (30%, 0.25 mL, 3 
mmol) at 0 °C.  The reaction was left to room temperature over 48 h.  Reaction was 
quenched and extracted as per Method A.  
Method C: To a solution of trans-stilbene (180 mg, 1.0 mmol), cyclohexanone (0.03 
mL, 30 mol%), MeCN (0.2 mL, 3.8 mmol), n-BuOH (3.0 mL) was added buffer 
solution (3.5 mL, 0.3 M K2CO3 in 4 × 10
-4 M aq Na2(EDTA)). Followed by H2O2 (35%, 
0.25 mL, 3 mmol) at 0 °C and left to warm to room temperature over 24 h. Reaction 
was quenched and extracted as per Method A.  
Method D: To a solution of trans-stilbene (180 mg, 1.0 mmol) and cyclohexanone 
(0.03 mL, 30 mol%) in MeCN-EtOH-CH2Cl2 (v/v, 1:1:2) (2.0 mL) was added buffer 
solution (1.5 mL, 2.0 M K2CO3 in 4 × 10
-4 M aq Na2(EDTA)). Followed by H2O2 (30%, 
0.25 mL, 3 mmol) at 0 °C for 24h.  Reaction was quenched and extracted as per 
Method A.    
Method E: To a solution of trans-stilbene (180 mg, 1.0 mmol) and catalyst (15 
mol%) in MeCN-EtOH-CH2Cl2 (v/v, 1:1:2) (2.0 mL) was added buffer solution (1.5 mL, 
2.0 M K2CO3 in 4 × 10
-4 M aq Na2(EDTA)). Followed by H2O2 (30%, 0.25 mL, 3 mmol) 
at 0 °C for 24h.  Reaction was quenched and extracted as Method A.  
Method F: To a solution of trans-stilbene (180 mg, 1.0 mmol) and catalyst (1 equiv) 
in MeCN-EtOH-CH2Cl2 (v/v, 1:1:2) (2.0 mL) was added buffer solution (1.5 mL, 2.0 M 
K2CO3 in 4 × 10
-4 M aq Na2(EDTA)). Followed by H2O2 (30%, 0.25 mL, 3 mmol) at 0 °C 
for 72 h.  Reaction was quenched and extracted as Method A.
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Table s1.  Crystal data and structure refinement for 55. 
  
  
      Identification code               h11sel3 
  
      Empirical formula                 C11 H15 N O7 
  
      Formula weight                    273.24 
  
      Temperature                       150(2) K 
  
      Wavelength                        0.71073 Å 
  
      Crystal system, space group       Orthorhombic,  P21 21 21 
  
      Unit cell dimensions              a = 5.88820(10) A   alpha = 
90 deg. 
                                        b = 14.2027(3) A    beta = 
90 deg. 
                                        c = 14.2431(2) A   gamma = 
90 deg. 
  
      Volume                            1191.13(4) A^3 
  
      Z, Calculated density             4,  1.524 Mg/m^3 
  
      Absorption coefficient            0.129 mm^-1 
  
      F(000)                            576 
  
      Crystal size                      0.60 x 0.50 x 0.50 mm 
  
      Theta range for data collection   3.75 to 30.07 deg. 
  
      Limiting indices                  -8<=h<=8, -20<=k<=20, -
20<=l<=20 
  
      Reflections collected / unique    25859 / 3476 [R(int) = 
0.0511] 
  
      Completeness to theta = 30.07     99.3 % 
  
      Absorption correction             Semi-empirical from 
equivalents 
  
      Max. and min. transmission        0.9385 and 0.9268 
  
      Refinement method                 Full-matrix least-squares on 
F^2 
  
      Data / restraints / parameters    3476 / 0 / 182 
  
      Goodness-of-fit on F^2            1.033 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0347, wR2 = 0.0801 
  
      R indices (all data)              R1 = 0.0454, wR2 = 0.0857 
  
      Absolute structure parameter      -0.1(7) 
  
      Largest diff. peak and hole       0.219 and -0.213 e.A^-3 
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          Table 2.  Atomic coordinates ( x 10^4) and equivalent 
isotropic 
         displacement parameters (A^2 x 10^3) for h11sel3. 
         U(eq) is defined as one third of the trace of the 
orthogonalized 
         Uij tensor. 
  
         
________________________________________________________________ 
  
                         x             y             z           
U(eq) 
         
________________________________________________________________ 
  
          N(1)         1931(2)       5240(1)       3519(1)       
34(1) 
          O(1)         4539(2)       6665(1)       1634(1)       
33(1) 
          O(2)         7757(1)       5897(1)       2052(1)       
23(1) 
          O(3)         8245(2)       3890(1)       2293(1)       
42(1) 
          O(4)         4072(2)       4759(1)       3783(1)       
30(1) 
          O(5)         5879(2)       6169(1)       4883(1)       
28(1) 
          O(6)         2764(2)       6936(1)       4464(1)       
37(1) 
          O(7)         3396(2)       6626(1)       5977(1)       
39(1) 
          C(1)         6861(2)       6548(1)       1373(1)       
27(1) 
          C(2)         8082(3)       7479(1)       1495(1)       
38(1) 
          C(3)         7059(3)       6160(1)        384(1)       
39(1) 
          C(4)         5970(2)       5301(1)       2376(1)       
22(1) 
          C(5)         6188(2)       4312(1)       1972(1)       
32(1) 
          C(6)         6036(2)       5248(1)       3453(1)       
22(1) 
          C(7)         6067(2)       6229(1)       3872(1)       
23(1) 
          C(8)         3963(2)       6576(1)       5169(1)       
29(1) 
          C(9)         3884(2)       6739(1)       3580(1)       
27(1) 
          C(10)        2451(2)       6087(1)       2978(1)       
29(1) 
          C(11)        3784(2)       5831(1)       2090(1)       
27(1) 
         
________________________________________________________________ 
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           Table 3.  Bond lengths [A] for h11sel3. 
           
_____________________________________________________________ 
 
            N(1)-C(10)                    1.4614(18) 
            N(1)-O(4)                     1.4820(16) 
            N(1)-H(1)                     0.93(2) 
            O(1)-C(11)                    1.4217(16) 
            O(1)-C(1)                     1.4264(16) 
            O(2)-C(4)                     1.4277(14) 
            O(2)-C(1)                     1.4373(15) 
            O(3)-C(5)                     1.4268(18) 
            O(3)-H(3)                     0.88(3) 
            O(4)-C(6)                     1.4284(15) 
            O(5)-C(8)                     1.3310(16) 
            O(5)-C(7)                     1.4478(14) 
            O(6)-C(8)                     1.3304(17) 
            O(6)-C(9)                     1.4482(15) 
            O(7)-C(8)                     1.2000(17) 
            C(1)-C(2)                     1.5147(19) 
            C(1)-C(3)                     1.5174(18) 
            C(2)-H(2A)                    0.9800 
            C(2)-H(2B)                    0.9800 
            C(2)-H(2C)                    0.9800 
            C(3)-H(3A)                    0.9800 
            C(3)-H(3B)                    0.9800 
            C(3)-H(3C)                    0.9800 
            C(4)-C(5)                     1.5241(16) 
            C(4)-C(6)                     1.5353(16) 
            C(4)-C(11)                    1.5461(17) 
            C(5)-H(5A)                    0.9900 
            C(5)-H(5B)                    0.9900 
            C(6)-C(7)                     1.5161(16) 
            C(6)-H(6)                     1.0000 
            C(7)-C(9)                     1.5329(17) 
            C(7)-H(7)                     1.0000 
            C(9)-C(10)                    1.5178(18) 
            C(9)-H(9)                     1.0000 
            C(10)-C(11)                   1.5328(18) 
            C(10)-H(10)                   1.0000 
            C(11)-H(11)                   1.0000 
           
_____________________________________________________________ 
   
           Table 4.  Bond angles [deg] for h11sel3. 
           
_____________________________________________________________ 
   
            C(10)-N(1)-O(4)             109.56(9) 
            C(10)-N(1)-H(1)             107.7(12) 
            O(4)-N(1)-H(1)              101.4(13) 
            C(11)-O(1)-C(1)             108.79(10) 
            C(4)-O(2)-C(1)              109.18(9) 
            C(5)-O(3)-H(3)              111.7(15) 
            C(6)-O(4)-N(1)              112.42(8) 
            C(8)-O(5)-C(7)              110.10(10) 
            C(8)-O(6)-C(9)              109.93(10) 
            O(1)-C(1)-O(2)              104.56(10) 
            O(1)-C(1)-C(2)              108.88(11) 
            O(2)-C(1)-C(2)              108.06(11) 
            O(1)-C(1)-C(3)              110.97(11) 
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            O(2)-C(1)-C(3)              111.23(11) 
            C(2)-C(1)-C(3)              112.77(12) 
            C(1)-C(2)-H(2A)             109.5 
            C(1)-C(2)-H(2B)             109.5 
            H(2A)-C(2)-H(2B)            109.5 
            C(1)-C(2)-H(2C)             109.5 
            H(2A)-C(2)-H(2C)            109.5 
            H(2B)-C(2)-H(2C)            109.5 
            C(1)-C(3)-H(3A)             109.5 
            C(1)-C(3)-H(3B)             109.5 
            H(3A)-C(3)-H(3B)            109.5 
            C(1)-C(3)-H(3C)             109.5 
            H(3A)-C(3)-H(3C)            109.5 
            H(3B)-C(3)-H(3C)            109.5 
            O(2)-C(4)-C(5)              111.23(10) 
            O(2)-C(4)-C(6)              109.52(9) 
            C(5)-C(4)-C(6)              109.27(9) 
            O(2)-C(4)-C(11)             103.86(9) 
            C(5)-C(4)-C(11)             114.76(10) 
            C(6)-C(4)-C(11)             107.99(10) 
            O(3)-C(5)-C(4)              109.75(10) 
            O(3)-C(5)-H(5A)             109.7 
            C(4)-C(5)-H(5A)             109.7 
            O(3)-C(5)-H(5B)             109.7 
            C(4)-C(5)-H(5B)             109.7 
            H(5A)-C(5)-H(5B)            108.2 
            O(4)-C(6)-C(7)              109.06(9) 
            O(4)-C(6)-C(4)              109.40(10) 
            C(7)-C(6)-C(4)              110.37(9) 
            O(4)-C(6)-H(6)              109.3 
            C(7)-C(6)-H(6)              109.3 
            C(4)-C(6)-H(6)              109.3 
            O(5)-C(7)-C(6)              109.69(9) 
            O(5)-C(7)-C(9)              103.51(9) 
            C(6)-C(7)-C(9)              108.53(10) 
            O(5)-C(7)-H(7)              111.6 
            C(6)-C(7)-H(7)              111.6 
            C(9)-C(7)-H(7)              111.6 
            O(7)-C(8)-O(6)              123.62(13) 
            O(7)-C(8)-O(5)              123.70(13) 
            O(6)-C(8)-O(5)              112.67(11) 
            O(6)-C(9)-C(10)             110.83(11) 
            O(6)-C(9)-C(7)              103.72(9) 
            C(10)-C(9)-C(7)             109.31(10) 
            O(6)-C(9)-H(9)              110.9 
            C(10)-C(9)-H(9)             110.9 
            C(7)-C(9)-H(9)              110.9 
            N(1)-C(10)-C(9)             108.74(11) 
            N(1)-C(10)-C(11)            110.30(11) 
            C(9)-C(10)-C(11)            109.07(10) 
            N(1)-C(10)-H(10)            109.6 
            C(9)-C(10)-H(10)            109.6 
            C(11)-C(10)-H(10)           109.6 
            O(1)-C(11)-C(10)            109.83(11) 
            O(1)-C(11)-C(4)             105.38(9) 
            C(10)-C(11)-C(4)            108.88(10) 
            O(1)-C(11)-H(11)            110.9 
            C(10)-C(11)-H(11)           110.9 
            C(4)-C(11)-H(11)            110.9 
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     Table 5.  Anisotropic displacement parameters (A^2 x 10^3) for h11sel3. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  




              U11        U22        U33        U23        U13        
U12 




    N(1)     22(1)      41(1)      38(1)      -3(1)       1(1)      
-7(1) 
    O(1)     29(1)      37(1)      34(1)       8(1)       1(1)      
11(1) 
    O(2)     21(1)      24(1)      25(1)       3(1)      -1(1)       
0(1) 
    O(3)     56(1)      33(1)      37(1)      -1(1)       3(1)      
19(1) 
    O(4)     28(1)      26(1)      37(1)       3(1)       5(1)      
-4(1) 
    O(5)     27(1)      36(1)      22(1)      -5(1)       0(1)       
6(1) 
    O(6)     36(1)      44(1)      31(1)      -7(1)       1(1)      
18(1) 
    O(7)     40(1)      50(1)      28(1)      -6(1)       9(1)       
4(1) 
    C(1)     29(1)      28(1)      24(1)       3(1)      -1(1)       
5(1) 
    C(2)     47(1)      27(1)      39(1)       6(1)       6(1)      
-2(1) 
    C(3)     51(1)      44(1)      23(1)       1(1)       0(1)       
9(1) 
    C(4)     21(1)      21(1)      24(1)      -2(1)      -1(1)      
-1(1) 
    C(5)     39(1)      24(1)      32(1)      -7(1)       0(1)      
-2(1) 
    C(6)     20(1)      21(1)      24(1)       0(1)       1(1)       
0(1) 
    C(7)     22(1)      25(1)      21(1)      -3(1)       0(1)      
-2(1) 
    C(8)     28(1)      28(1)      31(1)      -4(1)       2(1)       
1(1) 
    C(9)     31(1)      25(1)      26(1)      -1(1)       1(1)       
7(1) 
    C(10)    18(1)      38(1)      30(1)      -2(1)      -3(1)       
3(1) 
    C(11)    22(1)      33(1)      25(1)      -2(1)      -4(1)       
0(1) 
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         Table 6.  Hydrogen coordinates ( x 10^4) and isotropic 
         displacement parameters (A^2 x 10^3) for h11sel3. 
  
         
________________________________________________________________ 
  
                         x             y             z           
U(eq) 
         
________________________________________________________________ 
  
          H(1)         1290(40)      4803(13)      3110(14)      
56(6) 
          H(3)         9190(50)      3774(16)      1823(17)      
70(7) 
          H(2A)        7945          7687          2149          56 
          H(2B)        7399          7951          1080          56 
          H(2C)        9690          7401          1336          56 
          H(3A)        6074          5608           319          59 
          H(3B)        8637          5978           262          59 
          H(3C)        6595          6643           -68          59 
          H(5A)        4875          3925          2171          38 
          H(5B)        6190          4343          1277          38 
          H(6)         7431          4901          3654          26 
          H(7)         7451          6587          3677          27 
          H(9)         4239          7335          3237          33 
          H(10)        1007          6411          2800          35 
          H(11)        2838          5439          1656          32 
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      Table 1.  Crystal data and structure refinement for h10sel3. 
  
  
      Identification code               h10sel3 
  
      Empirical formula                 C14 H13 Br Fe O7 
  
      Formula weight                    429.00 
  
      Temperature                       150(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       Orthorhombic,  P 21 21 21 
  
      Unit cell dimensions              a = 8.6252(3) A   alpha = 90 deg. 
                                        b = 8.6773(3) A    beta = 90 deg. 
                                        c = 43.7286(16) A   gamma = 90 deg. 
  
      Volume                            3272.8(2) A^3 
  
      Z, Calculated density             8,  1.741 Mg/m^3 
  
      Absorption coefficient            3.394 mm^-1 
  
      F(000)                            1712 
  
      Crystal size                      0.45 x 0.30 x 0.15 mm 
  
      Theta range for data collection   3.31 to 27.56 deg. 
  
      Limiting indices                  -11<=h<=11, -10<=k<=11, -56<=l<=56 
  
      Reflections collected / unique    25844 / 6937 [R(int) = 0.0663] 
  
      Completeness to theta = 27.56     95.8 % 
  
      Absorption correction             Semi-empirical from equivalents 
  
      Max. and min. transmission        0.6300 and 0.3104 
  
      Refinement method                 Full-matrix least-squares on F^2 
  
      Data / restraints / parameters    6937 / 0 / 429 
  
      Goodness-of-fit on F^2            1.063 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0437, wR2 = 0.0788 
  
      R indices (all data)              R1 = 0.0677, wR2 = 0.0860 
  
      Absolute structure parameter      0.011(9) 
  
      Largest diff. peak and hole       0.554 and -0.567 e.A^-3 
   
Appendix 
 
Page | 314  
 
         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for h10sel3. 
         U(eq) is defined as one third of the trace of the orthogonalized 
         Uij tensor. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          Fe(1)       10630(1)       3004(1)       1789(1)       29(1) 
          C(10)       11952(6)       4506(7)       1691(1)       37(1) 
          O(10)       12725(4)       5543(5)       1637(1)       55(1) 
          C(20)        9414(5)       3129(5)       1460(1)       33(1) 
          O(20)        8621(4)       3203(5)       1252(1)       48(1) 
          C(30)       11935(7)       1555(7)       1656(1)       49(1) 
          O(30)       12798(6)        659(6)       1564(1)       82(2) 
          Br(1)        9092(1)       -631(1)       1945(1)       40(1) 
          O(1)         5849(4)       4037(4)       1661(1)       45(1) 
          O(2)         7164(4)       6167(4)       1767(1)       34(1) 
          O(3)         6991(3)       4460(4)       2354(1)       26(1) 
          O(4)         7042(3)       1862(4)       2372(1)       32(1) 
          C(1)         7613(5)       2229(5)       2075(1)       25(1) 
          C(2)         9181(5)       1552(5)       2031(1)       28(1) 
          C(3)        10416(5)       2056(5)       2218(1)       27(1) 
          C(4)        10515(5)       3662(5)       2237(1)       27(1) 
          C(5)         9388(5)       4487(6)       2071(1)       26(1) 
          C(6)         7726(5)       4003(5)       2075(1)       24(1) 
          C(7)         6801(5)       4696(5)       1809(1)       27(1) 
          C(8)         6394(5)       6928(6)       1514(1)       39(1) 
          C(9)         6190(5)       3148(5)       2481(1)       29(1) 
          C(11)        6334(6)       3219(7)       2823(1)       43(1) 
          C(12)        4525(5)       3111(6)       2376(1)       40(1) 
          Fe(2)       10537(1)       8236(1)        709(1)       31(1) 
          C(40)       12113(8)       9453(7)        814(1)       49(1) 
          C(50)       10325(5)       7159(6)       1058(1)       34(1) 
          C(60)        9096(8)       9641(7)        804(1)       52(2) 
          O(40)       13210(6)      10130(5)        881(1)       80(2) 
          O(50)       10073(5)       6542(4)       1279(1)       54(1) 
          O(60)        8167(6)      10514(6)        869(1)       86(2) 
          Br(2)        6891(1)       6719(1)        544(1)       39(1) 
          O(5)        11603(4)       3692(5)        904(1)       59(1) 
          O(6)        13814(4)       4496(4)        706(1)       36(1) 
          O(7)        11983(3)       4543(4)        163(1)       27(1) 
          O(8)         9357(4)       4498(4)        165(1)       34(1) 
          C(21)        9769(5)       5174(5)        451(1)       27(1) 
          C(22)        9099(5)       6770(5)        470(1)       29(1) 
          C(23)        9665(5)       7941(5)        278(1)       29(1) 
          C(24)       11290(6)       8018(5)        265(1)       32(1) 
          C(25)       12078(6)       6912(6)        448(1)       29(1) 
          C(26)       11539(5)       5273(5)        446(1)       24(1) 
          C(27)       12292(5)       4390(5)        715(1)       25(1) 
          C(28)       14656(6)       3757(6)        952(1)       37(1) 
          C(29)       10673(5)       3691(5)         53(1)       29(1) 
          C(31)       10679(7)       3765(6)       -290(1)       47(1) 
          C(32)       10713(6)       2062(5)        174(1)       44(1) 
         ________________________________________________________________ 
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           Table 3.  Bond lengths [A] for h10sel3. 
           _____________________________________________________________ 
  
            Fe(1)-C(30)                   1.785(6) 
            Fe(1)-C(10)                   1.785(6) 
            Fe(1)-C(20)                   1.785(5) 
            Fe(1)-C(4)                    2.044(4) 
            Fe(1)-C(3)                    2.054(4) 
            Fe(1)-C(2)                    2.066(5) 
            Fe(1)-C(5)                    2.079(5) 
            C(10)-O(10)                   1.143(6) 
            C(20)-O(20)                   1.141(5) 
            C(30)-O(30)                   1.149(6) 
            Br(1)-C(2)                    1.933(4) 
            O(1)-C(7)                     1.193(5) 
            O(2)-C(7)                     1.326(5) 
            O(2)-C(8)                     1.451(5) 
            O(3)-C(6)                     1.432(5) 
            O(3)-C(9)                     1.444(5) 
            O(4)-C(9)                     1.420(5) 
            O(4)-C(1)                     1.423(5) 
            C(1)-C(2)                     1.487(6) 
            C(1)-C(6)                     1.543(6) 
            C(2)-C(3)                     1.410(6) 
            C(3)-C(4)                     1.399(6) 
            C(4)-C(5)                     1.410(6) 
            C(5)-C(6)                     1.494(6) 
            C(5)-H(5)                     0.85(4) 
            C(6)-C(7)                     1.532(6) 
            C(9)-C(11)                    1.500(6) 
            C(9)-C(12)                    1.509(6) 
            Fe(2)-C(40)                   1.782(7) 
            Fe(2)-C(60)                   1.790(6) 
            Fe(2)-C(50)                   1.799(5) 
            Fe(2)-C(23)                   2.042(4) 
            Fe(2)-C(24)                   2.057(5) 
            Fe(2)-C(22)                   2.061(4) 
            Fe(2)-C(25)                   2.096(5) 
            C(40)-O(40)                   1.151(7) 
            C(50)-O(50)                   1.125(5) 
            C(60)-O(60)                   1.139(7) 
            Br(2)-C(22)                   1.933(4) 
            O(5)-C(27)                    1.184(5) 
            O(6)-C(27)                    1.317(5) 
            O(6)-C(28)                    1.447(5) 
            O(7)-C(29)                    1.433(5) 
            O(7)-C(26)                    1.441(5) 
            O(8)-C(29)                    1.421(5) 
            O(8)-C(21)                    1.426(5) 
            C(21)-C(22)                   1.503(6) 
            C(21)-C(26)                   1.528(6) 
            C(22)-C(23)                   1.404(6) 
            C(23)-C(24)                   1.405(7) 
            C(24)-C(25)                   1.422(7) 
            C(25)-C(26)                   1.496(7) 
            C(25)-H(25)                   0.93(4) 
            C(26)-C(27)                   1.547(6) 
            C(29)-C(31)                   1.500(6) 
            C(29)-C(32)                   1.509(6) 








           Table 4.  Bond lengths [A] and angles [deg] for h10sel3. 
           _____________________________________________________________ 
  
            C(30)-Fe(1)-C(10)            91.9(2) 
            C(30)-Fe(1)-C(20)            98.7(2) 
            C(10)-Fe(1)-C(20)            97.8(2) 
            C(30)-Fe(1)-C(4)            122.7(2) 
            C(10)-Fe(1)-C(4)             93.3(2) 
            C(20)-Fe(1)-C(4)            136.7(2) 
            C(30)-Fe(1)-C(3)             94.1(2) 
            C(10)-Fe(1)-C(3)            124.7(2) 
            C(20)-Fe(1)-C(3)            135.03(19) 
            C(4)-Fe(1)-C(3)              39.93(17) 
            C(30)-Fe(1)-C(2)             96.8(2) 
            C(10)-Fe(1)-C(2)            162.8(2) 
            C(20)-Fe(1)-C(2)             95.5(2) 
            C(4)-Fe(1)-C(2)              69.49(17) 
            C(3)-Fe(1)-C(2)              40.01(17) 
            C(30)-Fe(1)-C(5)            162.6(2) 
            C(10)-Fe(1)-C(5)             91.1(2) 
            C(20)-Fe(1)-C(5)             97.92(19) 
            C(4)-Fe(1)-C(5)              39.97(17) 
            C(3)-Fe(1)-C(5)              70.20(18) 
            C(2)-Fe(1)-C(5)              76.24(18) 
            O(10)-C(10)-Fe(1)           175.0(5) 
            O(20)-C(20)-Fe(1)           179.1(4) 
            O(30)-C(30)-Fe(1)           177.6(5) 
            C(7)-O(2)-C(8)              115.8(4) 
            C(6)-O(3)-C(9)              108.9(3) 
            C(9)-O(4)-C(1)              108.1(3) 
            O(4)-C(1)-C(2)              110.1(3) 
            O(4)-C(1)-C(6)              104.3(4) 
            C(2)-C(1)-C(6)              109.7(4) 
            C(3)-C(2)-C(1)              119.4(4) 
            C(3)-C(2)-Br(1)             116.6(3) 
            C(1)-C(2)-Br(1)             112.1(3) 
            C(3)-C(2)-Fe(1)              69.5(3) 
            C(1)-C(2)-Fe(1)             112.0(3) 
            Br(1)-C(2)-Fe(1)            121.4(2) 
            C(4)-C(3)-C(2)              113.0(4) 
            C(4)-C(3)-Fe(1)              69.6(3) 
            C(2)-C(3)-Fe(1)              70.4(3) 
            C(3)-C(4)-C(5)              115.6(4) 
            C(3)-C(4)-Fe(1)              70.4(3) 
            C(5)-C(4)-Fe(1)              71.4(3) 
            C(4)-C(5)-C(6)              120.9(4) 
            C(4)-C(5)-Fe(1)              68.7(3) 
            C(6)-C(5)-Fe(1)             109.1(3) 
            O(3)-C(6)-C(5)              110.9(3) 
            O(3)-C(6)-C(7)              107.9(3) 
            C(5)-C(6)-C(7)              112.4(4) 
            O(3)-C(6)-C(1)              104.3(4) 
            C(5)-C(6)-C(1)              109.9(4) 
            C(7)-C(6)-C(1)              111.1(4) 
            O(1)-C(7)-O(2)              123.3(4) 
            O(1)-C(7)-C(6)              125.6(4) 
            O(2)-C(7)-C(6)              111.1(4) 
            O(4)-C(9)-O(3)              104.0(3) 
            O(4)-C(9)-C(11)             109.0(4) 
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            O(3)-C(9)-C(11)             108.3(4) 
            O(4)-C(9)-C(12)             111.9(4) 
            O(3)-C(9)-C(12)             110.7(4) 
            C(11)-C(9)-C(12)            112.6(4) 
            C(40)-Fe(2)-C(60)            93.8(3) 
            C(40)-Fe(2)-C(50)            99.6(2) 
            C(60)-Fe(2)-C(50)            95.0(2) 
            C(40)-Fe(2)-C(23)           126.4(2) 
            C(60)-Fe(2)-C(23)            92.5(2) 
            C(50)-Fe(2)-C(23)           132.8(2) 
            C(40)-Fe(2)-C(24)            93.3(2) 
            C(60)-Fe(2)-C(24)           120.1(2) 
            C(50)-Fe(2)-C(24)           141.8(2) 
            C(23)-Fe(2)-C(24)            40.08(18) 
            C(40)-Fe(2)-C(22)           162.9(2) 
            C(60)-Fe(2)-C(22)            96.9(2) 
            C(50)-Fe(2)-C(22)            92.8(2) 
            C(23)-Fe(2)-C(22)            40.00(18) 
            C(24)-Fe(2)-C(22)            69.78(18) 
            C(40)-Fe(2)-C(25)            88.9(2) 
            C(60)-Fe(2)-C(25)           160.1(2) 
            C(50)-Fe(2)-C(25)           104.0(2) 
            C(23)-Fe(2)-C(25)            70.30(18) 
            C(24)-Fe(2)-C(25)            40.04(18) 
            C(22)-Fe(2)-C(25)            76.53(17) 
            O(40)-C(40)-Fe(2)           174.2(6) 
            O(50)-C(50)-Fe(2)           174.2(4) 
            O(60)-C(60)-Fe(2)           178.4(6) 
            C(27)-O(6)-C(28)            116.6(4) 
            C(29)-O(7)-C(26)            107.8(3) 
            C(29)-O(8)-C(21)            107.8(3) 
            O(8)-C(21)-C(22)            109.3(4) 
            O(8)-C(21)-C(26)            105.1(4) 
            C(22)-C(21)-C(26)           109.5(4) 
            C(23)-C(22)-C(21)           120.1(4) 
            C(23)-C(22)-Br(2)           117.4(3) 
            C(21)-C(22)-Br(2)           111.5(3) 
            C(23)-C(22)-Fe(2)            69.3(3) 
            C(21)-C(22)-Fe(2)           111.4(3) 
            Br(2)-C(22)-Fe(2)           121.4(2) 
            C(22)-C(23)-C(24)           114.0(4) 
            C(22)-C(23)-Fe(2)            70.7(3) 
            C(24)-C(23)-Fe(2)            70.5(3) 
            C(23)-C(24)-C(25)           114.9(4) 
            C(23)-C(24)-Fe(2)            69.4(3) 
            C(25)-C(24)-Fe(2)            71.5(3) 
            C(24)-C(25)-C(26)           119.3(4) 
            C(24)-C(25)-Fe(2)            68.5(3) 
            C(26)-C(25)-Fe(2)           109.0(3) 
            O(7)-C(26)-C(25)            109.8(3) 
            O(7)-C(26)-C(21)            104.7(4) 
            C(25)-C(26)-C(21)           111.4(4) 
            O(7)-C(26)-C(27)            108.9(3) 
            C(25)-C(26)-C(27)           109.6(4) 
            C(21)-C(26)-C(27)           112.3(4) 
            O(5)-C(27)-O(6)             123.8(4) 
            O(5)-C(27)-C(26)            125.0(4) 
            O(6)-C(27)-C(26)            111.2(4) 
            O(8)-C(29)-O(7)             105.1(3) 
            O(8)-C(29)-C(31)            109.0(4) 
            O(7)-C(29)-C(31)            108.1(4) 
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            O(8)-C(29)-C(32)            111.0(4) 
            O(7)-C(29)-C(32)            110.4(4) 
            C(31)-C(29)-C(32)           112.9(4) 
           _____________________________________________________________ 
  
   Table 5.  Anisotropic displacement parameters (A^2 x 10^3) for h10sel3. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
    _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    Fe(1)    30(1)      36(1)      20(1)      -1(1)       1(1)       3(1) 
    C(10)    29(3)      52(3)      32(3)      -6(3)      -4(2)       2(3) 
    O(10)    37(2)      68(3)      59(3)       3(2)       3(2)     -20(2) 
    C(20)    37(3)      30(3)      32(3)      -5(2)      11(2)      -6(3) 
    O(20)    48(2)      76(3)      19(2)       0(2)      -8(2)     -13(2) 
    C(30)    58(3)      61(4)      27(3)       6(3)      15(3)      19(3) 
    O(30)   109(4)      78(3)      58(3)      13(3)      42(3)      52(3) 
    Br(1)    59(1)      28(1)      34(1)      -3(1)      -5(1)       7(1) 
    O(1)     46(2)      37(2)      53(2)       3(2)     -30(2)      -7(2) 
    O(2)     37(2)      30(2)      33(2)       9(1)     -10(2)      -9(2) 
    O(3)     24(2)      28(2)      25(2)       0(1)       3(1)      -1(2) 
    O(4)     31(2)      28(2)      35(2)       6(2)       7(2)       2(2) 
    C(1)     24(2)      26(3)      23(2)       2(2)      -2(2)      -2(2) 
    C(2)     40(3)      26(2)      18(2)      -1(2)      -2(2)       0(2) 
    C(3)     30(2)      37(3)      15(2)       2(2)       3(2)       7(2) 
    C(4)     26(2)      38(3)      18(2)      -5(2)      -3(2)      -2(2) 
    C(5)     24(2)      29(3)      24(2)      -4(2)       1(2)      -8(2) 
    C(6)     22(2)      31(3)      19(2)       1(2)      -3(2)       1(2) 
    C(7)     28(2)      29(3)      24(2)       0(2)      -1(2)      -1(2) 
    C(8)     42(3)      34(3)      40(3)      13(2)     -11(2)      -6(2) 
    C(9)     26(2)      28(3)      33(2)       1(2)       5(2)      -1(2) 
    C(11)    39(3)      56(3)      34(3)       6(3)       9(2)       2(3) 
    C(12)    28(3)      40(3)      53(3)       4(3)       2(2)      -6(3) 
    Fe(2)    48(1)      24(1)      21(1)       0(1)      -1(1)       1(1) 
    C(40)    82(4)      32(3)      32(3)       2(3)       8(3)      -9(4) 
    C(50)    40(3)      35(3)      27(3)       1(2)       1(2)       3(2) 
    C(60)    79(4)      46(4)      33(3)      -8(3)     -19(3)      11(4) 
    O(40)   101(4)      79(4)      58(3)     -20(2)       6(3)     -54(3) 
    O(50)    72(3)      53(3)      36(2)      16(2)       7(2)      -2(2) 
    O(60)   108(4)      73(3)      76(4)     -33(3)     -25(3)      54(3) 
    Br(2)    34(1)      50(1)      33(1)       4(1)       2(1)      11(1) 
    O(5)     34(2)      84(3)      59(3)      46(2)       7(2)       4(2) 
    O(6)     34(2)      39(2)      33(2)       9(2)     -10(2)      -1(2) 
    O(7)     29(2)      30(2)      22(2)      -1(1)       3(1)      -3(2) 
    O(8)     33(2)      29(2)      39(2)     -10(2)      -7(2)       0(2) 
    C(21)    33(3)      20(2)      29(3)       1(2)       2(2)       2(2) 
    C(22)    32(2)      32(2)      22(2)      -2(2)      -1(2)       3(2) 
    C(23)    37(3)      30(3)      21(2)      -1(2)      -1(2)       9(2) 
    C(24)    52(3)      20(2)      23(2)       2(2)       5(2)      -4(2) 
    C(25)    28(2)      25(3)      32(2)       2(2)       3(2)      -3(2) 
    C(26)    27(3)      23(3)      23(2)       0(2)       3(2)       0(2) 
    C(27)    28(3)      26(2)      22(2)       1(2)      -2(2)       2(2) 
    C(28)    39(3)      37(3)      34(3)       2(2)     -19(2)       0(2) 
    C(29)    30(2)      26(2)      30(3)      -3(2)      -2(2)      -2(2) 
    C(31)    57(3)      51(3)      34(3)      -6(2)     -11(3)     -11(3) 
    C(32)    44(3)      21(2)      67(4)      -3(2)       5(3)       0(2) 
    _______________________________________________________________________ 
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         Table 6.  Hydrogen coordinates ( x 10^4) and isotropic 
         displacement parameters (A^2 x 10^3) for h10sel3. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          H(1)         6883          1862          1913          30 
          H(3)        11108          1375          2319          33 
          H(4)        11291          4164          2355          33 
          H(8A)        6639          6388          1323          58 
          H(8B)        6753          7998          1500          58 
          H(8C)        5271          6914          1547          58 
          H(11A)       5835          2313          2913          65 
          H(11B)       5829          4155          2899          65 
          H(11C)       7433          3234          2880          65 
          H(12A)       4493          2989          2153          61 
          H(12B)       4012          4078          2433          61 
          H(12C)       3988          2244          2473          61 
          H(21)        9404          4523           625          33 
          H(23)        9008          8622           168          35 
          H(24)       11823          8752           142          38 
          H(28A)      14395          4257          1147          55 
          H(28B)      15772          3849           915          55 
          H(28C)      14370          2665           962          55 
          H(31A)       9735          3281          -369          71 
          H(31B)      11589          3218          -369          71 
          H(31C)      10717          4844          -355          71 
          H(32A)      10663          2080           397          66 
          H(32B)      11676          1561           109          66 
          H(32C)       9824          1487            93          66 
          H(25)       13140(50)      7050(50)       436(9)       17(10) 
          H(5)         9480(40)      5460(50)      2082(9)       13(11) 
         ________________________________________________________________ 
  
 
